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ABSTRACT
EMOTIONAL DISTRESS AS A KEY CONSTRUCT IN THE PERSONAL
MODEL OF DIABETES MANAGEMENT: ASSOCIATIONS OF FATIGUE,
DIABETES-SPECIFIC DISTRESS, AND DEPRESSIVE SYMPTOMATOLOGY
WITH QUALITY OF LIFE IN TYPE 2 DIABETES MELLITUS
Chelsea L. Rothschild
May 14,2010
The importance of maximizing self-management and quality of life is welldocumented in the diabetes literature. Although maintaining self-care is known to be
important for individuals with type 2 diabetes, this is often difficult to maintain over
time. Emotional distress has also been shown to impact self-care behaviors in adults with
type 2 diabetes. Glasgow et al (1997) introduced a model of key variables influencing
diabetes self-management. This study examined specific emotional Personal Model
constructs of diabetes management. Independent and converging lines of research have
implicated several potentially overlapping constructs that may reflect emotional distress
in persons living with diabetes including: fatigue, distress, and global depression that is
specific to the demands of diabetes. These emotional distress constructs have all been
linked to self-management behavior and quality of life in chronic disease. This study
sought to explain the associations between these emotional constructs and their impact on
self-management and quality of life. Questionnaire and medical chart review data were
collected from adults (N=151) with type 2 diabetes at an outpatient diabetes clinic.
Depressive symptomatology, diabetes-specific distress, and fatigue were found to be
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moderately associated with one another. Fatigue and diabetes specific distress were
found to be associated with diet, mental, and physical quality of life. Findings suggest
the Problem Areas In Diabetes scale (PAID) had the strongest association with diet
adherence. Depressive symptomatology, diabetes-specific distress, and fatigue have a
significant negative impact physical and mental quality of life. Future research should
include the impact of fatigue on quality of life in adults with type 2 diabetes.
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INTRODUCTION
Overview of Diabetes
Prevalence of Diabetes
Diabetes mellitus (diabetes) is a chronic disease affecting approximately 20.8
million children and adults in the United States, 5 million of whom are undiagnosed
[American Diabetes Association (ADA), 2007]. There are three major types of diabetes:
(1) type 1 diabetes, which was previously known as insulin-dependent, or childhood
onset diabetes, (2) type 2 diabetes, which was previously known as non-insulin
dependent, or adult onset diabetes and comprises 95% of diabetes cases, and (3)
gestational diabetes, which is characterized by hyperglycemia occurring during
pregnancy and a return to a normal glucose levels after delivery (Report of the Expert
Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997). Symptoms
of diabetes include excessive thirst and urination, fatigue, blurred vision, nausea,
vomiting, increased appetite, and slow healing infections (National Institute of Health,
2005). Diabetes is the main cause of kidney failure and adult onset blindness, and
individuals with diabetes are at serious risk for cardiovascular disease, stroke,
hypertension, central and peripheral neuropathy, retinopathy, foot ulcers, and amputation
(ADA,2006).
Internationally, increasing rates of type 2 diabetes have reached epidemic
proportions. The World Health Organization anticipates prevalence rates of diabetes to
double by the year 2030 (WHO, 2006). This trend is also occurring in the United States
1

(Engel au et aI, 2004). Rising rates of diabetes parallel rising obesity rates, increases in
sedentary lifestyle, and a rapidly growing population of older adults (Visscher & Seidell,
2001). Additionally, the prevalence rate of diabetes is higher among ethnic minorities
(ADA, 2003). Prevalence rates indicate diabetes-related mortality will increase by more
than 50% in the next 10 years. According to the International Classification of Diseases
(loth Version), diabetes is the sixth leading cause of death in the United States.

Economic Impact of Diabetes
From an economic perspective, the cost of diabetes is increasing alongside
prevalence rates. According to the ADA, in 2002 direct and indirect medical costs were
estimated at $132 billion annually. This is a dramatic increase from the 1997 report,
which indicated the national cost of diabetes was estimated to be $98 billion (ADA,
1998). Per capita medical expenses totaled $13,243 for an individual with diabetes
compared to $2,560 per individual without diabetes (ADA, 2006). Diabetes is often a
result of a loss in productivity, resulting in an economic loss of $40 billion annually.
These statistics only approximate the toll of diabetes as they exclude expenditures
resulting from pain and suffering and impact on individuals and their families.
Rationale for Studying Diabetes
Due to the impact of diabetes on individuals, the healthcare system, and the
economy, it is essential to identify strategies to optimize diabetes management. Diabetes
is a unique chronic illness due to the fact approximately 95% of its treatment is based on
self-management (Anderson, 1985). Diabetes is believed to be one of the most
psychologically and behaviorally taxing of the chronic medical illnesses (Cox, GonderFrederick, 1992). The key to successful diabetes management is to control blood glucose
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levels and prevent additional complications. This is accomplished primarily by the
patient adhering to an involved self-management regimen designed to stabilize blood
glucose levels and prevent or delay further diabetic complications.
Diabetes self-management
Diabetes self-management is defined in the literature as "the various tasks in
which patients must engage on a regular basis to manage their diabetes" (Glasgow &
Eakin, 1998, p. 436). The Diabetes Control and Complications Trial (DCCT) concluded
that extensive blood glucose management could prevent the onset of additional comorbidity and diabetes-related complications (DCCT and Research Group, 2003).
Managing one's blood glucose is a complex daily regimen of self-management behaviors
that include monitoring and decision making related to diet, exercise, recognizing
hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar), administering
endogenous insulin/oral medications (i.e. oral agents), managing sick days, and testing
and recording blood glucose levels (Elliott, Shewchuk, Miller & Richards, 2001). Selfmanagement regimen for diabetes was believed to be one of the main factors that
distinguish diabetes from other chronic illnesses, which may require maintaining only a
select few of these behaviors (ADA, 2006). However it has been demonstrated in the
literature that this complex regimen is difficult to maintain over time (Hiss, Anderson,
Hess, Stepien, & Davis 1994; Cramer, 2004; Harris & Eastman, 2001).

Maintenance a/the Diabetes Self-management Regimen
Maintenance of the complex self-management regimen is believed to be inversely
related to the extent of behavioral modification required to adopt a new behavior
(Meichenbaum & Turk, 1987). The more complicated or involved the regimen becomes,
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the more difficult it is to maintain over time. People may be less inclined to change their
behavior when the health behaviors are difficult to maintain, or when immediate results
are not provided (Jacobsen, de Groot, & Samson, 1995). Individuals with type 2 diabetes
often are required to make several changes to their routine, they are encouraged to
incorporate exercise into their daily lives, monitor blood glucose, adhere to a medication
regimen, and make changes to their diet. These changes are often implemented with a
distal goal of delaying disease progression, and preventing the onset of comorbid health
conditions. However, persons with diabetes mellitus frequently report difficulty adhering
to their self-management regimen. This provides a unique opportunity for health
psychologists, who have the skills to evaluate the etiology of such difficulties, such as
environmental barriers or the psychosocial factors contributing to regimen nonadherence. The section below will begin the discussion of barriers to engaging in a selfmanagement routine.

Barriers to Self-Management: The Impact of Diabetes Burden
There is a small literature available that suggests that the complex regimen
individuals with diabetes must maintain can itself be perceived as a barrier to optimal
diabetes self-management. The demands of the self-management regimen can directly
contribute to decreased quality of life, suggesting quality of life is affected by the illness
itself and the lifestyle changes that accompany diabetes (Glasgow, Ruggiero, Eakin,
Dryfoos, & Chobanian, 1997). The burden of maintaining the self-management regimen
often leads to diabetes-specific distress, and has been discussed in the literature as a risk
factor for both poor glycemic control and poor adherence to the self-management
regimen. This introduces the possibility of an affective component impacting this already
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complex relationship, due to the distress associated with making these lifestyle changes
(particularly adhering to the prescribed self-management regimen). This will be
discussed in greater detail in the section below. Understanding the associations of affect,
distress and self-management is important, it implies that this is a pathway by which
affect contributes to the impact on both physical and psychological health in diabetes.

Providing a Conceptual Framework/or Self-Management: Personal Models 0/ Diabetes
Glasgow, Hampson, Strycker, and Ruggiero (1997) proposed a model of diabetes
self-management that has been validated in the literature. This model suggests both
personal models of diabetes and barriers to self-management are stronger predictors than
a combination of demographic and other patient characteristics. Personal models of
diabetes, according to Glasgow, Hampson, Strycker, and Ruggiero (1997) are "patient's
representations of their illness, including disease-related beliefs, emotions, knowledge,
and experiences" (p.556). This study included 2,056 adults with diabetes throughout the
United States. Glasgow's model of Diabetes Self-Management (Figure 1) suggests these
personal models influence the patient's ability to engage in self-management behaviors.
The personal models were tested in this cross-sectional study using Glasgow's
conceptualization, however only three components of the model were examined: (1)
barriers, or challenges the individuals face with managing their diabetes, (2) treatment
effectiveness, and (3) seriousness. Thus, while the authors' description of the Personal
Model of diabetes self-management highlights the importance of emotion, their
influential study did not integrate this key construct (emotion) into their actual research
and figure depicting the model (i.e. Figure 1). Recent research highlights the importance
of integrating emotion into conceptualization of disease and quality of life (Polonsky,
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2000). This suggests that the omission of emotion in the studies examining living with
diabetes self-management is meaningful, highlighting the importance of emotion as a
core component of the Glasgow et al (1997) model. As will be discussed in subsequent
sections of this paper, it is postulated that emotional distress may play an important role
in diabetes by influencing not only disease management, but also quality of life.
Emotion is conceptualized in the definition of "personal model", but studies
focused on models of diabetes have repeatedly excluded analysis of emotion or
symptoms associated with negative feelings. Due to the high comorbidity of depression
and diabetes (discussed in subsequent sections of this paper), it is important that studies
addressing self-management and Quality of Life examine the role of affect, as this could
provide information to guide future interventions targeting specific symptoms of
experiencing negative affect. This dissertation sought to address the emotion construct
of the personal model of diabetes by examining specific components of depressive
symptomatology that had previously been identified in the diabetes literature. Fatigue,
diabetes-specific distress, and global depressive symptomatology were examined in the
context of a personal model of diabetes framework, which is a modification of Glasgow
et aI's (1997) model of self-management (see Figure 2). The affective components have
been individually studied in the diabetes literature, but not in tandem within Glasgow's
Personal Model self-management framework.
Diabetes-specific Emotional Distress
Due to both physical (e.g. changes to diet, exercise, blood glucose monitoring,
administering medication) and psychological (e.g., problem solving ability, mental health
status) demands of living with diabetes, researchers have documented the occurrence of
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high levels of emotional distress and negative feelings in people with diabetes. Common
emotions reported include: anger, reduced motivation, burnout, guilt, and discouragement
(Welch, Jacobsen, & Polonsky, 1997). These emotions have been documented in the
literature as diabetes-related distress and have been identified as an important risk factor
for both poor adherence to diabetes regimen and poor glycemic control (Polonsky et aI.,
1995; Gary, Crum, Cooper-Patrick, Ford, and Brachati, 2000; Sultan and HeurtierHartemann, 2001) .

Measuring Diabetes-related Distress: The Problem Areas in Diabetes Scale
Due to the importance of diabetes-related distress in people living with diabetes,
the Problem Areas In Diabetes Scale (PAID) (Polonsky, Anderson, Lohrer, Welch,
Jacobson, Aponte, & Schwartz, 1995) was created as a tool to assess the construct of
diabetes-related distress both as a clinical tool and an outcome measure (Welch, Weinger,
Anderson, & Polonsky, 2003). The PAID is a 20-item single-factor measure of diabetes
related distress developed at the Joslin Diabetes Center and Harvard Medical School.
This instrument has a 5-point item scaling, ranging from "Not a Problem"
Problem"

=4.

= 0 to "Serious

Original scoring was a summed total; higher scores were indicative of

higher levels of diabetes-specific distress. Original scoring has been simplified to a
transformed scaled score ranging from 0-100, with higher scores demonstrating greater
diabetes-specific distress. The main focus of the items surrounds feelings and moods
associated with specific aspects of diabetes. The PAID has been found to be unrelated to
age, duration of diabetes, education, ethnicity, and gender (Welch, Weinger, Anderson, &
Polonsky, 2003).
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The PAID is the most widely used instrument to assess diabetes-specific distress.
A review of seven studies evaluating the utility of the PAID indicated internal reliability
remained high (a = .90), and test-retest reliability was found to be adequate (r = .83).
This study also found the PAID was correlated with a variety of theoretically relevant
constructs such as general emotional distress, depression, diabetes self-management,
diabetes coping, and health beliefs (Welch, Weinger, Anderson, and Polonsky, 2003).
The next section will focus on studies that further elaborate upon the diabetesrelated distress construct by discussing the potential sources and consequences of
diabetes distress. This section will also focus on the potential relationships between
diabetes-specific emotional distress and possible overlapping constructs to further
explore the relationships.
Potential sources of Diabetes-related Distress
One source of diabetes-specific emotional distress is thought to be the lifelong
burdensome regimen patients with diabetes are required to maintain (Polonsky,
Anderson, Lohrer, Welch, Jacobson, Aponte, & Schwartz, 1995). Recent studies have
provided additional support for the role of the treatment regimen (injection of exogenous
insulin vs. taking oral medication vs. diet-exercise regimen only) on diabetes-related
distress in individuals with type 2 diabetes. Researchers reported individuals on an
insulin regimen experienced greater diabetes-related distress than those on oral
medications or diet and exercise only treatment regimens (Delahanty et aI., 2007).
However, there is additional evidence that suggests patients with diabetes on high doses
of oral agents may also report levels of distress similar to those on insulin regimens. This
is believed to be due to a patient's heightened awareness that insulin injection therapy
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will be prescribed next, if blood glucose levels do not decrease (Welch, Jacobsen, and
Polonsky, 1997), or due to the complexity of the regimen itself.
Another potential source of diabetes-related distress may be awareness of the
necessity to adhere to self-management recommendations despite the knowledge that the
onset of complications is often unavoidable (Welch, Jacobson, and Polonsky, 1997;
Thomas, Jones, Scarinci, and Brantley, 2003). Changes in health status or adjusting to
managing diabetes-related symptoms may activate thoughts and fears related to the
progression of illness and the development of complications. Individuals with diabetes
report worrying about the future and the development of additional complications as a
primary source of diabetes specific distress regardless of type of diabetes and treatment
regimen (Welch, Jacobsen, & Polonsky, 1997; Delahanty et aI., 2007).
According to the literature presented above, the complexity of the treatment
regimen and the worry associated with both fearing and experiencing increases in
diabetic complications are potential sources of diabetes-related distress. Researchers
have discussed the necessity for studies that evaluate the relationships between diabeticspecific emotional distress and known overlapping constructs (e.g. depression and
diabetes self-management behavior) (Welch, Jacobsen, and Polonsky, 1997). Diabetesrelated distress has emerged as a valuable construct related to the psychosocial impact of
diabetes on both behavior and mental health. Depressive symptomatology may further
influence an individual's experience of distress by enhancing diabetes-specific distress
scores on the PAID, due to the overlapping emotional impact.
In a recent meta-analysis by Stone, Peters, Davies, and Khunti (2006)
psychological distress was described "as a natural and inevitable response" for
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individuals with diabetes. The presence of depressive symptoms can be detrimental to
diabetic outcomes. Diabetes-specific distress has been recently discussed in the literature
as a construct that also may reflect more global depression, highlighting the overlap
between these constructs. In a study comparing four measures of depressive
symptomatology in persons with diabetes, the PAID was found to reflect both major and
minor depression (Hermann, Kuzler, Krichbaum, Kubiak, & Haak, 2006). This study
also provided support for the link between diabetes-related distress and depression.
However, this is a relatively new area of research, and additional studies are needed to
verify the validity of using the PAID in clinical samples of individuals with diabetes
when screening for depression.
The relationship between diabetes and depression as a comorbid condition is well
established in the research literature. By examining this literature, additional information
related to the psychological impact of depression on diabetes outcomes can be further
evaluated to continue to explore existing relationships of the Personal Model emotional
constructs. Ciechanowski, Katon, and Russo (2000) found that depression itself has
detrimental influences on diabetes symptom burden. Depressed individuals with diabetes
were more likely to experience a higher burden of disease-specific symptoms than nondepressed individuals (Ciechanowski, Katon, and Russo, 2000). Given these depressiondiabetes burden associations, it seems highly plausible that depression would elevate
diabetes-specific distress due to a shared affective component. The diabetes-depression
literature will be examined in subsequent sections in order to address the potential
overlap between diabetes-specific distress and global depression and their impact on
diabetes self-management behaviors.
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Depression and Diabetes
Overview of Depression
Depression (Major Depressive Disorder) is relatively common in the United
States; the lifetime prevalence rate of major depression is approximately 16.2% (Kessler,
Berglund, Demler, Jin, Koretz, Merikangas, Rush, Walters, & Wang, 2003). Depression
manifests itself as a collection of both somatic (physical) and psychological (mental)
symptoms. According to the Diagnostic and Statistical Manual of Mental Disorders-4th
Edition-Text Revision (DSM-IV -TR), the diagnosis of Major Depressive Disorder is
warranted if 5 or more of the following conditions are met over a 2-week period: the
presence of a depressed mood or a loss of interest in once pleasurable activities,
significant changes in appetite, hypersomnia or insomnia, psychomotor agitation or
retardation, fatigue or loss of energy, feelings of worthlessness or inappropriate guilt,
impaired concentration or indecisiveness, and recurrent thoughts of death (including
suicidal ideation and/or intent) (APA, 2000). Depression can affect all areas of an
individual's life; severity is often conceptualized in terms of functional distress and
impairment.
Depression in Diabetes
The rates of depression are elevated in individuals with chronic medical disease
(Katon & Sullivan, 1990) including diabetes (Lustman, Clouse, & Freedland, 1998).
Recent research has indicated that adults with diabetes are twice as likely to have
depression compared to individuals that do not have diabetes (e.g., Edege, Zheng,
Simpson, 2002). Incidence rates of adults with diabetes in the United States are
estimated to be 9.3% compared to 6.1 % for individuals without diabetes (Edege &
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Zheng, 2003). Global depression has been extensively studied in the diabetes literature
due to the implications of depression on physical and mental well-being. Depression has
been found to be associated with poor glycemic control, increased functional impairment,
poor diet and medication adherence, higher health care costs in diabetic patients
(Ciechanowski, Katon, & Russo, 2000; Lin et aI., 2004) and has been found to have
profound effects on quality of life (Goldney, Phillips, Fisher, & Wilson, 2004).
Research in specific areas relevant to the complex relationship between diabetes
self-management and depression will be reviewed below. This relationship is a central
tenet of the framework of the model that will be introduced in this dissertation, modified
from the Glasgow et. ai. (1997) diabetes-specific model of self-management described
above.
In a study conducted by the ADA (2006), specific gaps in diabetes selfmanagement education were identified as related to depression; specifically medication
adherence, exercise, and diet. The literature on depression and diabetes and associations
with health and well-being will be reviewed below. Potential areas of research that would
inform these areas will be addressed.
Prevalence of Diabetes and Depression and Associations with Health and Well-Being
There is overwhelming evidence that comorbid depression in diabetes is
associated with increased health problems, including increases in severity of diabetes
symptoms, and an increase in risk of developing additional comorbid microvascular
complications (e.g. retinopathy, nephropathy, peripheral neuropathy, cardiovascular
disease) (Egede, 2006). Clinically relevant depression has been defined as "depression
severe enough to warrant clinical intervention" (Anderson, Freedland, Clouse, and
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Lustman, 2001). In a recent meta-analysis (Ali, Stone, Peters, Davies, and Khunti, 2006),
prevalence rates of co-morbid depression in adults with type 2 diabetes were found to be
significantly higher than in individuals without diabetes (17.6% vs. 9.8%). Another
recent meta-analysis examined prevalence rates of depression among individuals with
type 1 diabetes (Barnard, Skinner, and Peveler, 2006). In uncontrolled studies (the studies
that did not have a comparison group) rates of depression were estimated to be 13.4%. Of
the studies that had a control group, 12.0% of the diabetic population was depressed,
compared to 3.2% of the healthy comparison groups. In a third recent meta-analysis
(Anderson, Freedland, Clouse, & Lustman, 2001), a diagnosis of diabetes almost triples
the odds of comorbid depression (OR=2.9, 95% CI 2.3-3.7), with no differences by type
of diabetes, sex, subject source, or assessment method.
The evidence from these meta-analyses suggests depression is significantly higher
in individuals with diabetes compared to those without diabetes. The three studies
mentioned above relied on cross-sectional data to reach their conclusions, which prevents
causality or directionality from being determined. However, it is useful to examine this
literature to determine specific health related targets that are affected by having both
depression and diabetes. Due to the known benefit of maintaining optimal glucose levels
among individuals with diabetes, the effects of depression on glycemic control will be
reviewed below.
The Impact of Depression on Glycemic Control
A recent meta-analysis of studies conducted with individuals with type 1 and type
2 diabetes found significant associations between depression and glycemic control
(Lustman et aI., 2000). When comparing effect sizes between individuals with type 1 and

13

type 2 diabetes, there were no significant differences found in depression scores between
groups, indicating that the effect of glycemic control on depression is similar in both
populations. However, using diagnostic criteria for depression yielded a larger effect size
(ES = 0.28) than when self-report measures were utilized (ES = 0.15) to assess for the
presence of depression in both groups. The associations in both of these meta-analyses
suggest there is an existing relationship between depression and glycemic control
independent of type of diabetes, but that reported severity of depression may be a
function of the method of assessment.
Given the associations between depression and glycemic control and the impact
of self-management behaviors on glycemic control, literature addressing the effects of
depression on self-management behaviors will be reviewed below.
The Impact of Depression on Diabetes Self management

It has been well established that adoption of self-management behavior is crucial
to optimal diabetes care. Evidence from large clinical trials has demonstrated that the
effects of exercise, following dietary recommendations, and self-monitoring of blood
glucose (SMBG) are essential to achieving optimal glycemic control, blood pressure, and
lipid control (ADA, 2006). However, engaging and maintaining these recommendations
frequently present challenges for persons with diabetes (Edege & Zheng, 2002; Nelson,
Reiber, & Boyko, 2002; Harris, 2001). Co-morbid depression is believed to further
complicate maintenance of adherence to diabetes self- management recommendations. A
recent longitudinal study examined the relationship between depression and symptoms of
diabetes and concluded depression influenced self-management behavior by affecting
adherence to the self-management regimen (McKellar, Humphreys, & PIette, 2004).

14

Findings suggest that patient-initiated behaviors (e.g. exercise, dietary adherence,
5MBG) are impacted by depression more than they are by physician-initiated services
(e.g. HbAlc tests, physician visits) (Lin et aI., 2004). The above findings provide
additional support for the impact of depression on the self-management component of
successful diabetes management. Associations between depression and diabetes and
other emotion-related outcomes will be further examined, as seen in the section below.

The Relationship Between Depression, Diabetes, and Symptom Burden
Ciechanowski, Katon, and Russo (2000) found that depression has a detrimental
impact on diabetes symptom burden. In a sample of individuals with diabetes, those who
were depressed were more likely to experience a higher burden of disease-specific
symptoms than those who were not depressed.
One possible explanation of the findings of the above studies could be the
associations of the perceived burden of living with diabetic symptoms and complications,
or the complexity of the regimen itself. Surwit, van Tilburg, Parekh, Lane and Feinglos
(2005) demonstrated that the diabetes treatment regimen itself determined the
relationship between depression and glycemic control. In individuals injecting insulin 3
or more times a day (i.e. complex treatment regimen) depression was associated with
glycemic control. The burden of diabetes has been found to be significantly associated
with reporting more diabetic symptoms (Ludman et aI., 2004). This supports the
influence of depression and diabetes-specific distress on both the perceived burden of
living with diabetes symptoms and the demands of the treatment regimen itself. It
appears that the complexity of the regimen that an individual is required to adhere to is
associated with depression. However, there were no studies found that addressed the
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impact of diabetes-specific depressive symptoms in relation to diabetes self-management.
Such studies would be quite informative, due to the potential for shared heritability of the
somatic component(s) of diabetes and depression. If symptoms overlap with both
conditions, i.e. symptoms common to both diabetes and depression, it is important to
identify the etiology of those symptoms to maintain accuracy of both diagnostic and selfreport measurement of these symptoms. The subsequent section will review the existing
literature that link shared symptomatology of depression and diabetes, to explore
potential overlap in greater detail.
Possible Mechanisms Underlying Depression and Diabetes
Recent literature lends support to two potential hypotheses linking depression and
diabetes. One hypothesis suggests that depression precedes the onset of type 2 diabetes.
There are several studies that support this hypothesis (e.g. Eaton, Armenian, Gallo, Pratt,
and Ford, 1996; Golden et aI., 2004). However, this finding has not been universal,
findings that depression precedes the onset type 2 diabetes has been inconsistent (e.g.
Saydah, Brancati, Golden, Fradkin and Harris, 2003; Carnethon, Kinder, Fair, Stafford
and Fortmann, 2003). When examining the mechanisms that could support this
hypothesis, a recent literature review suggested that the increased risk of developing
diabetes following the onset of depression stems from increased counterregulatory
hormone release and action, mutations in glucose transporters, and increased
immunoinflammatory activity. These physiological changes are believed to add to
cellular insulin resistance, causing the onset of type 2 diabetes (Musselman, Betan,
Larsen, & Phillips, 2003). The mechanisms of this process remain poorly understood,
additional research in this area is needed to clarify these relationships (Edege, 2006).

16

A second hypothesis in the literature suggests depression in diabetes is caused by
the psychosocial stressors related to having a medical condition. In one prospective
study, youths who had Type 1 diabetes were followed over a lO-year period to assess for
the onset of psychiatric conditions. Results indicated that after 10 years, 27.5% of
participants developed major depression (Kovacs, Obrosky, Goldston, & Drash, 1997).
In another large study of older adults with diabetes, results indicated there was a 3.7 fold
increased odds of the onset of depression in type 2 diabetes (Palinkas, Barrett-Connor, &
Wingard, 1991). This research suggests that regardless of age and type of diabetes,
psychosocial factors playa role in the development of depression.
A third possibility that must be considered and has not been explored thus far is
that there may be symptoms that overlap both depression and the physical aspects of
diabetes. The somatic component of depression is one area that provides considerable
opportunity for symptom overlap between depression and diabetes. The next section will
review the current literature examining the shared somatic symptoms between depression
and diabetes.

Shared Somatic Symptoms of Both Depression and Diabetes.
The above section summarized the recent literature examining the relationship
between depression and diabetes. However, the potential overlap of somatic symptoms
of depression and symptoms of diabetes is virtually absent in the literature. In a recent
review by Edege (2006), it was suggested the overlap between symptoms of suboptimal
control of diabetes and depression are often overlooked in the medical community and in
the literature. Somatic symptoms such as fatigue, changes in appetite, changes in
weight, and sleep disturbance could share etiology from either illness (Edege, 2006).
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A recent large study examining the relationship between diabetes and symptom
burden highlights the relevance of examining the coexisting symptomatology between
depression and diabetes (Ludman et aI., 2004). In this study of 487 patients with both
diabetes and co-morbid depression, the association between depression-diabetes
symptoms was stronger than the association between number of diabetes symptoms and
glycemic control and diabetic complications. This study provides support for the strength
of the association between depression and diabetes symptomatology. However,
individual symptoms characterizing depression (e.g. fatigue, depressed mood, change in
appetite, etc.) were not specifically examined. Additionally, because the study was crosssectional, causality cannot be determined. However, the significant results observed in
this study remained significant after controlling for age, gender, marital status ethnicity,
HbA1 c , number of complications, additional medical comorbidity, duration of diabetes,
type of diabetes, and treatment intensity.
This study also used well-validated measures to assess the somatic symptoms.
Ludman et al (2004) used a self-report version of the PRIME-MD adapted from the
Patient Health Questionnaire Study (Spitzer, Kroenke & Williams, 1999) to assess both
prevalence and intensity of depression over time. Diabetes symptoms were measured
using the Self-Completion Patient Outcome instrument (Whitty, Steen, Eccles, 1997).
This instrument measures symptoms of diabetes including: cold hands and feet, numb
hands and feet, polyuria, excessive hunger and/or thirst, shakiness, blurred vision, feeling
faint and feeling sleepy. Items are scored on a Likert type scale that ranges from "never"
to "every day". Symptoms are considered positive if they are experienced at least
"several days" in the past month. Severity was identified via chart review. These
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measures also demonstrated adequate internal consistency that strengthens the results of
this study reviewed above. Ludman et al (2004) demonstrated that as the number of
symptoms of depression an individual experiences increases, the number of symptoms of
diabetes increase, even after controlling for complications and other potential
confounding variables.
Examining the somatic overlap between symptomatology shared by both
depression and diabetes could provide a framework for examining diabetes emotions and
symptom burden by providing additional information that could guide optimal medical
care (e.g. mental health screening vs. additional medical diagnostic testing).

Somatic Symptom Burden in Diabetes: The Potential Role of Fatigue
Surridge et ai. (1984) found that fatigue was the most commonly reported
diabetes physical demand including coping with fatigue by individuals with type 1
diabetes. Out of the 50 individuals enrolled in this study, 31 of them reported
experiencing an increase in fatigue, with 20 of them reporting considerable impairment as
a result of this fatigue (Surridge et aI., 1984). This unique descriptive analysis provides
preliminary evidence for the utility of examining fatigue in the diabetic population.
Although this evidence for the role of fatigue in diabetes health and well-being is
encouraging, the relatively small sample size in this study prohibits definitive conclusions
from being drawn. It is also worth noting that it was the only study found that
demonstrated the significance of this construct specifically in a diabetes sample.
However, a large literature on fatigue and well-being is present in the larger behavioral
medicine literature.
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Additional support for the significance of fatigue impacting quality of life in
individuals with chronic disease is demonstrated in a recent large longitudinal study that
examined the validity of the DSM-IV criteria for depression among individuals with and
without chronic co-morbid medical conditions (Simon & von Korff, 2006). There is an
existing debate surrounding the inclusion of somatic symptoms when assessing for
depression in a chronic disease population (Cavanaugh, Clark, & Gibbons, 1983). A
recent study by Simon and von Korff (2006) demonstrated that of all of the somatic
symptoms, the probability of reporting fatigue was greater in individuals with chronic
disease when compared to a general medical clinic population (54% vs. 45%
respectively). This suggests that health-related fatigue may be an independent construct
in chronic disease and that assessment of fatigue could provide information above and
beyond that of depression or other disease-specific distress measures alone. The results
of Simon and von Korff (2006) provide support for the utility of independently
examining fatigue and depression/disease specific distress, due to the increased
prevalence of fatigue in chronic disease populations, particularly diabetes.
The next section will focus on defining the construct of fatigue, in addition to
highlighting the importance of fatigue as a symptom of both somatic function and distress
in other chronic diseases. In addition, the utility of this construct in type 2 diabetes will
be discussed. Initially, the larger chronic disease literature will be discussed, due to the
limited representation of fatigue in the diabetes literature. Then, the smaller literature
that is specific to fatigue in diabetes will be presented and the methodologies critiqued.
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Fatigue in the Larger Chronic Disease Literature
As previously presented, fatigue is an important construct in the chronic disease
literature. Fatigue is considered to be one of the most commonly reported symptoms of
chronic disease. Due to the commonality of this symptom, it has emerged as a useful
construct relating to both functional status and quality of life. Fatigue has been identified
in a variety of conditions, resulting from the illness itself, treatment, or psychological
factors such as depression. Due to the complexity of this issue, the behavioral medicine
literature has examined both the impact and causes of fatigue in several populations.
Edege (2006) suggests an integrated approach to evaluating fatigue, which includes but is
not limited to the fields of psychology, behavioral science, nursing, and medicine.
One of the aims of this dissertation study was to examine self-reported fatigue as
a potential emotional symptom of diabetes. Thus far, it has been identified as a
potentially useful construct that has overlap with both physical (i.e. diabetes) and
psychological (i.e. disease-specific distress, depression) illness. However, within the
diabetes literature, there is limited evidence identifying definitions of fatigue and/or
possible associations with other physical or psychological constructs. Therefore the
section below will present the larger chronic disease literature to identify conceptual
frameworks and existing theoretical models that provides support for examining this
construct as a viable construct within the diabetes literature.
Definitions of the Fatigue Construct
Fatigue is a common complaint among patients suffering from a myriad of
chronic diseases, including various forms of cancer and associated treatment, multiple
sclerosis, and chronic fatigue syndrome. One of the greatest methodological challenges
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in the fatigue literature centers on a consistent definition of the construct. In the existing
literature, the definition of a symptom is often considered to be broadly defined as a
manifestation of any illness. More specifically, symptoms are often discussed in terms of
the individual's experience, and may not be directly observable (i.e. pain, nausea, fatigue,
Rhodes, Watson, & Hanson, 1988). Fatigue is consistently operationalized as a
subjective experience in the literature, which is consistent with the above description of
symptom experience. Although fatigue is typically conceptualized as a subjective
experience, the definitions of fatigue are inconsistent in the published literature. In a
recent study, Richardson (1998) concluded that in the existing literature there are a
variety of definitions that are ambiguous, numerous, and inconsistent across research
studies. The absence of a comprehensive, consistent definition across studies prevents
progress in the development of theoretical models that could potentially facilitate clinical
practices related to chronic disease management.
Defining Fatigue in Chronic Illness
Definitions of fatigue have often been conceptualized as a decrease in physical
performance or a loss of energy (Wu & McSweeny, 2001), but the debate over this
construct continues in the literature. Piper (1986) was one of the pioneering researchers
in operationalizing fatigue as an important symptom in cancer. Fatigue was described as
"a subjective feeling of tiredness that is influenced by circadian rhythm; it can vary in
unpleasantness, intensity, and duration" (Piper, 1986, p. 220). According to this
definition, fatigue is conceptualized as serving as a protective function when it is
experienced by the individual acutely. When fatigue becomes more chronic however, the
protective function is no longer served.
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In contrast, Rhodes, Watson, and Hanson (1988) suggested that fatigue in patients
with cancer leads to distress when it is inconsistent and experienced less often. They
report that when fatigue is experienced more frequently, cancer patients often do not
experience high levels of distress. This finding was contingent upon patients developing
appropriate self-management strategies to minimize their fatigue levels. Authors of this
article suggested that individuals who experience fatigue intermittently may not have
adequate self-management strategies in place to manage these symptoms, which may in
turn lead to increased distress. Additionally, there was an observed association between
engaging in appropriate self-management strategies and fatigue in patients with cancer.
"Tiredness" was the symptom that interfered with self-management most frequently.
Rhoten (1982) suggested intensity of symptoms differentiates fatigue from
tiredness, per se. He defined fatigue as a state of general negative feeling that is
associated with pain, discomfort, and pain medication. The sample studied was a
postoperative patient population. Tiredness was defined as resulting from physical
activity and was considered a normal physical phenomenon that could be relieved by
adequate amounts of rest. Fatigue was defined as being experienced in longer duration
and a more extreme state with both physical and mental aspects. This definitional
approach suggests the possibility of a multidimensional aspect of this construct due to its
impact on multiple areas of an individual's quality of life (i.e. physical, mental). This
definition is in sharp contrast to the definition provided by Rhodes, Watson, and Hanson
(1988), which defines the experience of fatigue as being associated with the frequency of
symptom experience. Rhoten (1982) conceptualizes an increase in frequency and
severity of the symptoms as differentiating fatigue from tiredness. These varied
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definitions of fatigue highlight the differences and contradictions present in the literature
that impede consistent results across studies. Without additional empirical support,
progress toward gaining better understanding of fatigue is limited.
As fatigue has gained increased attention from clinicians and researchers in
behavioral medicine, many professionals have operationalized fatigue as a
multidimensional construct. Individuals do not all share the same fatigue experience, it is
subjective, multidimensional, and difficult to measure (Glaus, Crow, and Hammond,
1996). One multidimensional definition proposes the development and establishment of
cancer related fatigue (CRF). Cancer related fatigue defines a host of criteria that would
standardize definition of fatigue for cancer patients (Cella, Peterman, Passik, Jacobsen,
and Breitbart, 1998). For the full list of criteria for CRF, the reader is referred to Table 1.
These proposed criteria were developed for inclusion in the International Classification of
Diseases-10th Edition (lCD-lO). The ICD-IO is widely used for diagnosis in the medical
community (World Health Organization, 1992), and the inclusion of CRF into this
classification system would solve the problems associated with inconsistency.
The majority of the information presented on fatigue thus far has been related to
cancer. Fatigue is also a prevalent symptom in the Multiple Sclerosis literature, but
literature is inconsistent when defining the construct. In a study examining the impact of
fatigue and depression on quality of life in mUltiple sclerosis, fatigue was defined as "an
abnormal sense of tiredness or lack of energy out of proportion to the degree of daily
effort or degree of disability" (Janardhan & Bakshi, 2001, p.54). An earlier study
conceptualized fatigue in terms of four distinct categories which supports a
multidimensional approach (Schwartz, Coulthard-Morris, & Zeng, 1996). In a recent
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study by Pittion-Vouyovitch et al. (2006) fatigue was defined as "a lack of physical or
mental energy or a feeling of tiredness. [It is believed] to affect social relations, daily
activities, cognitive and physical domains" (p.39). By comparing definitions used in
these studies, similar inconsistencies that exist in defining the experience of fatigue in
cancer are also found in the multiple sclerosis literature. There is a methodological
debate that encompasses the enmeshment of measurement and definition inconsistencies
in the existing literature for both cancer and Multiple Sclerosis.
Summary o/Conceptual and Methodological Issues in the Chronic Illness Fatigue
Literature.
Inconsistencies in definitions presented above are intended to highlight the
diverse definitions available in the chronic disease literature. This impedes progress in
further research by prohibiting generalizable conclusions from being drawn. Recent
research in this area presented in chronic disease suggests a multidimensional approach
would best capture the experience of fatigue; however this is not always apparent when
examining how fatigue is defined. Consistent factors of the definitions presented above
suggest fatigue is a subjecti ve symptom that can vary in intensity, frequency, and
duration. Additionally, fatigue is a symptom that surpasses "tiredness" in the sense it is
chronic and not alleviated by adequate amounts of rest. Multidimensional definitions that
capture the complexity of this issue are lacking consistency in the literatures reflecting
the chronic disease populations presented above. It appears the cancer quality of life
literature has examined this construct in greatest detail, and has developed criteria for
defining and assessing cancer-related fatigue. The cancer literature provides a framework
that may be applied to evaluating the diabetes literature. The complexities surrounding
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measurement of fatigue largely seen in the cancer literature are demonstrated by a review
of questionnaires that have been developed in this area, seen below.
Fatigue Measurement
Review of fatigue measurement instruments reflects inconsistencies in
measurement approaches. There is a current debate centering on the dimensionality of
fatigue that further complicates measurement approaches. The next section will explore
this debate, discussing evidence for both unidimensional and multidimensional methods
for assessment of fatigue in chronic disease. By exploring assessment measures of
fatigue, this may further explain the complicated relationships observed between fatigue,
physical symptom reports and distress/depression in persons living with chronic disease.

Measuring Fatigue in the Cancer Literature
Due to the definitional issues in the fatigue literature, it is not surprising that there
is a debate in the literature pertaining to optimal methods of assessing this construct. The
majority of current fatigue measures have been developed from a multidimensional
model that includes general, cognitive, affective, somatic, and vigor dimensions of
fatigue. Although theoretical foundations conceptualize fatigue as a multidimensional
construct, measures of fatigue often display substantial subscale intercorrelations and
lack sufficient discriminability from one another. An additional line of research suggests
the most efficient method of evaluating fatigue is the parsimonious assessment of a single
general fatigue construct or scale. This unidimensional approach is appealing when
assessing medical populations in clinical settings, due to the timeliness and simplicity of
this approach. Such approaches include fatigue by asking about it directly (i.e. using the
word fatigue), or through visual analogue scales. For example, in a recent study by
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Reyes-Gibby, Aday, Anderson, Mendoza, and Cleeland (2006) "Fatigue was defined by
the response to the question "Have you had any of the following persistent or
troublesome problems .... severe fatigue or exhaustion" (p.120). Some clinicians also
report assessing fatigue by simply asking if the patient is tired, or if they feel impacted by
fatigue, which eliminates the intensity dimension of fatigue has been examined and that is
validated in both unidimensional and multidimensional approaches.
The multidimensional vs. unidimensional debate regarding assessment of fatigue
is unresolved in the current fatigue literature. It is widely accepted in the literature
however, that due to the subjectivity of fatigue as a symptom, use of self-report
questionnaires is a valid measurement technique (Jacobsen, 2004). The next section of
this proposal will divide the discussion of fatigue assessment into two parts: 1)
Unidimensional measures of fatigue and 2) Multidimensional measures of fatigue. For a
complete list of measures including dimensional characteristics and psychometric
information, the reader is referred to Table 2. The following discussion will focus on the
conceptual frameworks that underlie these measurement approaches. Commonalities and
differences across measures will be discussed in detail. The measures have been
organized in terms of dimensionality, to illustrate both perspectives of this debate.

Unidimensional Measures of Fatigue
The majority of measures that unidimensionally assess fatigue focus on the
severity or intensity of the symptom. One consistent limitation is cited in the
methodological design of the studies using these measures. Frequently, researchers have
used measures without providing validity information specific to the illness of the subject
sample, or intention for the measurement tool selected. This can pose potential difficulty
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in the consistency of measurement in the literature, as some measures are defined in
terms of the medical population they are studying l e.g. Functional Assessment of Cancer
Therapy (FACT) Yellen, et aI, (1997)]. This prohibits generalizability of the possible
associations that could be uncovered by using a measure that is not specific to the disease
itself. In contrast, the Fatigue Severity Scale (FSS) [Krupp et aI, (1989)] is a commonly
used measure of fatigue that can be used across medical populations. Its name is
somewhat of a misnomer however, because the FSS actually measures the impact and
functional outcomes of fatigue rather than symptom severity.
The majority of other unidimensional instruments measure the severity of fatigue
on a single dimension. Close examination of these measures suggests that overall, the
majority of instruments measure severity of fatigue itself, but lack operational definitions
of the fatigue construct. The unidimensional measures do not provide consistency nor
clarity in terms of definitions, instead these measures mostly focused on severity while
ignoring individual factors that address some of the definitional confounds previously
described. Consistent with unidimensional definitions of fatigue (e.g. Rhoten, 1982) these
measures typically focus on the severity of the symptoms of fatigue. However little
information is actually provided in terms of symptom operationalization, rather assume
that the construct "fatigue" exists, and that it is often severe in chronic illness
populations.
Due to the limitations of the unidimensional approach, many researchers have
advocated for a multidimensional approach. Multidimensional assessment may provide
an opportunity to assess different aspects of the fatigue experience, while assessing for
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severity of fatigue in each of the factors that contribute to the overall experience of
fatigue (e.g. mental and physical fatigue).
Multidimensional Measures of Fatigue
Recent research reviewed in the cancer, multiple sclerosis, and chronic fatigue
syndrome literatures suggests that chronic disease fatigue assessment would benefit from
using a multidimensional approach to maximize understanding of experiencing fatigue,
given its subjective nature (Jacobsen, 2004; Smets, Garssen, Bonke, & De Haes, 1995).
When fatigue is measured in a multidimensional way, emotional, behavioral, and
cognitive components are commonly assessed (Lewis & Wessely, 1992). Two reviews
have discussed the multidimensional fatigue scales, and report them to be more
comprehensive (Alberts, Vercoulen, and Bleijenberg, 1999; Friedberg and Jason, 1998),
and due to the known differences between patients' experiences, essential to clarifying
the ambiguity of fatigue as a construct. Severity of a poorly understood construct that
remains ambiguous may not provide answers to more specific research questions.
Research that incorporates multidimensional measures provides an opportunity to assess
the actual experience of the individual in terms of which aspects of fatigue individuals are
experiencing (i.e. physical symptoms and affective symptoms), and possibly distinguish
differences in fatigue "profiles" across different chronic disease and working populations.
The Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) is an
excellent example of a multidimensional fatigue measure. Is was designed by researchers
based on the existing literature suggesting fatigue is a multidimensional symptom that
can be best captured by evaluating five dimensions: general (i.e. severity), affective,
physical, mental, and vigor (Stein, Martin, Han, & Jacobsen, 1998). Additionally, it has
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been argued that, due to the absence of disease-specific information, it is a flexible
measure that can be used in a variety of populations (Dittner, Wessely, & Brown, 2004).
The MFSI-SF is believed to have good psychometric properties, including excellent
internal consistency, good diagnostic validity, good test-retest reliability, and sufficient
ability to discriminate between fatigued and non-fatigued individuals (Wu & McSweeny,
2001).
The Checklist of Individual Strength (CIS) is another measure developed out of
the multidimensional assessment trend (Vercoulen, Swanink, Fennis, Glalma, van der
Meer, & Blegijenberg, 1994). The CIS was developed using CFS patients as a validation
sample (Vercoulen, Swanink, Fennis, Glalma, van der Meer, & Blegijenberg, 1996), and
has been validated in working populations (Beurskens, Bultmann, Kant, Vercoulen,
Bleijenberg, & Swaen, 2000), and MS patients (van der Werf, Jongen, Nijeholt, Barkhof,
Hommes, & Bleijenberg, 1998).
Issues in Assessment Tools Measuring Fatigue
One limitation in the multidimensional fatigue literature is the development of
questionnaires on an ad hoc basis, which hinders the possibility to advance the construct
and decreases the overall reliability of the results. Definitional confounds have also been
observed in measurement studies. Jacobsen (2004) discussed an absence of a commonly
agreed upon definition leading to a lack of a consensus regarding fatigue measurement.
Different research groups utilize different instruments that are theoretically dissimilar,
preventing a consensus regarding definition and measurement. In a review conducted by
Dittner, Wessely, and Brown (2004), this issue was presented as a "Catch 22 ... before a
concept can be measured, it must be defined, and before a definition can be agreed, there
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must exist an instrument for assessing phenomenology" (p. 166). They suggest when
considering dimensionality, research should address the purpose of the information they
are attempting to collect. It is unlikely that one assessment measure will develop as the
"gold standard" due to the complexity of fatigue measurement and the ambiguous issues
surrounding definition (Dittner, Wessely, & Brown, 2004).
Several unanswered questions in the multidimensional fatigue literature include
influences of the course of fatigue which remains unknown due to the prevalence of cross
sectional studies, and the lack of longitudinal information. Measurement approaches
contribute to this by the lack of consistency in measuring the fatigue construct and in the
study designs utilized. In addition, the measurement instruments themselves contribute
to the issues, some tapping fatigue in the past two weeks, some discussing at present
time, some relying on a 24-hour recall. Research could address these limitations by
cross-validating instruments over time, to provide information that can explain temporal
relationships of fatigue.
One final issue that must be addressed concerns the potential for measurement
overlap in assessing fatigue and chronic illness comorbidity. As previously discussed,
treatment issues and diseases themselves may contribute to the experience of fatigue, and
the overlap between the symptom of fatigue in depression and chronic disease also need
to be adequately addressed. Due to the absence of a biological marker for fatigue, a
heavy reliance is placed on self-report measures due to the subjectivity of the fatigue
experience. Fatigue can be experienced as a physical symptom due to the physical (or
somatic) dimension described by individuals that experience it. Additionally, chronicity
and severity contribute to the physical manifestations of fatigue, including weakness and
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tiredness that remain after rest. Studies that examine convergent and discriminant
validity across fatigue instruments and between fatigue, disease-specific distress and
global depression measures are currently non-existent in the chronic disease literature.

Fatigue and Chronic Illness: Summary and Future Directions
Thus far, this review has demonstrated the impact of depression and diabetesspecific distress on diabetic outcomes. More specifically, the literature discussed has
illustrated the impact of depression and diabetes-specific distress on diabetic symptoms,
glycemic control, and self-management behaviors. Fatigue was introduced as a symptom
that potentially shared an etiology with both depression and diabetes, and was found to be
a commonly reported symptom in this population. However, the fatigue literature is very
small within this population. Therefore, the existing current fatigue literature was
reviewed in other chronic diseases, to illustrate the importance of this construct in other
chronic disease populations.
Fatigue has been discussed thus far in this review in the context of cancer, MS,
and depression. However, measuring fatigue as a symptom of diabetes has not been welladdressed in the literature; and the few studies that exist have been primarily conducted
in working samples. The following section will review the studies on diabetes and
fatigue, to inform the reader of the current status of the research in this area. A
methodological critique will be presented. Results of the individual studies will be
integrated to suggest a potential model that will guide future research examining the
impact of fatigue on diabetes mellitus and the associations with measures of distress.
Within diabetes, fatigue may have several possible etiologies (e.g. physical vs.
psychological). This construct was selected for inclusion in this proposal due to the
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prevalence of fatigue among individuals with diabetes (e.g. Surridge et aI., 1984), the
overlap of fatigue and psychological distress, and the relative lack of data that addresses
these specific symptoms in the diabetes-distress literature.
Fatigue in Diabetes Mellitus
Integrating fatigue into the diabetes-distress research can expand the current
health psychology literature in behavioral diabetes. This integrative approach may guide
future research in this area by exploring the overlap of depression and physical symptoms
associated with diabetes and performance of self management behaviors. Thus far, this
review has highlighted the existing evidence and methodological problems in both the
definition of fatigue, and consistent measurement in this area of research.

A Critique a/the Studies an Fatigue in Diabetes
There were only five studies found in the literature that assessed fatigue as a
symptom in the diabetes population in any context. Four of these studies were crosssectional, preventing determination of causality. These four studies included type 1
diabetes, type 2 diabetes, diabetes with additional co-morbid chronic disease, and
gestational diabetes populations, which prevents generalizability across studies.
However, three of these studies used the Checklist of Individual Strength to measure
fatigue (Weijman, Ros, Rutten, Schaufeli, Schabracq, & Winnbust, 2003; Weijman, Kant,
Swaen, Ros, Rutten, & Schaufeli, et aI, 2004; Weijman, Ros, Rutten, Schaufeli,
Schabracq, & Winnbust, 2005) which has been validated in healthy working populations
(Beurskens, Bultmann, Kant, Vercoulen, Bleijenberg, & Swaen, 2000). This
multidimensional measure assesses severity and behavioral consequences of fatigue using
a 7-point Likert scale. All three studies reported a cut-score of 76 indicating prolonged
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fatigue, which is consistent with previous empirical research in a working population
(Bultmann, de Vries, Beurskens, Bleijenberg, Vercoulen, & Kant, 2000). Additionally,
this facilitates generalizability in terms of a valid point of reference across studies, which
has been lacking in previous research.
Two of these studies included both type 1 and type 2 diabetes (Weijman, Ros,
Rutten, Schaufeli, Schabracq, & Winnbust, 2003; Weijman, Ros, Rutten, Schaufeli,
Schabracq, & Winnbust, 2005), the third included "diabetics" and compared them to four
additional comparison groups that included both "healthy" individuals, individuals with
diabetes with additional co-morbidity, and individuals with other chronic illnesses
(Weijman, Kant, Swaen, Ros, Rutten, & Schaufeli, et aI, 2004).
Diabetes-illness related variables accounted for 43.5% of the variance in fatigue
in the Weijman et al (2003) study. An additional 16.3% of the variance in fatigue was
explained by work characteristics. In a similar study, 30% of the population of insulin
treated diabetics (type 1 and type 2 diabetes) reported CIS scores above 76, indicating
they experienced prolonged fatigue (Weijman et aI., 2004). This finding is supported by
two of the three studies described above (Weijman et aI., 2003; Weijman et aI., 2005),
suggesting fatigue is consistently reported more frequently in diabetic working
populations when compared to healthy controls without diabetes. It should be noted that
the third study did not support these findings, and reported contrasting findings with
results, indicating that individuals with diabetes and no other co-morbid conditions
reported similar fatigue levels to a "healthy" population. However, once additional comorbidity was included in analyses, fatigue severity was significantly higher for diabetic
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groups that also had additional physical illness (Weijman, Kant, Swaen, Ros, Rutten, &
Schaufeli, et aI, 2004).
An important consideration in the study of fatigue in diabetes is that associations
with self management have been examined. With respect to fatigue and self-management
behaviors, individuals who perceived insulin injections or dietary guidelines as a burden,
reported higher levels of fatigue, and more depressive symptoms. Those who perceived
diabetes self-management behaviors as less burdensome (i.e. less-diabetes-specific
distress) were more likely to engage in that behavior, and reported lower levels of fatigue
than if the behavior was perceived as more burdensome (Weijman, Kant, Swaen, Ros,
Rutten, & Schaufeli, et aI, 2004). This provides preliminary evidence of a relationship
between diabetes-specific distress, co-morbidity, and fatigue that warrants additional
attention. The results of this study should be interpreted with caution, due to the
inequality of sample size in the differing disease groupings (e.g. N = 8,946 in the healthy
group vs. N =76 in the DM only condition and N =65 in the DM group with
comorbidity). This is believed to be a significant finding in terms of building a
conceptual framework, as research has indicated higher disease comorbidity to be
associated with poorer diabetes outcomes.
The fourth cross sectional study included in this critique attempted to understand
exercise beliefs and behaviors in women with gestational diabetes (Downs & Ulbrecht,
2006). Researchers conducted this study without a priori hypotheses, to prevent "biased"
results. Furthermore, although fatigue was included as an outcome variable, it was not
defined and specific information as to how fatigue was assessed was not included in the
paper. Nonetheless, fatigue was reported as the strongest barrier preventing engaging in
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exercise during pregnancy. This result was no longer significant in a post-partum
assessment. These results are to be interpreted with caution due to associated
methodological limitations in the manner in which fatigue was assessed. As this was a
small descriptive study, there was a small sample size (N=28) and no comparison group.
Due to these issues, it is unclear if fatigue as a barrier to exercise is specific and unique to
a diabetic pregnant population or if this barrier is also relevant in healthy pregnant or
non-pregnant diabetes populations as well. Due to the known benefits of exercise on
diabetic outcomes, replication is warranted in both type 1 and type 2 diabetes
populations, as fatigue could be identified as a potential target for intervention. Exercise
has a known paradoxical impact on both fatigue and glycemic control. Continuing this
line of research is recommended to further explore this relationship.
One recent longitudinal study included in this review (conducted in 2005)
examined a diabetes-screening program for type 2 diabetes. The Hoorn Screening study
focused on the level of diabetes-specific symptom distress and its relationship to negative
mood in individuals enrolled in a screening program for type 2 diabetes (Adriaanse et aI.,
2005). This Dutch study included 319 participants recruited from a pre-existing study of
a screening program for type 2 diabetes (N=11 ,679). Questionnaires included the Type 2
Diabetes Symptom Checklist (Grootenhuis, Snoek, Heine, & Bouter, 1994) and the
Negative well-being subscale of the Well-being Questionnaire (Pouwer, van der Ploeg,
Ader, Heine, Snoek, 1999). The sample was divided based on their screening results; 156
of the participants received a diagnosis of type 2 diabetes, and the remaining 163 were
identified as non-diabetic. The final sample included 116 participants who received a
diagnosis and 130 who were non-diabetic.
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Results of this study demonstrated that subjects with type 2 diabetes were
significantly more burdened by fatigue symptoms in the first year post-diagnosis than
were the individuals in the non-diabetic group. This group difference was also found to
be stable over time. This provides longitudinal evidence that fatigue is a distressing
symptom for individuals with type 2 diabetes for the first year post-diagnosis. It is also
possible that the finding of greater psychological fatigue in the first year was due to
diabetes-specific distress associated with diabetic symptoms and the new attempts to
follow recommended self-management behaviors. This study provides evidence that
within the first year after diagnosis, fatigue is not only perceived to be significantly
different for individuals with type 2 diabetes compared to non-diabetic individuals, but
that it is stable over time. Since this study only followed participants for one year it is
unclear if this temporal relationship remains significantly longer than 12 months.

Summary and Limitations of Literature on Fatigue in Diabetes
The results of the five studies presented above suggest that fatigue is common in
the diabetic population and warrants further attention. Diabetes-specific distress has been
discussed above as a contributor to prolonged fatigue. Research has also linked diabetesspecific distress to depression. Finally, fatigue has been identified as an exercise barrier
for women with gestational diabetes. However, there were no studies identified in the
literature examining fatigue among diabetes in medical settings (i.e. primary care,
diabetes clinics) to gain additional insight into the impact of fatigue. Because these
studies included working populations and pregnant women, it is possible that assessment
within a medical setting would produce different results.
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The above sections have illustrated the importance of measuring fatigue and
depressive symptomatology in a diabetes population. Previous sections highlight the
essential role of self-management for successful diabetes management. However, the
impact of diabetes-specific distress, depressive symptomatology, and fatigue on quality
of life, specifically health related quality of life has not yet been addressed in this
proposal. Quality of life serves as an important outcome in the diabetes literature, as it
has been shown to be an essential construct when discussing self-management. The
following section will highlight the current literature focusing on what is known about
the relationship between diabetes and health-related quality of life.
Measuring Fatigue-related Outcomes in Diabetes

Defining Quality of Life
Quality of Life can be defined as the ways in which health, illness, and medical
treatment effect an individual's perception of their daily functioning and well-being
(Guyatt, Feeny, & Patrick, 1993). Recent literature suggests quality of life has
increasingly been utilized as an outcome measure with individuals with chronic disease,
including diabetes mellitus (Jacobson, de Groot, & Samson, 1997). Individuals with
chronic illnesses often report decreased Quality of Life when compared to individuals
without chronic illnesses (Stewart, Greenfield, Hays et aI, 1989). However, the reasons
for these differences are often multi-factorial, and poorly understood.

Quality of Life and Diabetes
There is a large body of literature evaluating Quality of Life in diabetes mellitus.
What is currently known about diabetes mellitus and Quality of Life is that Quality of
Life is influenced by the number of secondary illnesses co-occurring (Rubin & Peyrot,
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2002), and the frequency of serious metabolic complications that arise (Weinger &
Jacobson, 2001). As previously mentioned, depressive symptomatology has been shown
as an independent risk factor for decreased Quality of Life independent of physical
complications or chronic illnesses individuals may also have (Barge-Schaapveld,
Nicolson, Berkhow, and deVries, 1999). This has also been documented in the diabetes
specific literature; individuals who experience depressive symptomatology often
experience decreased Quality of Life, independent of number of secondary complications
(Hanninen, Takala, and Keinanen-Kiukaanniemi, 1999). As previously reviewed in this
paper, self-management is a key component of diabetes care and this plays an important
role in health-related outcomes and well-being. The next section will review the existing
Quality of Life literature to further explain what is known about this construct in
relationship to diabetes self-management.
Impact of Diabetes Self-Management on Quality of Life
Recent literature has suggested successful management of diabetes improves
quality of life. The inverse is also true; it has been suggested that suboptimal selfmanagement has been linked to decreased quality of life. Additionally, quality of life
decreases as a function of increased number of diabetic complications (Jacobsen, de
Groot, & Samson, 1995; Glasgow, Ruggiero, Eakin, Dryfoos, & Chobanian, 1997).
There is also evidence to suggest individuals with type 2 diabetes who are required to
adhere to a daily insulin regimen frequently report a decreased quality of life (Jacobsen,
de Groot, & Samson, 1995). It appears the insulin regimen itself can be another potential
source of distress for individuals with type 2 diabetes. However, there is limited
literature in this area; additional research is needed to better understand this relationship.
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Self-Management of Diabetes as an Outcome Variable.
Self-management has been studied extensively in the diabetes literature.
Research indicates diabetes is a unique disease due to the level of involvement of
behavior in self-management and required regimen adherence. According to the
American Association of Diabetes Educators (AADE), there are seven behaviors that
together are seen as necessary for successful diabetes management. These behaviors
include: being physically active, diet, medication taking, self-monitoring of blood
glucose, problem solving (managing high and low levels, sick days, etc.), reducing risks
of complications, and psychosocial adaptation to living with diabetes (AADE, 2003).
Literature indicates these ongoing, multiple behavioral demands are the key factors that
distinguish the demands of living with diabetes from those of other chronic illnesses,
which may require maintaining only a select few of these behaviors (ADA, 2006).
It is well-established that the seven self management behaviors components do

not correlate highly with one another, suggesting individuals can be adherent to one
behavior while ignoring another (Glasgow & Eakin, 1998; Rubin & Peyrot, 1992; Orme
& Binik, 1989). This suggests there is a multidimensional component to self-

management. Due to the relative independence of the behaviors research suggests each
component needs to be assessed separately when evaluating diabetes self-management
outcomes (Johnson, 1992). This assessment of individual behavioral domains discussed
in the behavioral diabetes literature as the preferred methodological approach to
measuring self-management outcomes rather than creating a composite score summing
all of the behaviors. For this dissertation project, blood glucose testing and diet are the
individual self-management behaviors targeted for inclusion due to the impact of these
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behaviors on maintaining optimal diabetes control. These two self-management
behaviors will be discussed below.
Blood Glucose Testing

Blood Glucose testing is recommended for individuals with diabetes to assess
glycemic control. The ADA (2007) recommends blood glucose testing for individuals
with type 2 diabetes. Individuals prescribed an insulin regimen are recommended to test
their blood glucose 3 or more times daily to achieve their glycemic goals. Individuals not
on an insulin regimen are recommended to test their blood glucose levels less frequently
than those on an insulin regimen. The frequency of self-monitoring of blood glucose
should be determined based on maximizing blood glucose control. Research suggests
individuals who maintain optimal glycemic control frequently report blood glucose
testing as a key element in their self-management regimen thus highlighting its
importance (ADA, 2007). Additionally, the negative impact of depression has also been
identified in the self-monitoring of blood glucose literature. It is useful to examine the
emotional impact of global depressive symptomatology, diabetes-specific distress, and
fatigue on frequency of self-management of blood glucose to gain a better understanding
of the impact of these constructs on blood glucose testing.
Diet

Diet was selected due to the importance of maintaining nutritional standards in
addition to minimizing or delaying the onset of additional complications. Obesity is an
independent risk factor for type 2 diabetes, and is often the result of poor nutritional
habits. Due to the rising rates of type 2 diabetes and obesity, diet was selected as a
behavior to assess, due to the health benefits of maintaining a healthy diet. Maintenance
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of a healthy diet is important for many individuals with type 2 diabetes because it can
lower blood sugar, triglycerides, blood pressure, cholesterol, and controlling weight
(ADA, 2007). Research suggests maintaining a healthy diet is difficult for individuals to
maintain (Toobert & Glasgow, 1994). This study sought to examine the frequency of
dietary adherence. Additionally, due to the potential impact of depression on diet, this
study examined the impact of global depressive symptomatology, diabetes-specific
distress, and fatigue on the self-management of diet in individuals with type 2 diabetes.
Purpose of Study
This study sought to explore the frequency and intensity of diabetes-specific
distress and depressive symptomatology, including fatigue in adults with type 2 diabetes
mellitus. Glasgow's Personal Models of Diabetes Self-management was used as a
conceptual framework for examining the associations between depressive
symptomatology, diabetes-specific distress, fatigue (and its potential for overlap with
depression), self-management behaviors, and health related quality of life. The results of
this study informed the literature on personal models of diabetes management by
including the emotion component and within this framework distinguishing global
depressive symptomatology, diabetes specific distress, and fatigue. Additionally, this
dissertation was designed to explore the associations between these constructs and selfmanagement behavior and quality of life.

Specific Aims
Aim!
The primary aim of this study was to examine personal model constructs of
diabetes management. Specifically, this study examined the individual levels of and
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relationships between potential emotional aspects of diabetes (depressive
symptomatology, diabetes-specific distress, and fatigue) using validated measures
HI (Hypothesis #1): Hypothesized individual correlations between independent

variables are listed in Table 3. It was believed the independent variables depressive
symptomatology, diabetes specific-distress, and fatigue would be moderately associated
with one another.

Aim 11
A second aim of this study was to examine the unique associations of emotional
distress with diabetes self-management behavior, physical, and mental quality of life,
controlling for demographic variables and diabetes regimen demand. Hypothesized
individual correlations between independent and dependent variables are listed in Table
4. Specifically, the following hypotheses were proposed:
H2 (Hypothesis #2)

Independent variable global depressive symptomatology (CESD-IO) controlling for
demographic (age, gender, and BMI) and diabetes-related history (insulin, duration of
diabetes, oral medication use), and anti-depressant use would be negatively and
significantly associated with frequency of blood glucose testing on the SDSCA. It was
hypothesized the variance accounted for by the independent variable would be beyond
that of demographics and medical history.
H3 (Hypothesis #3)

Independent variable global depressive symptomatology (CESD-IO) controlling for
demographic (age, gender, and BMI), diabetes-related history (insulin, duration of
diabetes, oral medication use), and anti-depressant use would be negatively and
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significantly associated with frequency of diet adherence on the SDSCA. It was
hypothesized the variance accounted for by the independent variable would be beyond
that of demographics and medical history.
H4 (Hypothesis #4)

Independent variable diabetes-specific distress (PAID) controlling for demographic (age,
gender, and BMI) and diabetes-related history (insulin, duration of diabetes, oral
medication use), and anti-depressant use would be negatively and significantly associated
with frequency of blood glucose testing on the SDSCA. It was hypothesized the variance
accounted for by the independent variable would be beyond that of demographics and
medical history.
H5 (Hypothesis #5)

Independent variable diabetes specific distress (PAID) controlling for demographic (age,
gender, and BMI) and diabetes-related history (insulin, duration of diabetes, oral
medication use), and anti-depressant use would be negatively and significantly associated
with frequency of diet adherence on the SDSCA. It was hypothesized the variance
accounted for by the independent variable would be beyond that of demographics and
medical history.
H6 (Hypothesis #6)

Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), and
anti-depressant use would be negatively and significantly associated with frequency of
blood glucose testing on the SDSCA. It was hypothesized the variance accounted for by
the independent variable would be beyond that of demographics and medical history.
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H7 (Hypothesis #7)

Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), and
anti-depressant use would be negatively and significantly associated with frequency of
diet adherence on the SDSCA. It was hypothesized the variance accounted for by the
independent variable would be beyond that of demographics and medical history.
H8 (Hypothesis #8)

Independent variable global depressive symptomatology (CESD-IO) controlling for
demographic (age, gender, and BMI) and diabetes-related history (insulin, duration of
diabetes, oral medication use), and anti-depressant use would be negatively and
significantly associated with the physical function scores on the SF-12. It was
hypothesized the variance accounted for by the independent variable would be beyond
that of demographics and medical history.
H9 (Hypothesis #9)

Independent variable global depressive symptomatology (CESD-lO) controlling for
demographic (age, gender, and BMI) and diabetes-related history (insulin, duration of
diabetes, oral medication use), and anti-depressant use would be positively and
significantly associated with mental well-being on the SF-12. It was hypothesized the
variance accounted for by the independent variable would be beyond that of
demographics and medical history.
HIO (Hypothesis #10)

Independent variable diabetes-specific distress (PAID) controlling for demographic (age,
gender, and BMI) and diabetes-related history (insulin, duration of diabetes, oral
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medication use), and anti-depressant use would be negatively and significantly associated
with physical function scores on the SF-12. It was hypothesized the variance accounted
for by the independent variable would be beyond that of demographics and medical
history.
H11 (Hypothesis #11)

Independent variable diabetes-specific distress controlling for demographic (age, gender,
and BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use),
and anti-depressant use would be positively and significantly associated with mental
well-being on the SF-12. It was hypothesized the variance accounted for by the
independent variable would be beyond that of demographics and medical history.
H12 (Hypothesis #12)

Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), and
anti-depressant use would be negatively and significantly associated with physical
function scores on the SF-12. It was hypothesized the variance accounted for by the
independent variable would be beyond that of demographics and medical history.
H13 (Hypothesis #13)

Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), and
anti-depressant use would be positively and significantly associated with mental wellbeing on the SF-12. It was hypothesized the variance accounted for by the independent
variable would be beyond that of demographics and medical history.
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METHODS
Description of Participants
Participants were adults with diabetes receiving diabetes care at the Joslin
Diabetes Center at Aoyd Memorial Hospital in New Albany, Indiana. Joslin Diabetes
Center offers both inpatient and outpatient clinic that offers a variety of treatment,
education, and exercise programs for adults with both type 1 and type 2 diabetes.
Participants included in this study were men and women who met the following
eligibility criteria: (1) must have received a diagnosis of type 2 diabetes mellitus, (2) be
over the age of 21 , (3) are taking medication for their diabetes (e.g. oral agents, insulin,
or both), (4) could successfully complete the Mini-Cog, and (5) read, write, and
understand English. This protocol was approved by the Institutional Review Board(s) of
both the University of Louisville, and Aoyd Memorial Hospital.
Procedure
Participant Recruitment
Individuals presenting to the Joslin Diabetes Center to receive routine care were
invited to participate in this study by research personnel. All research/project personnel
completed both HIPAA and CITI training requirements. Participants were invited while
waiting for routine clinic appointments. Research personnel determined eligibility of
patients by receiving a list of eligible participants from the medical administrative staff.
Individuals were invited to participate in one of two ways: (1) Research personnel called
the patient into an exam room for screening, or (2) research personnel approached the
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patient while already in an exam room. Both methods accommodated HIPAA
requirements. Participants then received consent and HIPAA forms and completed them
with the study personnel.
Screening

Screening approach consisted of the study personnel asking direct questions
related to the eligibility criteria. Questions assessed for diabetes status, medication use,
whether the participant was over the age of 21, and could read, write, and understand
English. In addition, the research personnel administered the MINI-COG to screen for
cognitive impairment. Participants were read three words then were asked to draw a
clock with hands pointing to a specific time. Upon completion of the clock drawing task,
participants were asked to recall the original three words they were read. If a participant
incorrectly drew the clock and/or could not remember the words they were read, they
were determined to be ineligible and were thanked for their time and participation.
Eligible individuals were invited to participate in the study, and received the
questionnaire packet. They were reminded their participation is voluntary, and that they
would be asked to read and fill out a survey that would take approximately 30 minutes to
complete.
Data Collection

Participants were given two options for questionnaire completion and return: (1)
completing the questionnaire while waiting for their clinic appointment and returning it in
the provided manila envelope directly to research staff, or (2) completing the
questionnaire and returning it directly to the research personnel at the University of
Louisville via mail, using a pre-stamped manila envelope. In addition to the self-report
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questionnaire packet, a subsequent chart review was conducted to collect information
regarding the participant's HbAlc value, height, weight, fasting glucose, duration of
diabetes, and use of medication (exogenous insulin, oral diabetes agents, and
antidepressants) corresponding to measurements made on the day on which they were
enrolled is the study. Additionally, chart recorded information listing complications
associated with diabetes and additional medical comorbidity information was recorded.
Diabetes related co-morbidities were compiled into a database using only a subject
identification number.
Measures
Table 5 and Table 6 summarize measures used for the independent and dependent
variables respecti vel y.

Sociodemographic Questionnaire. Data concerning background and
socioeconomic characteristics was collected from each study participant. This
questionnaire contains 12-items, which include age, gender, educational achievement,
marital status, current living arrangement, employment status, race/ethnic background,
height, and weight.

The Mini-Cog. The Mini-Cog is a composite measure used as a screenerfor
cognitive impairment (Borson, Scanlan, Brush, Vitaliano, & Dokmak, 2000). This test
was designed to discriminate between individuals with and without cognitive impairment.
This brief instrument includes a 3-item recall and a clock drawing task. Recent literature
addressed the utility of the Mini-Cog in primary care clinics; results indicated the MiniCog to be superior to the MMSE. This measure is believed to be easier to administer,
and displays believed less bias with literacy and low-education issues (Ismail, Rajji,
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Shulman, 2009). Screening criteria was consistent with the original scoring by Borson et
al (2000). Individuals who were able to correctly identify all three items on the 3-item
recall task were included in the study. If an individual correctly identified 1-2 items of
the 3-item recall task, the clock drawing was analyzed for accuracy. If the clock was
accurate (i.e. numbers accurately drawn, correct time, appropriate drawing and
placement) the participant was included in this study. If an individual could not recall
any of the 3-item recall items and/or could not produce an accurate clock, s/he was
excluded from the study.
Center for Epidemiological Studies of Depression Scale -10 (CESD-IO). The

CESD-IO (Andersen, Malmgren, Carter, & Patrick, 1994) is a shortened version of the
original 20-item measure designed to assess depressive symptomatology in a general
popUlation. Individuals are asked about the frequency or duration of which they
experience cognitive, affective, and behavioral symptoms of depression within the
preceding week. This measure uses a four point rating scale that ranges from "rarely to
none of the time (less than one day)' (0) to "most or all of the time (5-7 days)" (3). The
range of possible scores is from 0-60, with higher scores indicating a higher frequency of
depressive symptoms. The CESD-I0 has been used extensively in populations with
chronic diseases, and is believed to be a valid measure of global depressive
symptomatology. The CESD-IO has good psychometric properties, including a
reliability coefficient of 0.85.
Problem Areas In Diabetes Scale (PAID). Due to the importance of diabetes-

related distress, the Problem Areas In Diabetes Scale (PAID) (Polonsky, Anderson,
Lohrer, Welch, Jacobson, Aponte, & Schwartz, 1995) was created as a tool to assess the
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construct of diabetes related distress both as a clinical tool and an outcome measure
(Welch, Weinger, Anderson, & Polonsky, 2003). The PAID is a 20-item single-factor
measure of diabetes related distress developed by the Joslin Diabetes Center and Harvard
Medical School. This instrument has a 5-point item scaling, ranging from "Not a
problem" = 0 to "Serious Problem" = 4. Original scoring was a summed total; higher
scores were indicative of higher levels of diabetes-specific distress. Original scoring has
been simplified to a transformed scaled score ranging from 0-100, with higher scores
demonstrating greater diabetes-specific distress. The main focus of the items surrounds
feelings and moods associated with specific aspects of diabetes. The PAID has been
found to be unrelated to age, duration of diabetes, education, ethnicity, and gender
(Welch, Weinger, Anderson, & Polonsky, 2003).

Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF). The
Multidimensional Fatigue Symptom Inventory-Short Form is an excellent example of a
multidimensional fatigue measure. Is was designed by researchers based on the existing
literature suggesting that fatigue is a multidimensional symptom that can be best captured
by evaluating five dimensions: general (i.e. severity), affective, physical, mental, and
vigor (Stein, Martin, Hann, & Jacobsen, 1998). Additionally, it has been argued due to
the absence of disease-specific information, it is a flexible measure that can be used in a
variety of populations (Dittner, Wessely, & Brown, 2004). The MFSI-SF is believed to
have good psychometric properties, including excellent internal consistency, good
diagnostic validity, good test-retest reliability, and sufficient ability to discriminate
between fatigued and non-fatigued individuals (Wu & McSweeny, 2001).
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Personal Illness Models Questionnaire. This questionnaire has been previously
used in Glasgow et ai's (1997) study examining personal models of diabetes. This
measure assesses beliefs about treatment effectiveness by asking two specific questions
about individual areas of self-management (physical activity, glucose testing, recording
glucose test results, taking medication, checking feet, and eating low fat foods). Each
regimen area contains two personal model items: "How important do you believe _ __
is for controlling your diabetes?" and "How likely do you think it is that

will

prevent future complications?" Responses are provided on a five-point rating scale
ranging from (1) not at all importantllikely to (5) very important/likely. These scores are
averaged to produce a regimen-specific effectiveness score. This measure yielded
sufficient internal consistency reliability (a = .89) as a measure of treatment
effecti veness.

Medical Outcomes Study Short Form 12 (SF-12). The SF-12 is an abbreviated
version of the original SF-36, which was designed to measure global level of functioning
(Ware, Kosinski, & Keller, 1996). This measure contains 12-items that measure physical
function (physical) and well-being (mental), with higher scores indicating better
functioning. Estimates of reliability for the physical and mental component scales are
0.89 and 0.86 respectively. Normative data is also available for a diabetic population
suggesting this instrument is both reliable and valid.

The Summary of Diabetes Self-Care Activities Measure (SDSCA). The SDSCA is
a brief self-report measure that measures levels of self-management across multiple
diabetes self-management behaviors over the previous seven days using a 0-7 Likert scale
(Toobert & Glasgow, 1994). The revised SDSCA contains II-items that assess the
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frequency of performance of the following five self-management domains: (1) diet, (2)
exercise, (3) blood glucose testing, (4) foot care, and (5) smoking (Toobert, Hampson, &
Glasgow, 2000). Only the diet and blood glucose testing items will be administered in
this study. A recent review article reported the SDSCA is the most widely used selfreport instrument for measuring diabetes self-management in adults. This measure
demonstrates good inter-item reliability, test-retest reliability, and validity (Toobert,
Hampson, & Glasgow, 2000). The majority of published studies using the SDSCA have
focused on type 2 diabetes.
Covariates: Several covariates were selected for inclusion in this dissertation.
This study sought to explore the emotional component of Glasgow et ai's (1997) model
of self-management. This influential study included age, gender, oral medication, and
insulin use as covariates. This was replicated in this study due to the impact of these
variables on both self-management and quality of life. Duration of diabetes and BMI
were also selected for inclusion as covariates due to their potential impact on both
physical and mental health. Finally, use of anti-depressant medication was selected for
inclusion as a covariate due to the potential impact on self-reported emotional distress,
self-management, and quality of life.
Data Analysis
Sample Size Calculation
Cohen (1992) suggests a power analysis should be conducted to inform the
number of participants needed to achieve a specified effect size between or within
groups. This was conducted using the G* Power3 program adapted from Faul, Erdfelder,
Lang & Buchner (2007). Cohen (1992) recommends .80 as sufficient power to detect a
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moderate effect size (.30). Based on Cohen's recommendation, a minimum of 121
subjects is needed to detect a moderate effect size at a significance level of .05 using
multiple regression with 8 independent variables (including 3 demographic variables, 3
diabetes-specific variables, and anti-depressant use to be examined as covariates). The
number of participants providing valid data exceeded 121 for all hypotheses. This
sample size provided adequate power to this study to detect a moderate effect size with
95% confidence for the Primary and Secondary Aims at both the p < .05 and p <.01
levels.

Descriptive Statistics
Descriptive statistics are provided for data from both self-report and chart review.
This study focused on a clinical population of adults with type 2 diabetes who received
their diabetes care at Joslin Center for Diabetes. Due to the heterogeneity of this
population, demographic characteristics such as age, gender, level of education,
occupation, ethnicity and body mass index were assessed to describe the characteristics
of this sample with hopes to increase generalizability of this study to other populations of
individuals with diabetes. Additionally, diabetes-related history such as use of insulin,
duration of diabetes, and oral medication is described. Rates of current use of antidepressant medication are also presented. All questions reflecting independent and
dependent variable constructs were scored and descriptive data is presented. Data was
analyzed and reported in terms of frequencies, means standard deviations and ranges in
table form. T-Tests were used to compare means across groups to test for group
differences.
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Statistical Plan for Hypothesis Analysis
Hypothesis 1 was tested using Pearson correlations to explore the associations
between the total scores of the CESD-lO, PAID, and MFSI-SF. A correlation matrix was
formed to examine associations between these independent variables.
The hypotheses for Aim 2 (Hypothesis 2-Hypothesis 13) were analyzed using
hierarchical linear regression to test if independent variables predict dependent variables.
Based upon Glasgow's conceptual framework of Personal Illness Models and the
associations with both the independent and dependent variables included in this study,
demographic characteristics, diabetes regimen characteristics, and antidepressant use
were included as separate blocks in the regression analyses. Demographic variables age,
BMI, and gender were entered into the first block, diabetes regimen characteristics
(exogenous insulin use, duration of diabetes, and oral agent use) were entered into the
second block, antidepressant use was entered into the third block and the predictor term
(independent variable) was entered into the fourth block. The effects of the predictor
variables (independent variables) were interpreted individually and the change in
variance associated was used to evaluate the statistical significance of the predictor
variable (independent variable).
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RESULTS
Response Rates
Figure 3 presents a summary of the study recruitment rates. A total of 246 adults
with Type 2 Diabetes were invited to participate in this study. Of those invited, 18 (7%)
declined participation, 21 (6%) were not eligible to participate due to screening (MiniCog), and 207 (87%) were consented and given questionnaire packets. Of the 207
consented participants 151 (73%) completed and returned the questionnaire packet.
Fifty-six participants (27% of those consented) did not complete the questionnaire.
Completion Rates for Measures
Participants responded to measures at rates ranging from 94.7% to 98.7% per selfreport questionnaire. The SDSCA diet and blood glucose subscales were calculated
individually; the percentages of subscale completion rates were noted to be equal
(95.4%). The physical and mental component subscales of the Quality of Life measure
(SF-12) were also calculated separately; both subscales yielded a response rate of98.7%.
Study Completion Rate Group Differences
In order to examine potential differences between individuals who provided
consent but did and did not complete the study questionnaire packet, participants were
grouped by completion status (i.e. those that completed vs. those who did not). Groups
were compared on number of complications, Body Mass Index, and HbAl c using
independent sample t-tests. Significant differences were observed for both duration of
Diabetes and HbAl c . Those who completed the survey were more likely to have diabetes
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longer than those who did not complete the survey t (190) = -2.35,p=.02 (two-tailed).
When examining group differences based on HbAl c , those who completed the survey had
lower HbAl c than those who did not complete the survey t (191) = 3.81,p=.000 (twotailed). There were no statistically significant differences observed in terms of number of
complications and completion status. Means and Standard Deviations by completion
status are reported in Table 7.
Chi-square statistics were calculated to examine significant differences between
completion status and several categorical variables including hypertension,
hyperlipidemia, peripheral neuropathy, smoking status, antidepressant use, oral diabetes
agent use, and exogenous insulin use. There were no significant group differences
observed between completion status and oral agent use, insulin use, antidepressant use,
smoking status, hyperlipidemia, and peripheral neuropathy. Comparisons of groups on
presence of hypertension and completion status approached significance, with study
completers having a trend of being more likely to be hypertensive than those that did not
complete (p= .057).
Demographics
The demographic characteristics of participants (i.e. the study completers) are
summarized in Table 8. Of the total sample of 151 adults, the mean age of participants
was 60.7 years (SD=I1.2). Participants were comprised of 51.7% females, 93.2%
Caucasian, 72.5% married, and 58.9% were retired/disabled. Thirty three percent of
participants reported their education as completing high school. Over half of the sample
of participants had additional partial college/specialized training (54.1 %) with 16.9%
completing graduate or other professional training. Table 9 summarizes gender and
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ethnicity characteristics of this sample as compared to both Louisville, KY and New
Albany, IN (US Census Bureau, 2002).
Descriptive Information on Study Measures and Subscales
The means, standard deviations, and ranges of the total scores of the measures for
the independent and dependent variables are presented in Table 10.
With respect to the CESD-IO, the majority of this sample (93%) did not reach the
empirically derived cutoff score of 10 (i.e. 7% had scores greater than or equal to 10)
recommended by Andresen et al (Andresen, Malmgren, Carter, & Patrick, 1994)
suggesting a positive clinical presentation of depressive symptomatology in the present
sample.
Gender Comparisons
Emotion Constructs
Differences between genders on subscale scores for measures assessing emotion
(depressive symptomatology, diabetes-specific distress, and fatigue), self-management
(diet and blood glucose testing), and quality of life (physical and mental) were assessed.
Means, standard deviations and p-values for corresponding independent sample t-tests are
presented in Table 11. Women reported higher depressive symptomatology scores on the
CESD-IO, t (141) = 2.23,p=.03 (two-tailed). Women also reported lower scores on the
SF-12 mental component subscale relative to men t (146)

=-1.99,p=.048 (two-tailed).

Medication Use
Gender differences were also examined with respect to oral diabetes agent use,
exogenous insulin use, and antidepressant use using Chi-square statistics. There were no
significant differences observed between gender and oral agent use (p= .090) or
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exogenous insulin use (p= .482). There were significant differences observed between
gender and antidepressant use X2 (1, N = 143) = 4.19, p=.032, women were twice as likely
to taking antidepressants when compared to men.
Self-Management

Gender differences were also examined with respect to diet and blood glucose
testing. Women followed their diet recommendations more frequently according to the
Diet subscale of the SDSCA, t (142) = 2.21,p= .02 (two-tailed). There were no gender
differences observed with respect to blood glucose testing.
Health Status

Health Characteristics of participants was collected via-chart review at the time of
consent. Of the 207 participants consented, chart data was available for 191 (92.3%) of
the participants enrolled in this study. However, there were a number of participants who
provided consent but did not return the survey. These cases were excluded from analyses
including chart review, and the data is presented for 148 of the participants enrolled in
this study. The mean duration of diabetes was 143.64 months (11.97 years, SD= 102.54;
range = 2-554). In response to the SF-12 question "How would rate your present health
condition?", 1 (0.7%) participant responded "Excellent", 25(17.0%) participants
responded "Very Good", 68 (46.3%) "Good", 38 (25.9%) "Fair", and 15 (10.2%) "Poor",
respectively.
Most of the participants in this sample were non-smokers (88.8%), on diabetes
oral agent medication (92.3%), and Obese (80%). Additional analyses were conducted to
examine obesity rates by standard obesity classification. Four participants (2.7%) were
classified as Normal weight, 24 participants (17.1 %) Overweight, 41 participants (27.7%)
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Obesity Class 1,36 participants (24.3%) Obesity Class II, and 35 participants (23.6%)
Obesity Class III (National Heart, Lung, and Blood Institutes of Health, 2000).
Additionally, the mean number of co-morbid health conditions was 4.2 (SD=1.74) which
included all medical diagnoses included in the chart; general medical and diabetesspecific comorbidities were included in this calculation. All co-morbid health conditions
were diagnosed by clinic physicians and recorded in patients' charts. Patient's medical
diagnoses were collected from medical charts by research personnel. Diabetes-specific
comorbidities were selected from the comorbidity information and percentages were
calculated separately and presented in table 12. The majority of the sample had
diagnoses of hypertension (78.2%) and hyperlipidemia (88.7%). Forty-two percent of the
sample also had a diagnosis of Peripheral Neuropathy.
The mean sample HbAl c was 7.32 (SD=1.45). Sixty-two participants had HbAl c
below 7 (43.4%),29.4% of the sample had HbAl c between 7 and 7.9, 14.7% of the
sample had HbAl c between 8 and 8.9, 8.4% had HbAl c between 9.0 and 9.9 and 4.2%
had HbAl c greater than 10. Thirty-five percent of the sample was taking Exogenous
Insulin, and 23% of the sample was currently taking antidepressant medication. A
summary of participants' health characteristics including sub-groupings of age, HbA1 c ,
and Body Mass Index can be found in Table 12. Additionally, a chart depicting the
participants' use of diabetes medications can be found in Figure 4.
Medication Use Comparisons
Insulin Use Status
Participants were grouped and compared on blood glucose characteristics by
insulin use status (Exogenous Insulin Use versus No Insulin Use) and compared on blood
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glucose testing and health characteristics using independent sample t-tests. Means,
standard deviations, and p-values for corresponding independent sample t-tests are
reported in Table 13. Participants prescribed insulin were more likely to report that they
tested their blood sugar than those who were not, t (130)= 2.25,p= .03 (two-tailed). The
mean frequency of those on insulin testing their blood glucose levels was 5.46 (SD= 1.88)
days per week. Those participants who were not prescribed insulin reported better
physical quality of life on the SF-12, t (134)

=-2.65,p= .009 (two-tailed).

Participants

who were prescribed insulin were more likely to have higher HbAl c than those who were
not, t (133) = 5.30,p= .000 (two-tailed), indicating poorer metabolic control. There were
no differences observed in subject age, BMI, or number of complications by insulin use
status.
Diabetes Oral Agent Use Status

Participants were also grouped and compared by diabetes oral agent use status
(i.e. those that took oral agents versus those that did not) using an independent sample ttest. Comparisons were examined for self-management, quality of life, depressive
symptomatology, diabetes specific distress and fatigue. No significant differences were
observed.
Anti-Depressant Medication Use Status

Participants were also grouped and compared by antidepressant medication use
status (i.e. those that took oral agents versus those that did not) using an independent
sample t-test. Means, standard deviations, and p-values for corresponding independent
sample t-tests are reported in Table 14. Comparisons were examined for selfmanagement, quality of life, depressive symptomatology, diabetes specific distress and
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fatigue. Participants taking antidepressants reported higher depressive symptomatology
scores t (135)

=2.87,p= .005 (two-tailed), higher diabetes specific distress t (140) =2.54,

p= .015 (two-tailed), and higher fatigue t (139)

= 3.67, P < .001 (two-tailed) than those

that do not. Additionally, participants who were not taking antidepressants reported
lower physical t (141) = -2.53,p= .013 (two-tailed) and mental quality of life t (141) =3.79,p= .000 (two-tailed) scores relative to those not taking antidepressants. No

significant differences were observed for diet or blood glucose monitoring SDSCA scores
by anti-depressant medication use status.

Hypothesis testing and analyses
Analysis of individual aims and hypotheses are listed below.

Aim!
Hypothesis 1 Analysis
Hypothesis one examined the associations between depressive symptomatology,
diabetes specific-distress, and fatigue. It was hypothesized these variables would be
moderately associated with one another. The individual correlations between the
measures reflecting emotional distress are summarized in Table 15. Overall, correlations
supported this hypothesis: depressive symptomatology, diabetes specific-distress, and
fatigue were all moderately associated with one another. Table 16 summarizes the
correlations between emotional distress measures (independent variables) and selfmanagement and quality of life (dependent variables). Table 17 summarizes the
intercorrelations between the covariates, independent and dependent variables.
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Depressive Symptomatology

As seen in Table 17, depressive symptomatology was positively associated with
fatigue and diabetes-specific distress as hypothesized. Depressive symptomatology was
significantly negatively associated with gender, antidepressant use, physical quality of
life, mental quality of life, and diet. Depressive symptomatology was not significantly
associated with blood glucose testing, age, BMI, duration of diabetes, exogenous insulin
use or diabetes oral agent use.
Diabetes-Specific Distress

As seen in Table 17, diabetes-specific distress (PAID) scores were significantly
and positively associated with fatigue, depressive symptomatology, and HbAl c , and
significantly and negatively associated with antidepressant use, physical quality of life,
mental quality of life, and diet. Diabetes-specific distress was not significantly associated
with blood glucose testing, age, gender, BMI, duration of diabetes, exogenous insulin use
or diabetes oral agent use.
Fatigue

Fatigue (Total Score of the MFSI-SF) was positively associated with depressive
symptomatology and diabetes-specific distress, and negatively associated with
antidepressant use, physical quality of life, mental quality of life, and diet. Fatigue was
not significantly associated with blood glucose testing, age, gender, BMI, duration of
diabetes, exogenous insulin use or oral agent use.
Aim II

Self-Management Outcomes
Depressive Symptomatology Predicting Blood Glucose Testing
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Table 18 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 2, with blood glucose testing as the dependent variable and depressive
symptomatology as the independent variable. The table includes R2, ~R2, and ~F for each
step of the hierarchical regression analysis. The only step in the model that retained
significance was the demographic step, which included BMI, gender, and age F (3, 119)
= 6.17,p= .001 (R2= .135). The change in variance associated with the addition of the

predictor was not significant (p=.102). No further analyses were conducted.

Depressive Symptomatology Predicting Diet

Table 19 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 3 with diet as the dependent variable and depressive symptomatology
as the independent variable. The table includes R2, ~R2, and ~F for each step of the
hierarchical regression analysis. The change in variance associated with the addition of
the predictor was not significant (p=.107). Demographics, diabetes regimen demand, and
antidepressant use were also non-significant. No further analyses were conducted, this
hypothesis was not supported.

Diabetes-Specific Distress Predicting Blood Glucose Testing

Table 20 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 4 with blood glucose testing as the dependent variable and diabetesspecific distress as the independent variable. The table includes R2, ~R2, and ~F for each
step of the hierarchical regression analysis. The demographic step (block 1) retained
significance in this model, which included BMI, gender, and age F (3,124) = 6.23,p=
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.001 (R 2 = .131). The change in variance associated with the addition of the predictor
was not significant (p=.269). No additional analyses were completed.

Diabetes-Specific Distress Predicts Diet

Table 21 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 5 with diet as the dependent variable and diabetes-specific distress as
the independent variable. The table includes R2, ~R2, and ~F for each step of the
hierarchical regression analysis. Diabetes-specific distress retained statistical
significance in this model, which included PAID total score, F (1,119)

= 1O.23,p= .002

(R2 = .131). The PAID total was significantly (negatively) correlated with diet (r= -.234,
p=.004). Demographics, diabetes regimen demand, and antidepressant use were not

significant in this model.

Fatigue Predicts Blood Glucose Testing

Table 22 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 6 with blood glucose testing as the dependent variable and fatigue as
the independent variable. The table includes R2, ~R2, and ~F for each step of the
hierarchical regression analysis. The demographic step (block 1) retained significance in
this model, which included BMI, gender, and age F (3,122)

=6.38,p=.000 (R2 =

The change in variance associated with the addition of fatigue was not significant
(p=.115). No additional analyses were completed.
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Fatigue Predicts Diet

Table 23 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 7 with diet as the dependent variable fatigue as the independent
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression
analysis. Fatigue retained statistical significance in this model, which included the
MFSI-SF total score, F (1,117)

=6.37, p= .01 (R2 =

.116). The MFSI-SF total was

significantly negatively correlated with diet (r= -.221 ,p=.007). Demographics, diabetes
regimen demand, and antidepressant use variables were not significant in this model.

Quality of Life Outcomes

Depressive Symptomatology Predicts Physical Quality of Life

Table 24 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 8 with physical quality of life as the dependent variable (Physical
Component Score of the SF-12) and depressive symptomatology as the independent
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression
analysis. With respect to Physical Component Score interpretation on the SF-12, a higher
score is indicative of "better" quality of life. The demographic step (block 1) retained
significance in this model, which included BMI, gender, and age F (3,122)

= 3.94,p=.01

(R 2 = .088). Depressive symptomatology also retained statistical significance in this
model, which included the CESD-IO total score, F (1,117) =13.28,p= .000, (R 2 = .246).
CESD-IO total was significantly negatively correlated with the Physical Component
Score of the SF-12 (r

= -.294,p=.000).

Diabetes regimen demand and antidepressant use

variables were not significant in this model.
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Depressive Symptomatology Predicts Mental Quality of Life

Table 25 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 9 with mental quality of life (Mental Component Score of the SF-12) as
the dependent variable and depressive symptomatology as the independent variable, and
includes R2, ~R2, and ~F for each step of the hierarchical regression analysis. With
respect to Mental Component Score interpretation on the SF-12, a higher score is
indicative of "better" quality of life. Demographics and diabetes regimen demand were
not statistically significant in this model. Antidepressant use (block 3) retained
significance in this model, F (1,118) = 6.97,p=.009 (R2 = .111). Depressive
symptomatology also retained statistical significance in this model, which included the
CESD-lO total score, F (1,117)

= 68.58,p= .000 (R2 =

.246). Antidepressant use was

significantly (positively) correlated with the Mental Component Score of the SF-12
(r=.259,p=.002). Depressive symptomatology was significantly (highly negatively)

correlated with the Mental Component Score (r= -.622,p=.000).

Diabetes-Specific Distress Predicts Physical Quality of Life

Table 26 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 10 with physical quality of life as the dependent variable and diabetesspecific distress as the independent variable, and includes R2, ~R2, and ~F for each step
of the hierarchical regression analysis. The demographic step (block 1) retained
significance in this model, which included BMI, gender, and age F (3,127)

=4.66,p

=.046 (R 2 = .099). Antidepressant use (block 3) retained significance in this model, F (1,

123) = 4.08,p =.046 (R2 = .163). Diabetes-specific distress also retained statistical
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significance in this model, which included the PAID total score, F (1,117) = 4.44, p

=

.037 (R 2 = .192). Antidepressant use was significantly (positively) correlated with the
Physical Component Score of the SF-12 (r =.163,p =.032). Diabetes-specific distress
was significantly (negatively) correlated with the Physical Component Score (MCS) of
the SF-12 (r = -.244,p = .002). Diabetes regimen demand variables were not significant
in this model.

Diabetes Specific Distress Predicts Mental Quality of Life

Table 27 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 11 with mental quality of life as the dependent variable and diabetesspecific distress as the independent variable, and includes R2, ~R2, and ~F for each step
of the hierarchical regression analysis. The demographic step (block 1) retained
significance in this model, which included BMI, gender, and age F (3,127) = 2.79,p
2

=.043 (R = .062). Antidepressant use (block 3) retained significance in this model, F (1,
2

123) = 7.24,p =.008 (R = .130). Diabetes-specific distress also retained statistical
significance in this model, which included PAID total score, F (1,122) = 56.50,p = .000
2

(R = .406). An independent sample t-test was calculated to assess for differences in
Mental Component Score and antidepressant use. Those on antidepressants reported
higher scores on the Mental Component Score than those not prescribed antidepressants t
(141) = -3.80,p = .000 (two-tailed) A higher Mental Component Score is indicative of
"better" quality of life, indicating that those on antidepressants self-reported higher
quality of life scores than those that are not on antidepressants. The higher an individual's
score on the PAID, the more diabetes-specific distress they endorsed. Diabetes-specific
distress was significantly negatively correlated with the SF-12 Mental Component Score
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(r = -.614,p =.000). Diabetes regimen demand variables were not significant in this

model.

Fatigue Predicts Physical Quality of Life

Table 28 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 12 with physical quality of life as the dependent variable and fatigue as
the independent variable, and includes R2, ~R2, and ~F for each step of the hierarchical
regression analysis. The demographic step (block 1) retained significance in this model,
which included BMI, gender, and age F (3,126) = 4.23,p =.007 (R2 = .092).
Antidepressant use (block 3) retained significance in this model, F (1,122) = 5.04,p
= .027 (R2 = .035). Fatigue (MFSI-SF total score) also retained statistical significance in
this model F (1,121) =17.68,p = .000 (R2 = .107). Those on antidepressants reported
higher scores on the Physical Component Score than those not prescribed antidepressants
t

(141) = -2.53,p = .013 (two-tailed). Fatigue was significantly and negatively correlated

with the SF-12 Physical Component Score (r = -.374,p =.000). Diabetes regimen
demand variables were not significant in this model.

Fatigue Predicts Mental Quality of Life

Table 29 summarizes the findings of the hierarchical linear regression used to
assess hypothesis 13 with mental quality of life as the dependent variable and fatigue as
the independent variable, and includes R2, ~R2, and ~F for each step of the hierarchical
regression analysis. Demographics and diabetes regimen demand were not statistically
significant in this model. Antidepressant use (block 3) retained significance in this
2

model, F (1, 122) = 7.55, P = .007 (R = .112). Fatigue also retained statistical
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significance in this model, which included MFSI-SF total score, F (l ,121)

= 86.81,p =

.000 (R2 = .483). Those on antidepressants reported higher scores on the SF-12 Mental
Component Score than those that not prescribed antidepressants t (141)

=-253,p = .013

(two-tailed). Fatigue was significantly and highly negatively correlated with the SF-12
Mental Component Score (r = -.669,p =.000) suggesting as fatigue scores increase,
quality of life scores decrease.

Supplemental Analyses Representing Emotional Distress

Associations observed between measures indicate overlap in assessment
approaches. This raises additional issues for consideration in relation to study aims. One
of the aims of this study sought to evaluate the potential role of fatigue as a viable
construct within the diabetes literature. Three of the four original hypotheses pertaining
to fatigue were retained in the proposed analyses, suggesting fatigue plays an important
role in diet and physical and mental quality of life for individuals with diabetes. Fatigue
was not significantly associated with blood glucose testing. However, the associations
among the three dependent variable constructs ranged from 581 to .657, indicating
moderate to high associations with one another. A key question then remains, is fatigue
uniquely contributing to as an independent construct or is this measurement error? An
exploratory item analysis was conducted to explore this issue.

Item overlap across emotional distress measures

First, individual items were reviewed from the CESD-IO, PAID, and MFSI-SF to
address similarities of these items across measures. Several items were determined to be
similar in content and semantic structure and are presented in Table 30.
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Item overlap was explained by examining the associations between the specific
subscales of the MFSI-SF and the PAID, CESD-I0 to identify the possibility of
measurement error. This extends the original aims and hypotheses that were focused on
the utilization of the total scores on the MFSI-SF and the PAID. Second, the subscales of
the MFSI-SF were included in analysis examining the Physical and Mental Component
Scores of the SF-12 to examine convergence/divergence. Table 31 includes observed
associations between the specific MFSI-SF subscales and the PAID, CESD-I0, and both
SF-12 composite scores. These correlations ranged from -.091 to .657. Both the CESD10 and the PAID were positively associated with the general, emotional, physical, mental
and total fatigue subscales, and negatively associated with the vigor subscale. All of
these associations were in the moderate to high moderate range. The SF-12 physical
component score was positively associated with the vigor subscale, and negatively
associated with the general, physical, mental, and total fatigue subscales. Of note, the
association between the emotional subscale of the MFSI-SF and the physical component
score was not significant, suggesting minimal overlap between these items. The SF-12
mental component score was negatively associated with general, physical, emotional,
mental and total fatigue score and positively associated with the vigor subscale.

Unique contributions of fatigue measurement beyond depressive symptomatology
and diabetes distress.
One of the main goals of this project was to determine the utility of fatigue as a
viable construct in the diabetes literature. The overlap between emotional constructs (i.e.
depressive symptomatology, diabetes-specific distress and fatigue) that exists was
anticipated prior to the start of the study. Due to this overlap, an additional set of four
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regressions were also performed to examine the variance fatigue accounted for in this
model over and above that of depressive symptomatology and diabetes-specific distress.
This was accomplished by including depressive symptomatology and diabetes-specific
distress as an additional block in the regression equation. These variables were entered
as follows: Demographic variables (Block 1), diabetes regimen demand (Block 2),
antidepressant use (Block 3), depressive symptomatology and diabetes-specific distress
(Block 4), and Fatigue (Block 5). This approach minimizes error and is a more
conservative approach than comparing R2 across regression equations. The results of
these regressions are presented below.

Fatigue and Blood Glucose Testing

Table 32 summarizes the findings of the hierarchical linear regression used to
assess blood glucose testing as the dependent variable and fatigue as the independent
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression
analysis. The demographic step (block 1) retained significance in this model, which
included BMI, gender, and age F (3,119) = 6.17,p

= .001 (R2 = .135).

Diabetes

regimen demand, antidepressant use, depressive symptomatology/diabetes-specific
distress, and fatigue were non-significant in this model.

Fatigue and Diet

Table 33 summarizes the findings of the hierarchical linear regression used to
assess diet as the dependent variable and fatigue as the independent variable, and includes

R2, ~R2, and ~F for each step of the hierarchical regression analysis. Demographic
variables, diabetes regimen demand, and antidepressants did not reach statistical
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significance in this model. The depressive symptomatology/diabetes-specific distress
(block 4) did reach significance F (2,114) = 5.30,p =.006 (R2=.143). Fatigue did not
significantly contribute to the model (p = .803).

Fatigue and Physical Quality of Life

Table 34 summarizes the findings of the hierarchical linear regression used to
assess physical quality of life as the dependent variable and fatigue as the independent
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression
analysis. The demographic step (block 1) retained significance in this model, which
included BMI, gender, and age F (3,121) = 4.30,p =.006 (R2 = .096). Diabetes regimen
demand did not reach statistical significance in this model (p =.111). Antidepressant use
was statistically significant in this model F (1, 117) = 3.87, p = .05 (R 2 = .169). The
depressive

symptomatology/diabetes-specific

distress

(block 4)

also

did

reach

significance F (2, 115) = 5.98, p =.003 (R2 = .247). Of note, fatigue (block 5) was a
significant predictor over and above the depressive symptomatology/diabetes specificdistress block F (1,114) = 12.37, P =.001 (R2 = .321). This suggests fatigue may be
contributing unique variance to the model when predicting physical quality of life.

Fatigue and Mental Quality of Life

Table 35 summarizes the findings of the hierarchical linear regression used to
assess mental quality of life as the dependent variable and fatigue as the independent
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression
analysis. The demographic step (block 1) retained significance in this model, which
included BMI, gender, and age F (3,121) = 2.90,p = .038 (R2 = .067). Diabetes regimen
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demand did not reach statistical significance in this model (p
was statistically significant in this model F (1,117)

= .759).

Antidepressant use

=6.19,p = .014 (R2 = .123). The

depressive symptomatology/diabetes-specific distress (block 4) also did reach
significance F (2, 115) =52.46,p < .001 (R2 = .541). Of note, fatigue (block 5) was a
significant predictor over and above the depressive symptomatology/diabetes specificdistress block F (1, 114) =22.78,p < .001 (R 2 = .618). This suggests fatigue may be
contributing unique variance to the model when predicting mental quality of life.

74

-------------------------------------------------

DISCUSSION
In this study, relationships between the emotional component of Glasgow's
Personal Models of Diabetes Self-management, including blood glucose testing, diet,
physical and mental quality of life were assessed. Global depressive symptomatology,
diabetes-specific distress, and fatigue were used to examine the emotional construct
within this model. An aim of this study was to collect descriptive data to better
understand the extent of distress as assessed within each of these constructs and to
examine their associations with one another. An additional aim was to examine the
associations of each these constructs with key aspects of diabetes self-management and
quality of life.
To address the aims described above, a series of 13 specific hypotheses were
developed. The analytic plan included conduction of a correlation matrix and 12
individual hierarchical linear regressions. In addition, several supplemental analyses were
conducted (individual item examination, an additional regression) to further explain the
pattern of results observed. Given the relatively lengthy set 6f analyses, the discussion
section below is organized to first provide a context for interpreting the study results, in
order to guide the reader through the findings. This begins with a framework that
addresses the study focus in the context of the existing published literature (study
strengths, sample characteristics, scores on the key emotional constructs and outcome
measures) then notes the gender differences that emerged in the analyses. Following this
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contextual information, the discussion examines the findings for each individual aim and
hypothesis. An overall summary and discussion of the pattern of results and their
implications for the conceptual model and empirical literature follows the discussion
of the individual hypotheses.

Strengths of the Current Study
This study makes a unique contribution to the existing diabetes literature across
several domains. This study is the first study to explore the emotional component of
Glasgow et aI's (1997) model of self-management by integrating literature (e.g., Fisher et
aI, 2007) that addressed the impact of subclinical depressive symptomatology and
diabetes-specific distress on diabetes related outcomes, specifically self-management and
quality of life. Fatigue was introduced as a unique construct in the diabetes literature due
to its importance as a potential overlapping symptom of both depression and diabetes.
This study also contributes to the existing knowledge base by exploring the associations
between the emotional constructs (depressive symptomatology, diabetes-specific distress,
and fatigue) and self-management (blood glucose testing and diet) and quality of life
(physical and mental quality of life). This study is the first to explore these associations in
a clinic sample of adults; previously published research has examined the role of fatigue
in a adults with diabetes specifically in a worksite setting.
Chart review was conducted to gather relevant medical information including
BMI, duration of diabetes, medication use, insulin use, comorbidity status and HbAlc.
The chart review data collected in this study revealed the majority of this sample was
overweight/obese. These individuals also reported high levels of cardiovascular disease
(CVD) comorbidity; which has been cited as being a long-term complication of diabetes
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itself. This comorbidity information in the present sample highlights the "real world"
health issues of a clinical sample of adults with type 2 diabetes.
The observed findings of this study present opportunities for future research to
gain further understanding of the impact of fatigue on a population of adults with type 2
diabetes by addressing the impact of the subscales of fatigue with both physical and
mental quality of life. Some of the study's findings are consistent with current published
studies and thus provides an opportunity to guide future research addressing the impact of
fatigue on additional domains of self-management, specifically physical activity. Lastly,
the hypotheses were addressed within a conceptual framework that has been empirically
validated, which also greatly strengthens the opportunity for replication and future
research.

Representativeness of Sample
Individuals who screened out the study due to their performance on the Mini-Cog
were not included due to the cognitive capacity needed to complete questionnaire data.
The Mini-Cog was included as a screening tool for cognitive impairment; those that
completed this screener were included in the study and provided a questionnaire. Those
that did not successfully complete this screening tool were excluded due to potential for
cognitive impairment. Demographic and health-status information was not collected
once an individual did not successfully complete the screening measure. Thus, the study
sample was comprised of individuals whom were able to complete the cognitive screener
(suggestive of absence of cognitive impairment) and meet eligibility criteria (i.e. a
diagnosis of type 2 diabetes, currently prescribed medication, and can read, write, and
understand English).
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Those individuals who were eligible for participation and consented but did not
complete the study measures had significantly higher chart-recorded HBA l-c levels
relative to those who completed the study. This suggests that participants who completed
the study had relatively good metabolic control relative to those who did not complete the
study.
The present study was comprised of 93% Caucasian participants; with African
American participant representation considerably lower than the population of Metro
Louisville. Of note, New Albany Indiana (the location of the clinic recruitment site),
while in close proximity to Louisville KY, has a more rural catchment area and is more
populated by Caucasians relative to Louisville (Metro Louisville's population is
comprised of 62.9% Caucasians, 33.0% Black/African Americans, 1.4% Asians and 1.9%
Hispanics; New Albany Indiana's population is comprised of 90.0% Caucasians, 6.9%
Black/African Americans, 0.4% Asians and 1.4% Hispanics, U.S. Census Bureau, 2009).
This reflects the ethnic/racial representation in this study sample.

Health Characteristics and CVD Risk
The majority of this sample was well controlled in terms of their blood glucose
levels. Despite adequate blood glucose control (HbAl c < 8 =29.4%; HbAl c < 7

=

43.4%), the majority of this sample of participants were diagnosed with hypertension,
hyperlipidemia, and obesity. These factors have all been identified in the literature as
independent risk factors for cardiovascular disease (CYD), in addition to the diagnosis of
diabetes itself. CYD has been shown in the literature to be the most prevalent
complication of diabetes (Mooradian, 2003), and CYD accounts for approximately 65%
of mortality rates among persons with diabetes (Grundy, Benjamin, Burke, Chait, Eckel,
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et aI, 1999). Results from a meta-analysis indicate the rate ofCVD mortality for persons
with diabetes was 2.2 times greater in men and 2.8 times greater in women compared to
otherwise healthy controls (Kanaya, Grady, & Barrett-Connor, 2001).
Recent research is indicative of the severity of consequences CVD risk can have
on a population of individuals with diabetes. The UK Prospective Diabetes Study
(UKPDS) showed that intensive blood glucose control did not cause a significant
reduction in CVD risk or CVD complications (The UKPDS Prospective Diabetes Study
(UKPDS) Group, 1998). More recently, there were two large trials completed
examining the impact of intensive blood glucose control on reduction in CVD risk- the
Action in Diabetes and Vascular Disease-Preterax and Diamicron Modified Release
Controlled Evaluation (ADVANCE) and the Veterans Affairs Diabetes Trial (VADT).
Results of the ADVANCE trial indicate there are no observed differences in
cardiovascular mortality based on intensive blood glucose control (The ADVANCE
Collaborative Group, 2008). The V ADT yielded similar results; individuals with poorly
controlled blood glucose that began an intensive blood glucose regimen did not display
reductions in CVD risk (Duckworth, Abraria, Mortiz, Reda, Emanuele, et aI, 2009).
The majority of participants in this study maintained CVD risk factors similar to
the studies mentioned above (i.e. hypertension, hyperlipidemia, and obesity). This
information was collected via chart review. Of note, when participants were asked for
their perceptions of their health status (an item on the SF-12), only 18.4% rated their
health as Excellent or Very Good. It is believed CVD risk is an important factor to be
considered to explain these subjective health ratings. Individual explanations are beyond
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the scope of this study, however results suggest CVD risk may be contributing to
participant's self-reported health status that warrants further exploration.
Representativeness of Emotional Constructs
Depressive Symptomatology
The majority of this sample did not reach the empirically derived cutoff score of
10 on the CES-D 10 recommended by Andresen et al (Andresen, Malmgren, Carter, &
Patrick, 1994). This may suggests a positive clinical presentation of depressive
symptomatology (93.0%), since 23.1 % of the sample is currently prescribed antidepressant medication. The CESD-lO is not intended to diagnose depression, rather it's
function is to assess for the presence of depressive symptomatology. As discussed by
Fisher et al (2007), persons with diabetes often do not meet criteria for a Major
Depressive Disorder yet endorse symptoms of depression. Brown, Milburn, & Gary
(1992) assessed depressive symptomatology using the CESD-20 with older African
Americans and found that only 11 % of their sample met the cutoff score, consistent with
current findings. Large scale studies of depression in diabetes samples indicate that such
levels of endorsement are not uncommon; persons with diabetes have been shown to be
twice as likely to endorse symptoms of depression relative to those without diabetes
(Lustman & Clouse, 2002).
Diabetes-Specific Distress
The mean PAID score in the current study was 39.7, which is notably higher than
the mean PAID scores observed among depressed individuals in the Kokoszka et al
(2009) study. Findings of the present study suggest that despite overlap between
constructs, the PAID appears to be addressing a separate construct than the CESD-I0 in
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this study. This finding is consistent with recent literature, which also has indicated that
depressive symptomatology and diabetes-specific distress are distinct constructs
(Gonzalez, Delahanty, Safren, Meigs, & Grant, 2008).
Fatigue

Correlations observed in this study between the CESD-I0 and the MFSI-SF were
comparable to associations observed in previous research (Stein, Martin, Hann, &
Jacobsen, 1998; Stein, Jacobsen, Blanchard, & Thors, 2004). The mean of the total
fatigue score observed in this study was comparable to fatigue levels observed in cancer
patients (Prue, Rankin, Cramp, Allen, & Gracey, 2006). The MFSI-SF was developed
for use in the cancer population; however, items are not illness-specific and this measure
is increasingly being used in non-cancer populations (Stein, Jacobsen, Blanchard, &
Thors,2004). The present study findings support the use of the MFSI-SF in diabetes
populations.
Antidepressant Use

Despite individuals endorsing low levels of depressive symptomatology on the
CESD-lO, 23.1 % of the study sample is currently prescribed anti-depressants. When
comparing emotional distress across measures representing global and disease specific
constructs, those taking antidepressant medications were found to have significantly
higher distress scores --across depressive symptomatology, diabetes-specific distress,
fatigue, and quality of life measures. This suggests despite the antidepressant therapy, a
substantial percentage of participants continue to report higher scores on the CESD-I0,
PAID, and MFSI-SF indicating higher levels of emotional distress and lower scores on
both the Physical Component Score (PCS) and Mental Component Score (MCS) of the
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SF-12, indicating poorer perceptions of mental and physical quality of life than those not
taking antidepressants. This could be indicative of the benefits of antidepressant use on
depressive symptomatology, or a false negative on the self report measures. Women were
also more likely to be prescribed antidepressants compared to men. This is consistent
with women's relatively higher rates of depressive symptomatology on the CESD-10 as
mentioned above.
Representativeness of Self-Management

Self-management was measured using the SDSCA, which is often used in the
literature to assess the frequency of engaging in self-management regimen in the past 7
days. Blood glucose testing means available in the literature range from 4.31 to 5.80
(Forjuoh, Reis, Couchman, & Ory, 2008; Rose, Harris, Ho, &Jayasinghe, 2009). With
respect to diet, the mean SDSCA scores (expressed as days adhered to diet) in the
published literature range from 3.4 to 4.9 (Lin, Katon, Rutter, Simon, Ludman, et aI,
2006; Katon, Russo, Heckbert, Lin, Ciechanowski, et al 2010). Blood glucose testing
and diet scores on the SDSCA observed in the present study are consistent with the
findings in the current research literature.
Representativeness of Quality of Life

Mean scores observed for both the Physical and Mental Component Scores of the
_SF-12 were consistent with means observed with Ware, Kosinski, and Keller (1996).
This study also provided normative information for this sample; the observed mean
scores were comparable to a sample of individuals with physical limitations and mental
difficulty. A recent study examined the quality of life scores related to health status and
reported means for obese individuals with diabetes, hypertension, and hyperlipidemia
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(Sullivan, Ghushchyan, & Ben-Joseph, 2008) that are comparable to the means observed
in the current study. The findings of the studies presented are consistent with the current
study suggesting obese individuals with type 2 diabetes report significant deficits in
physical and mental quality of life.

Gender Differences
Depressive symptomatology was significantly negatively associated with gender.
Females were more likely to have higher scores on the CESD-lO than males. This is
consistent with the literature; Egede, Zheng, and Simpson (2003) also found that in a
sample of adults with diabetes, women were more likely to maintain higher scores on
measures of depression relative to men.
Diabetes-specific distress was unrelated to gender, consistent with findings from
Welch, Weinger, Anderson, & Polonsky (2003). Blood glucose testing, age, insulin use,
oral agent use, and BMI were all unrelated to PAID scores in this study. Women have
been cited in the literature as reporting higher levels of emotional distress than men
(Edege, Zheng, and Simpson, 2003). Despite women scoring higher on depression
constructs, they did not score differently than males with respect to diabetes-specific
distress. This gender difference could provide evidence these distress constructs are
independent constructs.
With respect to quality of life, women were more likely to report lower Mental
Component Summary scores compared to men. McCollum, Hansen, Ghushchyan, and
Sullivan (2007) assessed quality of life using the SF-12 and found that women reported
poorer Mental Component Scores than males, which provides support for the current
study's findings. Women were also more likely to be prescribed antidepressants, which is

83

also consistent with reporting higher levels of depressive symptomatology and lower
Mental Component Scores.
There were significant group differences observed for men and women with
respect to diet. Women had higher SDSCA diet scores, consistent with greater adherence
to their recommended diet (approximately one half day per week more) than men. Over
half of the sample was married, women could be preparing foods for their husbands.
Additionally, women may also be feeding children and grandchildren in the home, which
also could explain this finding. This was not formally assessed, future research could
assess this issue by adding a single item inquiring who prepares the meals in the home.
This could assess this explanation more directly.
Aim 1: Examining the associations between depressive symptomatology, diabetesspecific distress, and fatigue for adults with type 2 diabetes.
Hypothesis 1
The primary aim of this study was to examine the individual levels of and
relationships between potential emotional aspects of diabetes, namely depressive
symptomatology, diabetes-specific distress, and fatigue. This hypothesis was supported
in this study, moderate associations were observed between depressive symptomatology,
diabetes-specific distress, and fatigue in this sample of adults with type 2 diabetes.
Depressive Symptomatology
Depressive symptomatology was assessed in this study using the total score of the
CESD-IO. Fisher et al (2007) discuss this measure and concluded the CESD-IO is more a
measure of global depressive symptomatology and less a diagnostic measure of
depressive disorder. Fatigue and diabetes-specific distress were significantly associated
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with depressive symptomatology as hypothesized. Fisher et al (2007) discussed concern
with potential overlap between depression and diabetes-specific distress and contended
these are distinct constructs, but may be contributing to misdiagnosis of depression
among individuals with diabetes due to the noted overlap between constructs and the
likelihood for participants to endorse items on a depression measure that likely would be
better explained by diabetes-specific distress. This may guide researchers and/or
clinicians when selecting measures depending on the intended use of the information.
Diabetes-Specific Distress
Diabetes-specific distress was positively associated with fatigue and depressive
symptomatology, as hypothesized. Diabetes-specific distress includes common emotions
such as anger, reduced motivation, burnout, guilt, and discouragement related to specific
aspects of diabetes. In a study comparing four measures of depressive symptomatology
in persons with diabetes, the PAID was found to reflect both major and minor depression
(Hermann, Kuzler, Krichbaum, Kubiak, & Haak, 2006). The Hermann et al (2006) study
also provided support for overlap between diabetes-related distress and depression. The
results of the current study replicate existing empirical support for the overlap between
the independence of depressive symptomatology and diabetes-specific distress. In a
recent study by Kokoszka, Pouwer, Jodko, Radzio, Mucko et al (2009), the PAID was
used to evaluate diabetes-specific distress in a sample of patients with type 2 diabetes.
This study concluded PAID scores are lower for individuals without depression than
those with both depressive disorders and subclinical depression also supporting overlap
between these emotional constructs.
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Insulin regimens have been identified in the literature as burdensome for
individuals (Makine, Karsidag, Kadioglu, Ilkova, Karsidag, et aI, 2009). Participants on
an insulin regimen did not differ from those not on an insulin regimen with respect to
PAID scores in this sample. The perceived burden of the insulin regimen discussed in
recent literature suggested insulin regimens are burdensome and would likely contribute
to higher diabetes-specific distress scores. Diabetes-specific distress scores were not
associated with insulin use in this study, which is inconsistent with the current literature.
Participants on an insulin regimen had higher HbAlc than those who were not
prescribed insulin. Type 2 diabetes varies with respect to treatment options ranging from
diet and exercise only, diabetic oral agent medication, an insulin regimen, or a
combination of the above. Individuals are often prescribed an insulin regimen when their
blood glucose is not optimally maintained with oral agent medication.
Although the insulin regimen was not associated with PAID scores, HbAlc was
positively associated with total PAID scores. Additionally, results of the current study
found that diabetes-specific distress (PAID) was also negatively associated with SDSCA
diet scores, suggesting higher levels of diabetes-specific distress are related to less
frequent adherence to diet recommendations. Diabetes-specific distress may be a
significant contributor to poor glycemic control and diet adherence that warrants
additional attention.
Fatigue

Fatigue is one of the most commonly reported somatic symptoms associated with
depression (Vaccarino, Sills, Evans, & Kalali, 2008) and is included in the diagnostic
criteria for Major Depressive Disorder in the Diagnostic and Statistical Manual of Mental
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Disorders, 4th Edition, Text Revision (American Psychiatric Association, 2000). Fatigue
has also been identified as an overlapping symptom construct for both depression and
diabetes. The present study was the first known to incorporate the construct of fatigue
into emotion-based constructs with individuals with type 2 diabetes. Fatigue was found
to be significantly and positively associated with both depressive symptomatology and
diabetes-specific distress in this study. Fatigue was negatively associated with physical
and mental quality of life, diet, and antidepressant use. This suggests that fatigue may
impact an indi vidual's perception of their functional status and their mental quality of
life. Fatigue is believed to interfere with an individual's ability to adhere to diet
recommendations. Fatigue was unrelated to blood glucose testing, age, gender, BMI,
duration of diabetes, exogenous insulin use, and oral agent use.
Despite the overlap of fatigue, depressive symptomatology, and diabetes-specific
distress, it appears fatigue is a useful construct to assess in adults with type 2 diabetes.
Published research has examined the overlap of fatigue and psychological distress
in a working population of adults with diabetes (Jansen, Kant, & van den Brandt, 2002).
The present study found results similar to this previous research -- fatigue converged
with depressive symptomatology, but it also appears to be an independent construct.
Results of this study highlight the utility of fatigue in a clinical population of adults with
type 2 diabetes.
Aim 2: Examine the unique associations of emotional distress with diabetes selfmanagement behavior, physical, and mental quality of life, controlling for demographic
variables and diabetes regimen demand.
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Hypothesis 2 (H2): Global depressive symptomatology (CESD-IO) will be negatively and
significantly associated with frequency of blood glucose testing on the SDSCA,
controlling for demographic variables (age, gender, and BMl), diabetes-related history
(insulin, duration of diabetes, oral medication use), and anti-depressant use.
Hypothesis 2 tested the idea that depressive symptomatology decreases adherence
to a blood glucose testing regimen in individuals with type 2 diabetes. Hypothesis 2
explored depressive symptomatology as an independent variable used to predict scores on
the blood glucose testing sub scale of the SDSCA. The results showed that scores on the
CESD-lO did not significantly predict scores on the blood glucose testing subscale of the
SDSCA. These results suggest that global depressive symptomatology was not a
significant contributor to the frequency of blood glucose testing in this sample. This
could be explained by participants' low scores on the depressive symptomatology
measure. It was hypothesized the variance accounted for by the independent variable
(depressive symptomatology) would be beyond that of demographics and medical
history. This hypothesis was not supported.
The negative impact depressive symptomatology has on one's ability to test their
blood glucose has been identified in the self-monitoring of blood glucose literature but
results are mixed. Evidence from large clinical trials have demonstrated that the effects of
exercise, following dietary recommendations, and self-monitoring of blood glucose
(SMBG) are essential to achieving optimal glycemic control, and blood pressure and lipid
control (ADA, 2010). However, engaging and maintaining these recommendations
frequently present challenges for persons with diabetes (Edege & Zheng, 2002; Nelson,
Reiber, & Boyko, 2002; Harris, 2001). A recent meta-analysis indicated co-morbid
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depression is believed to further complicate adherence to blood glucose testing
recommendations (Lustman & Clouse, 2002). In contrast, Paschalides et al (2004)
concluded that depression influences physical and mental functioning - not blood glucose
testing in individuals with type 2 diabetes (Paschal ides et aI, 2004). These studies are
presented to highlight the mixed findings present in the current literature. The present
study differs from others in the published literature with respect to the relatively lower
levels of depressive symptomology observed in the sample. The present study found that
depressive symptomatology was not associated with blood glucose testing. The relatively
low levels of depressive symptomatology likely influenced the ability to accurately detect
the influence of symptomology on blood glucose testing.

H3 (Hypothesis #3)
Global depressive symptomatology (CESD-10) will be negatively and significantly
a$sociated with frequency of diet adherence on the SDSCA, controlling for demographic
variables (age, gender, and BM!), diabetes-related history (insulin, duration of diabetes ,
oral medication use), and anti-depressant use.
Hypothesis 3 examined the impact of depressive symptomatology on diet
adherence. It was proposed that diet would be negatively impacted by depressive
symptomatology above and beyond the effects of demographic and diabetes-related
history. This hypothesis was not supported. There were no significant findings observed.
It is difficult to address the impact of depressive symptomatology on diet given the

minimal depressive symptomology present in this sample. The CESD-lO is a screener for
detecting the presence of depressive symptomatology, it is not intended to serve as a
diagnostic tool.
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Summary of impact of depressive symptomatology on self-management.

The impact of depressive symptomatology on self-management of diabetes has
been well documented in the research literature. Depressive symptomatology has been
linked to poor glycemic control (Lustman et aI, 2000; Lustman & Clouse, 2005), a higher
risk for diabetes complications (de Groot, Anderson, Freedland, Clouse, & Lustman,
2001), and increased mortality (Ismail, Winkley, Stahl, Chalder, & Edmonds, 2007).
Results of this study were unable to provide information related to the effects of
depressive symptomatology on blood glucose testing and diet adherence largely due to
the relatively low representation of depressive symptomology reported by this sample.
Recent literature has addressed the issue of subclinical depression and identified this as a
risk factor for later development of major depressive disorder (Cuijpers & Smit, 2004).
Fisher et al (2007) discussed most patients with diabetes are reporting high levels of
depression are not clinically depressed, rather these individuals often are experiencing
subthreshold depressive symptomatology.
H4 (Hypothesis #4)
Independent variable diabetes-specific distress (PAID) controlling for demographic
(age, gender, and BM/) and diabetes-related history (insulin, duration of diabetes , oral
medication use), and anti-depressant use will be negatively and significantly associated
with frequency of blood glucose testing on the SDSCA. It was hypothesized the variance
accounted for by the independent variable will be beyond that of demographics and
medical history.

Hypothesis 4 explored the associations between diabetes-specific distress and
blood glucose testing when controlling for demographic, diabetes-related history
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variables and antidepressant use. Results of these findings failed to reject the null
hypothesis, demographic variables were the only significant findings observed in this
regression analysis. Age was the only variable to retain significance upon further review
of the regression model. This suggests that as individuals get older, they are checking
their blood glucose more often. This could be explained as a result of the trend for
individuals with type 2 diabetes beginning an insulin regimen often as the result of onset
of complications or long-standing suboptimal blood glucose control.
Previous literature has established the PAID as a reliable and valid instrument for
assessing disease-specific diabetes related distress (Welch, Weigner, Anderson, &
Polonsky, 2003). One recent study examined depressive symptomatology and diabetes
specific distress with respect to self-management outcomes using the SDSCA. Results
were consistent with the observed findings in the current study; the PAID scores were not
significantly associated with blood glucose testing (Gonzalez, Delahanty, Safren, Meigs,
& Grant, 2008). The null findings for Hypothesis 4 support existing literature, diabetes-

specific distress was not found to be statistically significant, consistent with the findings
of Gonzalez and colleagues (2008).

H5 (Hypothesis #5)
Independent variable diabetes specific distress (PAID) controlling for demographic (age,
gender, and BMI) and diabetes-related history (insulin, duration o/diabetes, oral
medication use), and anti-depressant use will be negatively and significantly associated
with frequency

0/ diet adherence on the SDSCA. It was hypothesized the variance

accounted/or by the independent variable will be beyond that o/demographics and
medical history.
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Hypothesis 5 explored the associations between diabetes-specific distress and diet
when controlling for demographic/diabetes-related history variables and antidepressant
use. It was hypothesized there would be a negative association observed between
diabetes-specific distress and diet. Findings of this study provide support for this
hypothesis. Diabetes-specific distress and diet were negatively correlated, suggesting that
individuals who are currently experiencing more diabetes-specific distress are less likely
to adhere to their diet recommendations. Due to the cross-sectional data collected in this
study, causality cannot be determined. Results of this data would also suggest those with
lower diabetes specific distress had higher frequency of diet adherence. Demographic
variables, diabetes regimen demand, and antidepressant use were not statistically
significant in this hypothesis consistent with previous literature. Diabetes specific-distress
was also a significant predictor of diet adherence in the Gonzalez and colleagues (2008)
study providing additional support for this hypothesis. The null hypothesis was rejected
in this study, providing the evidence diabetes-specific distress has a negati ve impact on
diet adherence in this sample of adults with type 2 diabetes mellitus.
Summary of impact of diabetes-specific distress on self-management
Fisher et al (2007) recently reported that diabetes-specific distress is a better
indicator of self-management than depressive symptomatology. Gonzalez and colleagues
(2008) concluded depressive symptomatology is a better indicator of self-management
than diabetes specific distress. Further exploration revealed the studies presented above
may not be producing conflicting results. These researchers both suggest that the
variability in results can be explained by the measurements selected, and argue that
depression measures do not assess etiology of symptoms, rather they provide information
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related to presence or absence of symptoms. However etiology of depressive symptoms
endorsed in the clinical interview have not been explored in diabetes samples. The
authors suggested assessing content of depressive symptomatology collected via
interview may have informed the nature of the symptoms, suggesting the overlap
between these constructs would likely explain a subset of the sample of depressed
individuals (Gonzalez, Delahanty, Saffron, Meigs, & Grant, 2008).
In the present study, diabetes specific distress was found to predict diet scores on
the SDSCA but not SDSCA blood glucose testing scores. These results replicated
findings observed by Gonzales and colleagues (2008). Our results suggest diabetes
specific distress is a better predictor of self-management than depressive
symptomatology, but these findings should be interpreted with caution due to the low
scores observed on the CESD-I0 in this study. Observed scores on the PAID were
consistent with a population of depressed individuals with type 2 diabetes in the
Kokoszka et al (2009) study. These authors concluded diabetes-specific emotional
problems are equally likely with clinical depression and subclinical depression. This
finding is consistent with the results of this study, diabetes-specific distress was a
significant contributor to diet. Our study provided additional support for the existing
literature, the PAID is a valid measure of diabetes-specific distress, and this diseasespecific distress is capable of predicting self-management behaviors in a population of
individuals with type 2 diabetes. Additional research is needed to further explore the
validity of the PAID with respect to individual domains of self-management (i.e. diet,
medications, blood glucose testing) since these behaviors are believed to be mutually
exclusive (Johnson, 1992).
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Literature indicates these ongoing, multiple behavioral demands are the key
factors that distinguish the demands of living with diabetes from those of other chronic
illnesses, which may require maintaining only a select few of these behaviors (ADA,
2006). It is well-established that the seven self management behavioral components of
diabetes self-management do not correlate highly with one another, suggesting
individuals can be adherent to one behavior while ignoring another (Glasgow & Eakin,
1998; Rubin & Peyrot, 1992; Orme & Binik, 1989). Due to the relative independence of
the behaviors research suggests each component needs to be assessed separately when
evaluating diabetes self-management outcomes (Johnson, 1992).

H6 (Hypothesis #6)
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and
BMf) and diabetes-related history (insulin, duration of diabetes, oral medication use),
and anti-depressant use will be negatively and significantly associated with frequency of
blood glucose testing on the SDSCA. It was hypothesized the variance accountedfor by
the independent variable will be beyond that of demographics and medical history.
Hypothesis 6 sought to assess the impact of fatigue on blood glucose testing
recommendations. This study was the first known study to incorporate the construct of
fatigue into the literature differentiating emotion-based constructs with individuals with
diabetes. This study proposed there would be a negative association between fatigue
levels and blood glucose testing behavior. This hypothesis was not supported. However,
age and BMI retained significance in this regression suggesting those that are overweight
and/or obese and those that are older check their blood glucose more frequently than
those that are not. Observed correlations indicate older individuals in this sample are
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heavier, have had diabetes longer, and check their blood sugar more often. It is believed
these associations significantly contributed to the inability to reject the null hypothesis.
There were no observed associations between fatigue and blood glucose observed in this
study therefore no conclusions can be made.
There was a significant difference observed in the frequency of blood glucose
testing based on medication use. Individuals on insulin were more likely to test their
blood glucose more frequently than those individuals on oral agents. This is likely
explained by the health provider's recommendations for blood glucose testing. Blood
glucose testing recommendations differ for individuals on oral agents and those on
insulin. In the overall sample, individuals were testing their blood sugar on average 4.87
days per week. Further exploration revealed there were significant differences noted
based on types of medication prescribed. Those on insulin checked their blood sugar 5.42
times per week vs. those on oral agents checked their blood glucose 4.57 times per week.
Interestingly, those on Byetta tested their blood glucose more often; 5.95 times per week.
ADA recommends those individuals on insulin should check their blood glucose up to 3
times daily. This study did not inquire about frequency of daily blood glucose testing,
rather how many times in the previous week had participants adhered to their physician
recommendations for blood glucose testing. It is believed those on insulin should be
checking their blood glucose daily; results reveal this is not the case. Rather findings
from this study indicated individuals on insulin are not checking as often as they should
according to the ADA recommendations.
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H7 (Hypothesis #7)
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and
BM!) and diabetes-related history (insulin, duration of diabetes, oral medication use),
and anti-depressant use will be negatively and significantly associated with frequency of
diet adherence on the SDSCA. It was hypothesized the variance accounted for by the
independent variable will be beyond that of demographics and medical history.
Hypothesis 7 sought to assess the impact of fatigue on diet self-management.
This study was the first known study to incorporate the construct of fatigue into the
literature differentiating emotion-based constructs with individuals with diabetes. This
study proposed there would be a negative association between fatigue levels and
adherence to diet. This hypothesis was supported, fatigue was found to negatively impact
an individual's ability to adhere to diet recommendations. Fatigue was the only
significant predictor of diet observed in this regression. There were no significant
demographic or diabetes-specific variables observed in this regression.
There are several possible explanations for this finding. First, it is possible
fatigue can be identified as a barrier for an individual to select, prepare, and consume
foods that are consistent with a diabetes diet. This is the first known study that examined
the relationship between fatigue and diet in diabetes independent of depression. The
depression research has long suggested depression impacts an individual's selfmanagement ability; however specific symptoms of depression have often not been
assessed to further explain specific symptoms of depression (i.e. fatigue) and its potential
impact on an individual's ability to adhere to diet recommendations.
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Summary of the impact offatigue on self-management
Fatigue has been identified in the literature as an overlapping symptom of both
depression and diabetes, but the etiology of fatigue is less clear. This study sought to
explore the impact of fatigue on self-management. Results provided preliminary
evidence on the impact of fatigue on diet adherence. This relationship suggested
individuals with higher fatigue were less likely to adhere to their diet recommendations
than those with lower levels of fatigue. These findings may guide future research in this
area by exploring the overlap of depression and physical symptoms associated with
diabetes and performance of self management behaviors, due to fatigue being identified
in both depression and diabetes.

H8 (Hypothesis #8)
Independent variable global depressive symptomatology (CESD-IO) controlling for
demographic (age, gender, and BM/) and diabetes-related history (insulin, duration of
diabetes, oral medication use), and anti-depressant use will be negatively and
significantly associated with physical function scores on the SF-I2. It was hypothesized
the variance accounted for by the independent variable will be beyond that of
demographics and medical history.
Hypothesis 8 was supported; but results should be interpreted with caution.
Examination of this hypothesis was complicated by the low rates of depressive
symptomatology endorsed in this sample. Findings suggest depressive symptomatology
is predictive of the Physical Component Score of quality of life, in addition to the
demographic variables included in this model (age, gender, and BMI). Results also
revealed that age and BMI specifically predict higher scores on the Physical Component
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Score of the SF-12, suggesting individuals who are older and have higher BMI report
experiencing poor physical quality of life. An underlying assumption of this hypothesis
is that participants' self-report of their physical well-being may be impacted by
depressive symptomatology. This provides support for low levels of depressive
symptomatology can also impact an individual's physical function.
The results of this hypothesis are supported by Fisher et aI's (2007) contention
that subclinical depression also affects an individual's perception of their physical quality
of life. It has been established in the literature those with type 2 diabetes often report
multisystem complications including poorer perceptions of their functional status.
Studies have also implicated the progression of complications associated with diabetes is
often associated with a sharp decline in self-report of functional status (Mayou, Bryant, &
Turner, 1990). Although co-morbid diagnoses were not included in this study, obesity has
been linked to increased co-morbidity among individuals with diabetes. Lopez-Garcia et
al (2003) recently concluded that obesity was indicative of poorer perceptions of physical
health regardless of age and gender compared to normal weight controls. These findings
support this hypothesis -obesity was found to be associated with poor physical quality of
life.
Age was also found to be significant despite controlling for the effects of age in
the regression analyses; suggesting that older adults often report poor physical
functioning. The diabetes literature discussed the likelihood of developing complications
increases as individuals get older. Aside from diabetes-related complications, other
physical illness may impact an individual's functional status (i .e. arthritic conditions may
impair someone's ability to function). This provides a platform for inclusion of all
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physical complications when assessing physical quality of life. Qualitative information
related to why individual's feel their functional status is poor may also inform future
longitudinal research. For this sample, older obese individuals who reported higher
levels of depressive symptomatology reported poor functional status.

H9 (Hypothesis #9)
Independent variable global depressive symptomatology (CESD-IO) controlling for
demographic (age, gender, and BM/), diabetes-related history (insulin, duration of
diabetes, oral medication use), and anti-depressant use will be positively and
significantly associated with mental well-being on the SF-12. It was hypothesized the
variance accounted for by the independent variable will be beyond that of demographics
and medical history.
Hypothesis 9 was largely supported; depressive symptomatology was negatively
associated with the mental component score on the SF-12. This finding suggests
consistency in terms of reporting; individuals are more likely to experience poor mental
quality of life when they are also experiencing depression. Additionally, consistencies
were also noted with respect to gender; women reported both higher depressive
symptomatology and poorer mental quality of life relative to men. This hypothesis
originally suggested a positive association, however the scoring criteria of the SF-12
suggests higher scores indicate better quality of life, as with the CESD-IO higher scores
are indicative of higher levels of depressive symptomatology. Taking the scoring into
consideration, there was a negative association observed in this study, the higher an
individual's depressive symptomatology, the lower their mental quality of life scores.
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Consistent with findings on global depressive symptomatology, participants who
were prescribed antidepressants reported a lower Mental Component Summary score than
did those who were not prescribed antidepressants. This is an interesting finding worthy
of discussion. Antidepressant therapy has been shown to be very effective for the
treatment of depression, however recent literature suggests despite the effectiveness of
antidepressant therapy, individuals may experience residual symptoms of depression
(American Psychiatric Association, 2000). This may be contributing to this study's
findings. Additional research can specifically address the effects of antidepressants on
mental quality of life.
An individual's perceptions of their quality of life may also be contributing to
their scores on the quality of life measure in addition to the symptoms they may be
experiencing. It is possible taking antidepressants may be linked to a perception of "doing
worse" which could also be contributing to these findings.
HIO (Hypothesis #10)
Independent variable diabetes-specific distress (PAID) controlling for demographic
(age, gender, and BM/) and diabetes-related history (insulin, duration of diabetes, oral
medication use), and anti-depressant use will be negatively and significantly associated
with physical function scores on the SF-I2. It was hypothesized the variance accounted
for by the independent variable would be beyond that of demographics and medical
history.
Hypothesis 10 examined the construct of diabetes-specific distress having a
negative impact on physical quality of life. This hypothesis suggested as PAID scores
increased (higher levels of diabetes-specific distress), functional status (SF-12 Physical
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Component Score) would decrease (poorer functional status). In testing hypothesis 10
the association of diabetes-specific distress and physical quality of life was assessed
using the PAID total score and the physical component score (PCS) of the SF-12 while
controlling for demographics (age, gender, and BMI), diabetes related history (insulin,
duration of diabetes, and oral medication use), and antidepressant use.
The demographic variables, antidepressant use, and the PAID total score all
retained statistical significance in this model, rejecting the null hypothesis that no
conclusions can be made. With respect to the demographic variables, age and BMI were
both statistically significant, suggesting individuals who are older and have higher BMI
report poorer physical quality of life. This is consistent with obesity literature, which has
identified obesity as a risk factor for decreased functional status (Wee, Wu, Thumboo,
Lee, & Tai, 2010). Obesity has been identified in the literature as an independent risk
factor for a host of physical illnesses. Disease comorbidity also may contribute to the
observed findings in this study.
Antidepressant use also retained statistical significance, accounting for 16.3% of
the variance in this model. Results suggest participants who were prescribed
antidepressants are more likely to report higher levels of functional impairment that those
that are not. Interestingly, those who were currently taking antidepressants reported
higher levels of diabetes-specific distress compared to those that were not taking
antidepressants. This finding is believed to be related to the overlap between depressive
symptomatology and diabetes-specific distress, however it is unknown if the emotional
distress that initiated antidepressant therapy may have been related to the level of diseasespecific distress that the individual reported to their physician, rather than Major
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Depressive Disorder. Current findings were consistent with Fisher et al (2007) study
suggesting diabetes-specific distress is a better predictor of quality of life than major
depression.
Diabetes-specific distress has been identified in the literature as a reasonable
construct to assess in clinical practice (Hermanns, Kulzer, Krichbaum, Kubiak, & Haak,
2006). Patients with diabetes often report diabetes-related stressors, and these diseasespecific stressors have been cited in the literature as an independent risk factor for
depression and reduced quality of life (Peyrot & Rubin, 1997; Hermanns, Kulzer,
Krichbaum, Kubiak, & Haak, 2006; Snoek, Pouwer, Welch, & Polonsky, 2000).
Diabetes-specific distress scores were shown to be elevated in this sample for individuals
with poor diet adherence and higher HbAl c . Additionally, obesity has also been
identified in this sample as a significant risk factor for decreased functional status.
Additional comorbidity is also a potential contributor to Physical Component Scores,
however, this was not addressed in the present study.
The directionality of the relationship between diabetes-specific distress and
physical quality of life remains poorly understood. It is likely this relationship is
bidirectional. It is feasible an individual will experience higher levels of diabetesspecific distress due to "feeling bad". On the other hand, an individual's physical health
may cause disease-specific worry (i.e. diabetes-specific distress). Additional longitudinal
research is needed to further explore the directionality of this relationship.
HI I (Hypothesis # II)
Independent variable diabetes-specific distress controlling for demo graphic (age, gender,
and BM!) and diabetes-related history (insulin, duration of diabetes, oral medication
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use), and anti-depressant use will be positively and significantly associated with mental
quality of life on the SF-12. It was hypothesized the variance accounted for by the
independent variable will be beyond that of demographics and medical history.
Hypothesis 11 examined the construct of diabetes-specific distress having a
negative impact on mental quality of life. This hypothesis suggested as PAID scores
increased suggesting higher levels of diabetes-specific distress, mental quality of life (SF12 MCS) would decrease suggesting increased severity of the impact of psychological
distress on an individual's quality of life. In testing hypothesis 11 the association of
diabetes-specific distress and mental quality of life was assessed using the PAID total
score and the mental component score (MCS) of the SF-12 while controlling for
demographics (age, gender, and BMI), diabetes related history (insulin, duration of
diabetes, and oral medication use), and antidepressant use.
The demographic variables, antidepressant use, and the PAID total score all
retained statistical significance in this model, rejecting the null hypothesis that no
conclusions can be drawn. With respect to the demographic variables, age and BMI were
both statistically significant, suggesting individuals who are older and have higher BMI
report poorer mental quality of life. Recent literature suggests that obesity may be an
independent risk factor for psychological distress, specifically depression (Sacco et ai,
2007). The present findings are consistent with Sacco et al (2007), with BMI linked to
higher levels of both diabetes-specific distress and decreased mental quality of life.
Additionally, the association between diabetes-specific distress and mental quality
of life is a logical finding. It was expected diabetes-specific distress would have a
negative impact on mental quality of life, due to the distress associated with diabetes
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impacting an individual's psychological functioning. Directionality of this relationship
cannot be addressed due to the cross-sectional design of this study, but it appears this
relationship could be bidirectional. Health status may be driving higher scores on the
PAID, which is indicative of higher levels of diabetes-specific distress. High levels of
distress may lead to a decreased psychological quality of life, as reflected by a decrease
in scores on the Mental Component score of the SF-12 .. Alternatively, the inverse could
also be true, having poor perceptions of mental quality of life may impair one's ability to
view their illness rationally, which also would likely produce similar findings.
Additional research is needed to further explore this relationship.

H12 (Hypothesis #12)
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and
BM/) and diabetes-related history (insulin, duration of diabetes, oral medication use),
and anti-depressant use will be negatively and significantly associated with physical
function scores on the SF-12. It was hypothesized the variance accountedfor by the
independent variable will be beyond that of demographics and medical history.
Hypothesis 12 sought to assess the impact of fatigue on physical function scores
on the SF-12. This study was the first known study to incorporate the construct of
fatigue into the literature differentiating emotion-based constructs with individuals with
diabetes. This study proposed there would be a negative association between fatigue
levels and physical quality of life. Findings provided support for this hypothesis.
However, age and BMI also retained significance in this regression suggesting those that
are overweight and/or obese and those that are older subjectively report lower physical
quality of life scores. Observed correlations indicate older individuals in this sample are
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heavier, have had diabetes longer, and check their blood sugar more frequently; all which
can potentially contribute to decreased quality of life. Additionally, co-morbid health
conditions are more prevalent in older adults, but were not included as a covariate in this
analysis. It is likely disease co-morbidity is also contributing to the decrease in physical
function observed in this sample. Results revealed mean co-morbidity of 4.2 co-morbid
health conditions. The impact of disease co-morbidity on quality of life has been welldocumented in the literature (Jacobson, de Groot, Samson, 1994). A recent study
indicated obese individuals reported decreased physical quality of life compared to
normal weight individuals even when controlling for the impact of diabetes and disease
co-morbidity (Hlatky, Sheng-Chia, Escobedo, Hillegass, Melsop, et aI, 2010).
Fatigue was also found to be contributing to an individual's Physical Component
Score from the SF-12. As an individual's fatigue score increased their Physical
Component Score score decreased, suggesting that fatigue is contributing to an
individual's poor functional status. However, one cannot ignore the impact of obesity and
age. Age and obesity likely contribute to an individual's fatigue level. Recent literature
suggests fatigue and obesity are positively associated with one another and that these
factors both contribute to an individual's decreased physical quality of life.
Proinflammatory cytokines have been implicated as a contributor to the fatigue levels
observed in obese individuals (V gontzas, Bixler, & Chousos, 2006), however this
relationship is beyond the scope of this study. Results from this study suggested obesity
and fatigue both contribute to increased fatigue levels, but how they are independently
affecting quality of life is uncertain.
HI3 (Hypothesis #13)
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Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use),
and anti-depressant use will be negatively and significantly associated with mental
component summary scores on the SF-I2. It was hypothesized the variance accounted
for by the independent variable will be beyond that of demographics and medical history.
Hypothesis 13 examined the construct of fatigue having a negative impact on
mental quality of life. This hypothesis suggested as MFSI-SF scores increased suggesting
higher levels of fatigue, mental quality of life (SF-12 MCS) would decrease suggesting
fatigue has a negative impact on an individual's mental quality of life. The association of
fatigue and mental quality of life was assessed using the MFSI-SF total score and the
mental component score (MCS) of the SF-12 while controlling for demographics (age,
gender, and BMI), diabetes related history (insulin, duration of diabetes, and oral
medication use), and antidepressant use. This hypothesis was supported, suggesting
higher fatigue levels significantly contribute to an individual's perception of their mental
quality of life.
The purpose of antidepressant therapy is to effectively treat symptoms of
depression. The majority of participants in this sample reported low levels of depressive
symptomatology, yet it is likely residual symptoms of depression remain. Recent
literature suggests despite the efficacy of antidepressant treatment it is not uncommon for
patient's to experience residual symptoms, most commonly to include fatigue, sleep
disturbance, and apathy (Fava, 2006). These residual symptoms are often linked to
increased risk of poor psychosocial functioning. Results indicate fatigue has a significant
negative impact on mental quality of life scores.
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Obesity has been linked to higher levels of self-reported fatigue in the literature.
In one recent study examining the role of obesity and fatigue, fatigue was identified as a
common symptom for obese individuals (V gontzas, Bixler, Chrousos, 2006). However,
BMI was not significant in this model. This finding is inconsistent with V gontzas et al
(2006) study, but may have important implications. The findings of this study suggest
fatigue is a significant contributor to an individual's mental quality of life. This is likely
multidimensional in terms of etiology; additional research is needed to clarify this
relationship.
Summary of Fatigue and Quality of Life findings
Fatigue has been shown in this study to contribute to an individual's poor physical
and mental quality of life. The relationship requires additional research to tease out the
multiple factors that have been identified as significant contributors to causality.
Additional analyses were performed to better understand this relationship.

Additional Analyses
Multidimensional Aspects of Fatigue
The total score of the Multidimensional Fatigue Symptom Inventory-Short Form
total score was used in this study to assess fatigue as a unidimensional construct. This
was done because this is the first known study to specifically address the impact of
fatigue on a population of clinic-based adults with diabetes. The results of this study
indicated fatigue is a useful construct that warrants additional attention. Convergent
validity across measures was assessed to explore the associations between depressive
symptomatology, diabetes specific distress, and both physical and mental quality of life
with the individual subscales of the MFSI-SF (general, physical, mental, and vigor).
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Results revealed moderate to high associations among constructs, suggesting a moderate
to high degree of overlap across measures. This overlap was anticipated prior to the start
of the study.

The subscales of the MFSI-SF were included in analysis examining the Physical
and Mental Component Scores of the SF-12 to examine convergent/divergent validity.
Both the CESD-lO and the PAID were positively associated with the general, emotional,
physical, mental and total fatigue subscales, and negatively associated with the vigor
subscale. This finding suggests moderate to high levels of convergent validity across
measures.
Fatigue and Blood Glucose Testing
This analysis examined the relationship between fatigue and blood glucose testing
while controlling for demographics, diabetes-related history, anti-depressant use, and
emotion. Age and BMI retained significance in this model, which is consistent with the
original hypothesis that explored the associations between fatigue and diet. This is
consistent with the findings of this study presented thus far, the hypothesis that examined
fatigue and blood glucose testing was not significant.
Fatigue and Diet
This hypothesis explored the associations of fatigue and diet while controlling for
demographics, diabetes-related history, anti-depressant use, and emotion. Block 4
included depressive symptomatology (CESD-IO). Diabetes-specific distress retained
significance in this model. Depressive symptomatology was not significant in the
original hypothesis examining the associations with diet. PAID total scores retained
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significance in these analyses and the original analyses presented thus far, which is
consistent with the current literature (Gonzalez et aI, 2008).
Fatigue was found to be significant in the originally proposed, individual
analyses, but did not remain significant when controlling for depressive symptomatology
and diabetes-specific distress. Beta weights were examined to gain information related
to which construct is believed to have the strongest associations with diet adherence;
diabetes-specific distress accounted for a significant amount of the variance in this
model. This suggests the total score of the PAID may be a stronger predictor of diet than
is the total score of the MFSI-SF. In conclusion, diabetes-specific distress appears to be
the strongest predictor of diet adherence across the measures included to assess emotion
in this study.
Fatigue and Physical Quality of Life
This analysis explored the associations of fatigue and physical quality of life
(functional status) while controlling for demographics, diabetes-related history, antidepressant use, and emotion. The demographic variables, antidepressant use, depressive
symptomatology (CESD-IO) and diabetes-specific distress (PAID) retained significance
in this model. As previously discussed, age and BMI were significant contributors to
decreased physical quality of life in this sample. Those who are older and heavier
reported decreased functional status. Antidepressant use was significant in both of the
original analyses that examined the associations of diabetes-specific distress and fatigue
and their impact on functional status. Antidepressant use retained significance in this
model; however once fatigue was entered into the model the effect of antidepressant use
was no longer significant.
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Block 4 of this five-step regression included depressive symptomatology (CESD10) and diabetes-specific distress (PAID) to control for the impact of these constructs on
the association between fatigue and physical quality of life. Diabetes-specific distress
was a significant predictor of physical quality of life; depressive symptomatology was not
significant. Diabetes-specific distress assessed an individual's level of distress related to
their diabetes. Those who reported higher levels of diabetes specific distress also
reported poorer physical quality of life. This is likely a bidirectional association, an
individual may experience distress as a result of decreased functional status, or decreased
functional status may cause an individual to experience diabetes-specific distress.
In addition to the findings discussed above, fatigue was significant, suggesting as
one's fatigue level goes up, their physical quality of life goes down. This finding
remained significant when controlling for demographics, diabetes-related history, antidepressant use, and emotion. This analysis utilized the total score of the MFSI-SF which
is a unidimensional summary score of an individual's fatigue level. This also provides
support for the original question in this study, fatigue is a unique construct when
assessing physical quality of life in a sample of adults with type 2 diabetes. Fatigue
assumed 32% of the variance over and above depressive symptomatology and diabetesspecific distress.

Fatigue and Mental Quality of Life
This analysis explored the associations of fatigue and mental quality of life while
controlling for demographics (age, gender, and BMI), diabetes-related history (insulin,
duration of diabetes, oral medication use), anti-depressant use, and emotion (depressive
symptomatology and diabetes-specific distress). Body Mass Index retained significance
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in this model, suggesting that heavier individuals report decreased mental quality of life.
This is consistent with original hypotheses examining the associations between fatigue
and mental quality of life. Antidepressant use also retained significance, consistent with
original hypotheses. Depressive symptomatology and diabetes-specific distress also
retained significance in this analysis. These variables were entered into a block in the
regression equation to explore if fatigue provided a unique contribution to an individual's
mental quality of live over and above the variance accounted for by the emotion
constructs included. Fatigue retained significance in this model, suggesting fatigue is
contributing something different to the model.
The SF-12 mental component summary score reflects the frequency of
endorsement of emotional difficulty as a barrier to accomplishing tasks, and doing things
as carefully as usual. The mental component summary score also addressed the impact of
feeling "downhearted and blue", "calm and peaceful", in addition to asking about an
individual's energy level. These items are highly consistent with emotional items that are
addressed in both the CESD-lO and the PAID. However, the unique contribution of the
SF-12 highlights the impact of these emotional distress constructs on participant's ability
to accomplish tasks and do work or activities. Literature suggests as an individual
experiences emotional distress, this emotional distress acts as a barrier for an individual
accomplishing things as often and as effectively as they would like (Ware, Kosinski, &
Keller, 1996). When examining the specific contributions of the emotional constructs
included in this analysis, depressive symptomatology was not significant. Rather
diabetes-specific distress accounted for 41.6% of the variance accounted for with this
model. This suggests an individual's disease-related distress has a significant impact on
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their mental quality of life. Perceptions of diabetes likely impacted the mental of quality
of life in this sample. Fatigue contributed an additional 7.6% of the variance accounted
for. The differences across these emotional constructs suggest despite overlap between
constructs, depressive symptomatology, diabetes-specific distress, and fatigue appear to
be distinct but not mutually exclusive constructs.

Limitations
Limitations of the Current Study
Conclusions from this study are limited by the cross-sectional design. Another
limitation of this study is the retrospective recall of several constructs included in these
analyses (depressive symptomatology, diabetes-specific distress, fatigue, quality of life,
and blood glucose testing and diet) in addition to the nature of self-report measures.
There is a possibility of the moderate to high correlations of self-report measures of
distress being due to shared measurement variance. That is, the similar self-report
approach of the measures could introduce bias and pose limitations for validity of
associations among the proposed constructs. Studies may benefit from prospective
assessment of these distress constructs and other indices of distress (e.g. physiological) to
further assess the associations observed in this study. With respect to blood glucose
testing, improved technology now affords the opportunity for the provider to download
information from the meter directly into a data file to include time, date, and blood
glucose reading. Additionally, use of ecological momentary analysis also would be a
useful approach to collection of longitudinal data to address the issue of causality.
The present study assessed fatigue using the total score of the MFSI-SF. This
approach limits consideration of the multidimensionality of the fatigue construct.
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However, this study did explore the overlap of the total score of fatigue with both
depressive symptomatology and diabetes-specific distress. Examination of the individual
subscales of fatigue with the overlapping emotional constructs was discussed, but
additional research is needed to explore this relationship.
Finally, there were demographic limitations in this study. African-Americans and
other ethnic minorities, were under-represented compared to general Louisville, KY and
greater United States population. Assessing an individual's emotional state while waiting
for a physician appointment may also be a limitation, specifically if those people are
experiencing health related difficulty, these scores may be inflated compared to a nonclinic sample. Specifically, the effects of completing these questionnaires while waiting
for their physician may increase their distress and that attending their doctor's
appointments may have impacted their distress scores. Longitudinal assessment will also
potentially remedy this issue by assessing these constructs over a period of time to
strengthen the current findings.
Recommendations for future research
Research often struggles with the inherent limitations of self-report measurement
methodologies. Clinical settings are pressured to assess for symptoms that are
problematic for the patient and interfere with both the disease process and the
individual's quality of life. This study addressed the utility of measures that assessed
different domains of emotional distress to gain understanding into the utility of these
measures and their associations with self-management and quality of life. Replication of
this study with a longitudinal design would allow for examination of causality which
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would further enhance the current level of understanding of the associations discussed in
this study.
With respect to gender, women were more likely to be more depressed and report
lower mental quality of life when compared to men. Future research would benefit from
a better understanding these gender differences in order to design interventions to best
meet the needs of both women and men living with diabetes.
This sample in this study was primarily Caucasian. Future research is needed to
address the constructs examined in this study in minority populations. Additionally,
further exploration of CVD risk factors would address the effects of comorbid conditions
on an individual's emotional distress, fatigue, and quality of life. Obesity is another
construct that should be included in future research, as the impact of obesity on physical
quality of life and fatigue has been well documented in the literature. Specifically, the
relationship between fatigue and obesity in adults with diabetes remains poorly
understood.
Recommendations for Use of Emotion Measures in Research and Clinical Practice
The CESD-lO is a brief lO-item measure of global depressive symptomatology.
Fisher et al (2007) discussed the impact of subthreshold depression impacting outcomes
and often being misdiagnosed as depression. One could argue that diabetes-specific
distress is a contributing factor to that misdiagnosis. If the emotional distress is related to
a disease-specific etiology, the symptoms endorsed may be misattributed to depression.
This study found a significant relationship between depressive symptomatology and
quality of life - despite a relatively low level of depressive symptomology overall.
Future research approaches could include a comparative study with two groups of
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individuals; one that is clinically depressed and one that is not to examine potential
differences between groups to further understand this relationship. Additionally,
longitudinal research could provide information related to the change of the subthreshold
depressive symptomatology over time. Results of this study indicate the CESD-lO is a
useful screening tool for global depressive symptomatology.
The PAID was used to assess diabetes-specific distress, which is a more diseasespecific representation of emotional distress. PAID total scores observed in this study
were comparable to scores observed in previous research. Clinically, the PAID provides
useful information for the treating provider to address specific concerns the patient may
have with respect to their diabetes. From a research perspective, the PAID is a valid,
useful measure to assess diabetes-specific distress.
One of the major questions this study sought to address was the utility of fatiguespecific measurement in a sample of adults with type 2 diabetes. Results from this study
suggest that fatigue is an important construct to assess in diabetes. Fatigue was found to
be associated with physical and mental quality of life, obesity, and diet. With respect to
both physical and mental and quality of life outcomes, fatigue remained significant over
and above the impact of diabetes-specific distress, suggesting fatigue is an independent
construct.
This study provides useful information related to the role of fatigue in a sample of
individuals with diabetes. Additional support is needed for this finding, however these
results provide a unique opportunity to explore a potentially useful construct. Analysis of
the subscales may provide information about the ability of the MFSI-SF to accurately
distinguish physical and mental dimensions of fatigue, which sets the stage for future
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research. Of note, the vigor subscale of the MFSI was not associated with depressive
symptomatology, diabetes-specific distress, or mental quality of life. This fatigue
subscale may be a particularly useful in clinical evaluations, as it is brief and will provide
information related to physical energy level, and possibly guide differentiating this from
mental fatigue.

Self Care Recommendations
Self-management is often discussed in the diabetes research literature as a single
construct despite the multitude of behaviors required to fully adhere to self-management
recommendations. Johnson (1992) suggested these self-management behaviors are
mutually exclusive and should be assessed separately. The present findings provide
additional support for separating each self-management behavior, as diet was found to be
impacted by diabetes-specific distress and fatigue. Assessment of self-management
behaviors independently also provides useful information for a clinician to design a
treatment plan targeting these behaviors independently. Future research should focus on
specific self-management behaviors. They have been identified in the literature as
constructs that should be addressed separately. This suggests outcome research should
address this issue by utilizing specific self-management behaviors. Examining these
behaviors independently will increase the understanding of what variables are actually
impacting the adherence rates and the SDSCA is believed to be a valid instrument to
assess this frequency. The SDSCA is a reliable measure of self-management that is brief
and provides information to a clinician or researcher quickly to identify areas for
intervention.
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There were no significant differences observed between any of the emotional
constructs and blood glucose testing in this study. The blood glucose testing and diet
subscale scores observed in this study were consistent with scores observed in the
literature, providing support for the representativeness of this sample with respect to selfmanagement. The new ADA (2010) Standards of Medical Care are less clear with regard
to specific standards of blood glucose monitoring for individuals who have not been
prescribed an insulin regimen, or who take insulin less frequently. Hence, specific
prescriptions for blood glucose monitoring largely become the decision of the clinician.
The SDSCA is recommended to assess behaviors for clinicians and healthcare providers,
as this is a brief, valid measurement of self-management. With respect to diet, women in
the present study reported adhering to diet recommendations more often than did men.
Future research can further explore this relationship, focusing on both benefits and
barriers to adhering to diet recommendations. Additionally, diet was found to be
associated with both diabetes-specific distress and fatigue, additional research examining
the subscales of these measures would provide additional information related to possible
targets for intervention.
Recommendations for Quality of Life Assessment
The results of the current study highlight the poor quality of life scores observed
in this sample. The SF-12 is a reliable and valid instrument that provides a substantial
amount of information in a brief amount of time, minimizing both participant burden and
clinical time. The Physical and Mental Component Scores are heavily utilized in the
literature, which provides additional utility in terms of replication. Although there are
additional subscales available for the SF-12, the Physical and Mental Component Scores
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are most frequently used in research settings. Clinically, it provides qualitative
information that target specific difficulties for an individual, and may guide interventions
to address these concerns.
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Table 1
Proposed ICD-I0 Criterion of Cancer-Related Fatigue

A. There are eleven symptoms within this criterion, one of these MUST be (1)
significant fatigue. These are listed below:
1. Significant fatigue, diminished energy, or increased need to rest disproportionate
to any recent change in activity level.
2. Complaints of generalized weakness or limb heaviness.
3. Diminished concentration or attention.
4. Decreased motivation or interest to engage in usual activities.
5. Insomnia or hypersomnia.
6. Experience of sleep as unrefreshing or nonrestorative.
7. Perceived need to struggle to overcome inactivity.
8. Marked emotional reactivity (e.g. sadness, frustration, or irritability) to feeling
fatigued.
9. Difficulty completing daily tasks attributed to feeling fatigued.
10. Perceived problems with short- term memory.
11. Postexertional malaise lasting several hours.
B. The symptoms cause clinically significant distress or impairment in social,
occupational, or other important areas of functioning.
C. There is evidence from the history, physical examination, or laboratory findings that
the symptoms are a consequence of cancer or cancer therapy.
D. The symptoms are not primarily a consequence of comorbid psychiatric disorders
such as major depression, somatization disorder, somatoform disorder, or delirium.
*For a diagnosis of CRF to be warranted, six of the above criteria must be present for at
least a 2-week period every day or nearly every day.
Adapted from Cella, Peterman, Passik, Jacobsen, and Breitbart, 1998.
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Table 2
Summary of Fatigue Assessment Measures

Author/
Date

Instrument

Population

Definition

Reliability/
Validity

Dimensionali
ty

Hann et
aI.,
1998

Fatigue
Symptom
Inventory
(FSI)
3 items; 010 numeric
scale

N=107 women
currently
undergoing
treatment for
breast cancer.

Fatigue was not
discussed in terms of
definition; it was
assessed due to its
impact on quality of
life

Reliability:
Alpha = 0.94,
0.95,0.93 for
the three
groups

U

N=113 women
that completed
treatment for
breast cancer.

Test-retest
reliability was
0.35-0.75 was
found in the
active
treatment
group and
0.10-0.74 in
the normal
group.

N=50women
with no history
of cancer

HazdiPavlovic
et aI,
2000

Schedule of
Fatigue and
Anergia
(SOFA)
scale
10-items

N=770 patients
with CFS.
N=1593
pnmary care
and CFS
primary care

Fatigue was
discussed in terms of
severity.

5-point
Likert scale
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Construct
Validity:
Active Tx and
post-Tx both
had higher
fatigue scores
than the
healthy group
in terms of
intensity,
duration, and
impact on
QOL.
The only
validity
information
regarding
discrimination
between
patients with
CFS/primary
care patients.

U

Krupp et
al,1989

Fatigue
Severity
Scale (FSS)
9-items

A large number
of patients with
MS and
systemic lupus
erythematosus
(SLE)

This measure
assesses the impact
and functional
outcomes affected by
fatigue, rather than a
direct

7-point
Likert

McNair
et aI.,
1992

Profile of
Mood States
(POMS)
37 items

Large
Not defined; Fatigue
psychiatric
is addressed in terms
populations and of intensity.
college
students

5-point
Likert scales

Piper et
aI.,1998

Revised
Piper
Fatigue
Scale
(Revised
PFS)
22 items
0-10
numerical
rating scale,
and 5 open
ended
questions

N=382 Breast
cancer
survivors

Fatigue was defined
as a subjective
feeling of tiredness
that is affected by
circadian rhythm.
Four dimensions are
assessed:
behavioral/severity,
affective meaning,
sensory, and
cognitive mood.
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Internal
consistency:
Alpha=0.88.
Discriminative
Validity: This
measure
sufficiently
discriminated
between MS
and CFS
groups
Reliability:
Wellexamined in
the literature,
Fatigue
subscale has
not been
validated
separately.
Construct
Validity: not
discussed
Reliability:
Alpha=0.97
(entire scale)
and ranged
from 0.92-0.96
for the four
subscales.
Construct
validity:
Demonstrated
due to four
factor solution.

U

U

M

Rhoten,
1982

Rhoten
Fatigue
Scale (RFS)

N=5 adults
admitted for
abdominal
surgery

Postoperative fatigue
is defined as a
general state of
negative feeling
associated with pain,
discomfort, and pain
medication

N=166 patients
with various
forms of
cancer.

CRF is a subjective
state that is captured
in four dimensions:
physical, emotional,
cognitive, and
temporal.

One item
II-point
severity
scale

Schwartz
, 1998

Schwartz
Cancer
Fatigue
Scale
(SCFS)
28-items
5-point
Likert rating

Schwartz Fatigue
et ai,
Assessment
1993
Instrument
(FAI)
29 items

Smets et
aI., 1995

7-point
Likert scale
Multidimens
ional
Fatigue
Inventory
(MFI)
20-items
7-point
Likert scale

N=235
individuals
with Lyme
disease, CFS,
SLE,MS,
dysthymia, and
controls

N=111 patients
with various
forms of cancer
N=357 patients
with CFS

Fatigue is measured
in terms of four
subscales: Fatigue
severity, situation
specificity,
consequences of
fatigue, and
responsiveness to
sleep.
Definition unclear,
fatigue is a
multidimensional
symptom with 5
dimensions: general
fatigue, physical
fatigue, reduced
activity, reduced
motivation, and
mental fatigue.
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Reliability:
not discussed
Validity:
Patients'
ratings on the
RFS are
correlated with
the
investigators
ratings.
Reliability:
Alpha=0.96 for
the total scale,
0.82-0.93 for
the subscales.
Construct
Validity:
Differences
were observed
between those
receiving
treatment and
those who had
completed
treatment.
Internal
consistency:
range from
0.70-0.91

Reliability:
Alpha=0.650.80 internal
consistency.
Construct
Validity:
Significant
differences
observed for

U

M

M

M

groups that
reported
symptoms as a
result of
circumstances
vs. activity
level
Stein et
aI., 1998

.

Vercoule
net aI,
1994.

1.
Multidimens
ional
Fatigue
Symptom
Inventory
(MFSI)

1. N=15
patients with
breast cancer;
N=lO with no
history of
cancer, and
N=8 oncology
care providers
85-items
2. N=146
women
2. MFSIcurrently
Short Form
undergoing
(MFSI-SF)
treatment for
breast cancer,
30-item
N=92 women
that were postBoth
treatment for
measures
cancer,and
use a 5-point N=54 with no
Likert rating history of
cancer.

Checklist of
Individual
Strength
(CIS).
20 items
5-point
Likert scale

N=298 CFS
patients

Fatigue was
conceptualized for
both measures in
terms of fi ve
dimensions: global
experience, somatic,
cognitive, affective,
and behavioral. It is
defined as a
subjective feeling of
tiredness and
weariness both in
association of
activity and/or
independent of
physical effort,
decreased
performance
motivation, and an
altered mood state.
MFSI-SF included a
vigor dimension
rather than a
behavioral
dimension.
Fatigue is assessed in
terms of both
severity and
behavioral
consequences using
four subscales:
subjective experience
of fatigue,
concentration,
motivation, and
physical activity.
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1. Reliablity:
Alphas were as
follows:
global= 0.92,
affective=0.88,
somatic=0.90,
cognitive=0.91
, and
behavioral=0.8
7

Multidimen
sional

2. Reliability:
Alphas were as
follows:
general= 0.96,
affective=0.93,
physical =0.85,
mental=0.90,
and vigor=0.88

Internal
Consistency:
Alpha=0.90
Test-retest
reliability has
not been
demonstrated,
however this
measure is
sensitive to
changes in
fatigue over

Multidimen
sional

time.

Yellen et
al,1997.

Functional
Assessment
of Cancer
Therapy
(FACT)
scale

N=49 patients
receiving
cancer
treatment

Fatigue was assessed
in terms of severity
and impact of the
symptom itself.

Internal
Consistency:
Alpha=0.93.
Test-retest
reliability:
0.90

Fatigue
subscale
(FACT-F)
13-items
5-point
Likert rating
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Unidimensi
onal

Table 3
Hypothesized Individual Correlations between Independent Variables
(CESD-lO)

Construct

Depressive
Symptomatology

(PAID)

(MFSI-SF)

Moderate/+

Moderate
to High/+

(CESD-lO)
Diabetes Specific
Distress (PAID)
(PAID)

Moderate/+

Fatigue (MFSI-SF)

Moderate to High/+

Note. None

Moderate/+

Moderate/+

=0 to .10; Low = .11 to .30; Moderate = .31 to .50; High .51 and larger.
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Table 4
Hypothesized Relationships between Diabetes Emotional Distress Constructs and Selfmanagement and Quality of Life

(CESD-lO)

(PAID)

(MFSI-SF)

Diet

Moderate/-

Moderate/-

Moderate/-

Blood
Glucose
Monitoring

Moderate/-

Moderate/-

Moderate/-

Physical
Component

High/-

Moderate/-

High/-

Mental
Component

High/-

Construct

Diabetes
Self-Care Behavior
(SDSCA)

Quality of Life (SF-12)

Note. None

High/+

High/-

=0 to .10; Low = .11 to .30; Moderate = .31 to .50; High .51 and larger.
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Table 5.
Measures Assessing Constructs Reflecting Diabetes Emotional Distress
Observed Construct

Measure

Depressive Symptomatology

Center for Epidemiological Studies of
Depression Scale-lO (CESD-lO)

Diabetes-Specific Distress

Problem Areas In Diabetes Scale (PAID)

Fatigue

Multidimensional Fatigue Symptom
Inventory-Short Form (MFSI-SF)

Note: Total scores of these measures used as independent variables
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Table 6.
Measures Assessing Diabetes Self-Care Behavior and Quality of Life Constructs and Subscales.
Observed Construct

Measure

Relevant Subscales

Diabetes Self-Care Behavior

Summary of Diabetes Self-Care Activities
(SDSCA)

Diet
Blood Glucose Testing

Quality of Life

Medical Outcomes Study Short Form 12 (SF-12)

Physical Component Score
Mental Component Score

...-

~

Table 7
Diabetes Characteristics by Completion Status
Observed Construct

Completion Status

n

M

SD

Number of Complications

Complete

143

4.23

1.74

Non-Complete

49

4.12

1.88

Complete

143

143.64*
(11.97)

102.54
(8.54)

Non-Complete

49

105.65
(8.80)

80.69
(6.72)

Complete

143

7.33**

1.45

Non-Complete

50

8.29

1.79

Complete

143

35.38

6.83

Non-Complete

50

36.82

8.59

Duration of Diabetes in months
(years presented in parenthesis)

.j::>.

tv

HbAl c

Body Mass Index

* p=.02; ** p=.OOO

Table 8
Demographic Characteristics of Participants
Characteri sti c

n
(Total N=148)

%

Age

M
60.68

Age Under 40

5

3.4

In 40's

16

10.8

In 50's

45

30.4

In 60's

51

34.5

In 70's

24

16.2

In 80's

7

4.7

Male

71

48.0

Female

77

52.0

Caucasian

137

93.2

African American

7

4.8

Hispanic

2

1.4

Asian

1

0.7

Never Married

11

7.4

Currently Married

107

72.3

Separated

1

0.7

Divorced

14

9.5

Gender

Ethnicity

Marital Status

143

SD
11.24

n

Characteristic

%

15

10.1

Live Alone

27

18.l

Live with spouse/partner

84

56.8

Live w/spouse and children

26

17.6

Live with children

3

2.0

Live with roommate

3

2.0

Live with parents

2

1.4

Other

3

2.0

Less than 7th Grade

1

0.7

Junior High School

4

2.7

Partial High School

13

8.8

High School Graduate

49

33.3

Partial college/specialized training

37

25.2

College or University Graduate

18

12.2

Graduate Professional Training

25

17.0

Full time

43

29.7

Part time

8

5.5

On Leave Without Pay

1

0.7

Widowed
Living Arrangement

Education

Employment

144

M

SD

n

Characteristic

%

Disabled

21

14.5

Retired

64

44.1

Homemaker

8

5.5

Less than $10,000

3

2.2

$10,000-19,999

20

14.5

$20,000-39,999

28

20.3

$40,000-59,999

39

28.3

$60,000-100,000

32

23.2

Greater than $100,000

16

11.6

Income

145

M

SD

Table 9.
Representativeness of study sample in comparison to U.S. Census demographic
information.

Characteristic

Study Sample

New Albany, IN

Louisville, KY

Gender
Male

48.3%

46.9%

48.4%

Female

51.7%

53.1%

51.6%

93.2%

90.0%

82.8%

African American

4.7%

6.9%

13.9%

Hispanic

1.4%

1.4%

1.6%

Asian

0.7%

0.4%

1.1%

Ethnicity
Caucasian

Note: Comparisons based on 2000 Census data
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Table 10
Means and Standard Deviations of Personal Illness Models Construct Measures (emotional distress, self-management, quality of life)
Observed Construct

Measure and Subscales

n

M(Range)

SD

Depressive Symptomatology

CESD-IO

142

4.87 (0-13)

2.60

Diabetes Specific-Distress

PAID

147

39.69 (19-87)

14.36

Fatigue

MFSI-SF

147

13.90 [( -19)-78]

19.46

Self-Management

SDSCA
Blood Glucose Testing

143

4.87 (0-7)

2.24

Diet

143

3.67 (0-7)

1.40

Physical

148

41.82 (12.9-63.4)

12.37

Mental

148

43.89 (11.3-64.4)

12.73

:!:l
Quality of Life

SF-12

Table 11.
Means and Standard Deviations between Insulin Use, Emotional Constructs, Diet, Blood Glucose, and Quality of Life Outcomes
Gender
Construct

-

Male

n
69

M

Depressive Symptomatology (CESD-lO)
Diabetes Specific Distress (PAID)

71

Fatigue (MFSI-SF)

Female
SD
2.50

SD
2.64

n
73

M

37.65 13.94

76

41.61 14.59

71

11.41 18.18

75

15.91 20.37

Diet

68

3.39

1.50

75

3.93

1.27

Blood Glucose Monitoring

68

4.66

2.31

75

5.06

2.18

Physical Component

71

41.68 11.82

77

41.94 12.93

Mental Component

71

46.05 11.99

77

41.91 13.16

4.39

5.33

p

.032*

.j:::.

00

Diabetes Self-Care Behavior (SDSCA)
.020*

Quality of Life (SF-12)

Note: Exact p-values are reported for significant difference

.048*

Table 12
Health Characteristics of Participants
Characteristic

%

n

Duration of DM (months)

M

143.64

SD

102.54

35.38 6.83

Body Mass Index
Body Mass Index by Group
Normal

4

2.9

Overweight

24

17.1

Obesity I

41

29.3

Obesity II

36

25.7

Obesity III

35

25.0

HbAl c

7.33

HbAl c by Group
<7.0

62

43.4

7.0-7.9

42

29.4

8.0-8.9

21

14.7

9.0-9.9

12

8.4

>10

6

4.2

Antidepressant Use

33

23.1

DM Oral Agent Use

132

92.3

Exogenous Insulin Use

47

34.8

Byetta Use

10

7.4

Medication Use

149

1.45

Orals Only

78

54.5

Insulin Only

11

7.7

Both Insulin and Oral Agents

54

37.8

Tobacco User

16

11.2

Non-Smoker

127

88.8

Excellent

1

0.7

Very Good

25

17.0

Good

68

46.3

Fair

38

25.9

Poor

15

10.2

Smoking Status

How would you rate your present health condition?

No. of Complications

4.23

Hypertension

111

78.2

Hyperlipidemia

126

88.7

Peripheral Neuropathy

60

42.3

Note: Data based on chart review

150

1.74

Table 13.
Means and Standard Deviationsfor Personal Illness model Construct measures (Emotional Constructs, Self-Management, and
Quality of Life Outcomes) by insulin use status

Exogenous Insulin Use
Construct

YES

Depressive Symptomatology (CESD-lO)

n
44

M
4.93

Diabetes Specific Distress (PAID)

46

Fatigue (MFSI-SF)

NO
SD
2.67

SD
2.57

n
85

M
4.78

42.28 15.32

88

38.63 14.09

46

13.63 19.00

87

12.28 18.72

Diet

45

3.74

1.26

86

3.70

1.50

Blood Glucose Monitoring

46

5.24

1.89

85

4.57

2.32

Physical Component

47

38.34 12.57

88

43.87 12.08

Mental Component

47

41.99 12.56

88

45.09 12.53

47

8.12

88

6.84

p

Diabetes Self-Care Behavior (SDSCA)
VI

.035*

Quality of Life (SF-12)

HbAlc

1.65

Note: Exact p-values for independent sample t-tests are reported for significant differences by insulin use status

1.13

.014*

.000*

Table 14.
Means and Standard Deviations/or Personal Illness model Construct measures (Emotional Constructs, Self-Management, and
Quality 0/ Life Outcomes) by antidepressant use status

Antidepressant Use
Construct

NO

YES
n
31

M

Depressive Symptomatology (CESD-lO)
Diabetes Specific Distress (PAID)

33

Fatigue (MFSI-SF)

SD
2.43

n
106

M

46.82 19.65

109

37.67 11.69

.015*

32

23.09 19.61

109

9.98

17.20

.000*

Diet

32

3.67

1.32

106

3.69

1.45

Blood Glucose Monitoring

33

4.76

2.19

105

4.92

2.23

Physical Component

33

37.21 13.53

110

43.29 11.66*

.013*

Mental Component

33

37.20 12.84

110

46.27 11.79*

.000*

5.97

SD
2.76

4.50

l2

.005*

VI
N

Diabetes Self-Care Behavior (SDSCA)

Quality of Life (SF-12)

Note: Exact p-values for independent sample t-tests are reported for significant differences by antidepressant use

Table 15
Associations between emotional distress measures

Construct

Depressive Symptomatology
(CESD-lO)

Depressive Symptomatology
(CESD-lO)
Diabetes Specific Distress
(PAID)
VI
W

Fatigue (MFSI-SF)
Note. p-values for Pearson Correlations are listed in parentheses.

Diabetes Specific Distress
(PAID)

.581 (.000)

Fatigue
(MFSI-SF)

.657 (.000)

.619 (.000)

Table 16.
Associations between Personal Illness Model measures (emotional distress, diabetes self-management, and quality of life)

Construct

Depressive Symptomatology
(CESD-IO)

Diabetes Specific Distress
(PAID)

Fatigue
(MFSI-SF)

Diabetes Self-Care Behavior (SDSCA)
Diet

-.181 (.032)*

-.231 (.005)*

-.173 (.040)*

Blood Glucose Monitoring

-.140 (.101)

-.015 (.863)

-.066 (.438)

Physical Component

-.290 (.000)*

-.262 (.000)*

-.392 (.000)*

Mental Component

-.612 (.000)*

-.574 (.000)*

-.685 (.000)*

Quality of Life (SF-12)
...+:>.

V\

Note: Pearson correlations p-values are listed in parentheses,

* denote significance

Table 17
Associations of primary study variables including independent variables, dependent variables and covariates.
Construct

1

2

3

5

4

6

7

8

9

10

11

12

1. OM-Specific Distress

...-

VI
VI

2. Fatigue

.617**

3. Depressive Sx.

.579**

.644**

4. Gender

-.136

-.105

-.184*

5. Age

-.066

-.083

-.133

.024

6. Body Mass Index

.146

.086

.057

-.193*

-.398**

7. HbAl c

.227**

.040

.094

.008

-.082

.241 **

8. Duration of OM

-.008

-.026

-.121

-.058

.353**

-.106

-.044

9. Antidepressant Use

-.268**

-.289**

-.242**

.174*

.144

-.071

-.099

-.037

10. Physical QOL

-.262**

-.392**

-.290**

-.020

-.138

-.112

-.126

-.162

.201 *

11. Mental QOL

-.574**

-.685**

-.612**

.146

.046

-.096

-.130

-.035

.291 **

.361 **

12. Diet

-.231 **

-.173*

-.181*

-.183

.033

-.073

-.232**

.077

mo

-.081

.169*

13. Blood Glucose Testing

-.015

-.066

-.140

-.081

.222**

.055

-.021

.161

.035

-.158

.029

Note: * p < .05; ** P < .01 Variables in italics are point bi-serial correlations

.203*

13

Table 18.
Summary of Hierarchical Linear Regression Analysis with Blood Glucose Testing
(SDSCA Blood Glucose Testing) as Criterion (N=123)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.135

.135

6.17*

2

Insulin, Duration of DM,
Oral Agents

.174

.040

1.86

3

Antidepressant Use

.175

.001

.100

4

Depressive Sx (CESD-lO)

.194

.019

2.73

* p = .001
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Table 19.
Summary of Hierarchical Linear Regression Analysis with Diet (SDSCA Diet) as
Criterion (N=124)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.037

.037

1.55

2

Insulin, Duration of DM,
Oral Agents

.061

.023

0.975

3

Antidepressant Use

.063

.003

.320

4

Depressive Sx (CESD-lO)

.105

.042

5.4
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Table 20.
Summary of Hierarchical Linear Regression Analysis with Blood Glucose Testing
(SDSCA Blood Glucose Testing) as Criterion (N=128)

llF

Step

Predictor Variable

1

BMI, Gender, Age

.131

.131

6.23*

2

Insulin, Duration of DM,
Oral Agents

.168

.037

1.81

3

Antidepressant Use

.169

.001

.164

4

DM Specific Distress (PAID) .178

.009

1.23

* p = .001
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Table 21
Summary of Hierarchical Linear Regression Analysis with Diet (SDSCA Diet) as
Criterion (N=128)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.042

.042

1.79

2

Insulin, Duration of DM,
Oral Agents

.066

.024

1.05

3

Antidepressant Use

.069

.003

.375

4

DM-Specific Distress (PAID) .143

.074

10.23*

p<.05
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Table 22
Summary of Hierarchical Linear Regression Analysis with Blood Glucose Testing
(SDSCA Blood Glucose Testing) as Criterion (N=126)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.136

.136

6.38*

2

Insulin, Duration of DM,
Oral Agents

.172

.037

1.76

3

Antidepressant Use

.173

.001

.157

4

Fatigue (MFSI-SF)

.191

.017

2.52

* p < .001
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Table 23
Summary of Hierarchical Linear Regression Analysis with Diet (SDSCA Diet) as
Criterion (N=126)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.040

.040

1.68

2

Insulin, Duration of DM,
Oral Agents

.066

.026

1.11

3

Antidepressant Use

.068

.002

.293

4

Fatigue (MFSI-SF)

.116

.048

6.37*

p=.013
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Table 24
Summary of Hierarchical Linear Regression Analysis with Physical Quality of Life (SF12 Physical Component Score) as Criterion (N=126)

Step

Predictor Variable

R2

~R2

~F

1

BMI, Gender, Age

.088

.088

3.94*

2

Insulin, Duration of DM,
Oral Agents

.129

.040

1.83

3

Antidepressant Use

.160

.031

4.42

4

Depressive Sx (CESD-I0)

.246

.086

13.28**

*p <.05; **p<.OOI
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------------------------------------------

Table 25
Summary of Hierarchical Linear Regression Analysis with Mental Quality of Life (SF12 Mental Component Score) as Criterion (N=126)

Step

Predictor Variable

R2

~R2

~F

1

BMI, Gender, Age

.051

.051

2.18

2

Insulin, Duration of DM,
Oral Agents

.058

.007

.312

3

Antidepressant Use

.111

.053

6.99*

4

Depressive Sx (CESD-lO)

.440

.329

68.58**

*p <.05; **p<.OOI
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Table 26
Summary of Hierarchical Linear Regression Analysis with Physical Quality of Life (SF12 Physical Component Score) as Criterion (N=13l)

Step

Predictor Variable

R2

L\R2

L\F

1

BMI, Gender, Age

.099

.099

4.66**

2

Insulin, Duration of DM,
Oral Agents

.135

.036

1.70

3

Antidepressant Use

.163

.028

4.08*

4

DM-Specific Distress (PAID) .192

.029

4.44*

*p <.05; **p<.005
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Table 27.
Summary of Hierarchical Linear Regression Analysis with Mental Quality of Life (SF12 Mental Component Score) as Criterion (N=131)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.062

.062

2.79*

2

Insulin, Duration of DM,
Oral Agents

.079

.017

.771

3

Antidepressant Use

.130

.051

7.24*

4

DM-Specific Distress (PAID).406

.275

56.50**

*p <.05; **p<.OOl
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Table 28.
Summary of Hierarchical Linear Regression Analysis with Physical Quality of Life (SF12 Physical Component Score) as Criterion (N=130)

Step

Predictor Variable

R2

~R2

~F

1

BMI, Gender, Age

.092

.092

4.23*

2

Insulin, Duration of DM,
Oral Agents

.126

.034

1.60

3

Antidepressant Use

.160

.035

5.04*

4

Fatigue (MFSI-SF)

.267

.107

17.68**

*p <.05; **p<.OOl
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Table 29.
Summary of Hierarchical Linear Regression Analysis with Mental Quality of Life (SF12 Mental Component Score) as Criterion (N=130)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.047

.047

2.06

2

Insulin, Duration of DM,
Oral Agents

.057

.011

.468

3

Antidepressant Use

.112

.055

7.55*

4

Fatigue (MFSI-SF)

.483

.371

86.81 **

*p <.05; **p<.OOI
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Table 30.
Overlapping items across Measures representing emotional distress constructs

Item Wording

Item Number

Emotional Distress
Construct

Measure

Depression

CESD-IO

I felt depressed.

3

MFSI-SF

I feel depressed.

21

SF-12

Have you felt downhearted and depressed?

11

PAID

Feeling depressed when you think about your diabetes?

11

CESD-1O

I had trouble keeping my mind on what I was doing.

2

MFSI-SF

I am unable to concentrate.

20

MFSI-SF

I have trouble paying attention.

15

MFSI-SF

I feel energetic.

24

SF-12

Did you have a lot of energy?

10

0\

00

Concentration

Energy

...-

0'1
1.0

Item Wording

Item Number

Emotional Distress
Construct

Measure

Calm

MFSI-SF

I feel calm.

29

SF-12

Have you felt calm and peaceful?

9

--------.~-----------------------------------

Table 31.
MFSI-SF subscales and their associations with CESD-lO, PAID, and SF-12
component scores.
CESD-I0

PAID

SF-12
physical

SF-12 mental

General

.559 (.000)

.492 (.000)

-.385 (.000)

-.489 (.000)

Physical

.539 (.000)

.451 (.000)

-.502 (.000)

-.537 (.000)

Emotional

.624 (.000)

.573 (.000)

-.091 (.272)

-.604 (.000)

Vigor

-.427 (.000)

-.333 (.000)

.300 (.000)

.573 (.000)

Mental

.410 (.000)

.553 (.000)

-.218 (.008)

-.396 (.000)

Total

.657 (.000)

.619 (.000)

-.384 (.000)

-.680 (.000)

MFSI-SF
Subscale

Note: p-values are listed in parentheses.
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Table 32
Summary of Hierarchical Linear Regression Analysis with Blood Glucose Testing
(SDSCA Blood Glucose Testing) as Criterion (N=122)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.135

.135

6.17*

2

Insulin, Duration of DM,
Oral Agents

.174

.040

1.86

3

Antidepressant Use

.175

.001

.100

4

CESD-lO, PAID

.195

.020

1.41

5

Fatigue (MFSI-SF)

.197

.002

.250

*p <.05
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Table 33.
Summary of Hierarchical Linear Regression Analysis with Diet (SDSCA Diet) as
Criterion (N=123)

~F

Step

Predictor Variable

1

BMI, Gender, Age

.037

.037

1.55

2

Insulin, Duration of DM,
Oral Agents

.061

.023

.975

3

Antidepressant Use

.063

.003

.320

4

CESD-lO, PAID

.143

.080

5.30*

5

Fatigue (MFSI-SF)

.144

.000

.062

*p <.05
Note----Step 4 significance comes from the PAID (p=.027) compared to CESD
(p=.521)
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Table 34
Summary of Hierarchical Linear Regression Analysis with Physical Quality of Life
(SF12 Physical Component Score) as Criterion (N=124)

Step

Predictor Variable

R2

~R2

~F

1

BMI, Gender, Age

.096

.096

4.30*

2

Insulin, Duration of OM,
Oral Agents

.141

.045

2.05

3

Antidepressant Use

.169

.027

3.87*

4

CESD-lO, PAID

.247

.078

5.98*

5

Fatigue (MFSI-SF)

.321

.074

12.37**

*p ~.05; **p<.OOI
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Table 35
Summary of Hierarchical Linear Regression Analysis with Mental Quality of Life
(SF12 Mental Component Score) as Criterion (N=124)

Step

Predictor Variable

R2

~R2

1

BMI, Gender, Age

.067

.067

2.90*

2

Insulin, Duration of DM,
Oral Agents

.076

.009

.392

3

Antidepressant Use

.123

.046

6.19*

4

CESD-lO, PAID

.541

.419

52.46**

5

Fatigue (MFSI-SF)

.618

.076

22.80**

*p <.05; **p<.OOl
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~F

Figure 1: Glasgow et ai's Model of key variables influencing diabetes self-management

Personal Illness Models
• Disease related beliefs
• Knowledge
• Experiences
• Emotions

Socio-Demographic
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Self-Management
•
•
•
•

- .l
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Medical History Status

Barriers to SelfManagement

Glasgow, Hampson, Strycker, & Ruggiero (1997).
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Exercise
Glucose Testing
Medication

Figure 2: Proposed Revision of Glasgow's Model of Self-Management modified to include affect

Personal Illness Models

-
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•
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•

Emotions
o depressive symptomatology
o DM specific distress
o fatigue

/
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•
•
•
•

Medical History
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Barriers to SelfManagement
Modified from Glasgow, Hampson, Strycker, & Ruggiero (1997).
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Fi gure 3.
Study Recruitment

Total Invited to
Participate
N=246

Declined
Participation

Not Eligible to
Participate
N=21

N= 18

Consented and
Given Packet
N=2f17

Non-Completer
N=56

(27% of those
consented)

Comnleted Study
N= 151
(73% of those
consented)
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Figure 4. Participant Diabetes Medication Use

Total Exogenous
Insulin
N=47 (34.8%)

Insulin Only
N=l1 (7.4%)

Total Oral Agents
N=132 (89.2%)

Insulin and Oral
Agents
N=54 (37.8%)

Oral Agents
Only
N=68 (47.5%)

Total Byetta Use
N=lO (7.4%)

Byetta and oral
agents
N=1O(7.4%)

Note. Patients cannot be on Insulin and Byetta simultaneously, nor can they be on Byetta
without Oral Agents. Additionally, 5 participants medicine regimen was not available
from the chart and is not represented in thisfigure.
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Measures Packet.
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ID#DDDDDD
GENERAL BACKGROUND INFORMATION
1.

Today's date: _ _ _ _ _ _ _ _ _ (month/day/year)

2.

How old are you? _ _ _ _ _ _ _ _ _ _ (years old)

3.

Gender

D
4.

Male

How tall are you?

feet

5.

D

Female

inches

How much do you currently weigh?

_ _ _ pounds
6.

7.

Ethnic group (check one box):
1 White (non-Hispanic)
2 Black
3 Hispanic

D 4 Asian
D 5 Other Specify Below

Marital status (check one box):
D 1 Never married
2 Currently married
3 Separated

D4
D5

D
D
D

(

D
D

8.

9.

Current living arrangement (check one box):
1 Live alone

D

Divorced
Widowed

D5

D2

Live with spouse/partner

D6

D3
D4

Live with spouse/partner and children

Live with roommate
who is not partner

Live with parents

D7

Other

Live with children (no spouse/partner)

Level of school completed (check one box):
1 Less than 7th grade

D

D5

Partial college
or specialized training
6 College or
university graduate
7 Graduate
professional training
(graduate degree)

D2

Junior High School (7th, 8th, & 9th grade)

D

D3

Partial high school (10th or 11th grade)

D

D4

High School graduate (Includes G.E.D.)
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10.

Approximate annual gross income for your household: (check one number)
(Remember all information you provide will remain completely confidential)
1 Less than $ 10,000
04 $40,000 - $59,999
2 $10,000 - $19,999
05 $60,000 - $100,000
3 $20,000 - $ 39,999
0 6 Greater than $100,000

o
o
o

11.

Which category best describes your usual occupation? If you are not currently
employed, which category best describes your LAST job? (check one number)

o1

Professional (e.g., teachers/professors, nurses, lawyers, physicians, &
engineers)

02

Manager/Administrator (e.g., sales managers)

03

Clerical (e.g., secretaries, clerks or mail carriers)

04

Sales (e.g., sales persons, agents & brokers)

o5

Service (e.g., police, cooks, waitress, or hairdressers)

06

Skilled Crafts, Repairer (e.g., carpenters)

07
08

Equipment or Vehicle Operator (e.g., truck drivers)

09

Farmer (e.g., owners, managers, operators or tenants)

Laborer (e.g., maintenance factory workers)

010 Member of the military
011

Homemaker (with no job outside the home)

012 Other (please
describe)_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
12.

Current employment situation (check all that apply):
1 Full time at job

o
o2
o3
o4
05
o6
07
o8
09

Part time at job
On leave with pay
On leave without pay
Disabled
Seeking work
Retired
Homemaker
Student
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Below is a list of statements that describe how people sometimes feel. Please read each
item carefully. Then circle the number next to each item which best describes how true
each statement has been for you in the past 7 days.
Not at all

1. I have trouble remembering things

o
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A little

Quite

Moderately

a bit

2

3

Extremely

4

Mood
Below is a list of some of the ways you may have felt or behaved. Please indicate
how often you have felt this way during the PAST WEEK by checking the
appropriate box for each question.
Occasionally or a
All of
Rarely or
the
moderate
none of
the time
amount of
time
(less than
3-4 da s
1 da )

These questions below are about your level of concern about your health, worries, and
frustration, and how you feel about your diabetes. Please choose the answer that best
describes how you FEEL about each question asked.
1. How serious is your diabetes?
___ Not at all serious
2

Slightly

3

Fairly

4

Very

5

Extremely Serious

2. How worried are you about developing complications of diabetes (like eye problems, foot
ulcers, or heart attacks)?
Not at all worried
2

Slightly

3

Fairly

4

Very

5

Extremely worried
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3. How important is following tour self-care recommendations (for example: diet, exercise, and
glucose testing) for controlling your diabetes?
Not at all important
2

Slightly

3

Fairly

4

Very

5

Extremely important

4. How frustrated do you feel when trying to take care of your diabetes (e.g., diet, exercise,
glucose testing)?
Not at all frustrated
2

Slightly

3

Fairly

4

Very

5

Extremely frustrated

5. How important is controlling your blood glucose levels for avoiding complications from
diabetes?
Not at all important
2

Slightly

3

Fairly

4

Very

5

Extremely important

6. How much has having diabetes changed your activities (that is, your family and social events,
work, and hobbies)?
None
2

Slightly

3

Moderately

4

A lot

5

Completely

7. How important do you believe healthy eating is for controlling your diabetes?
Not at all important
2

Slightly

3

Fairly

4

Very

5

Extremely important
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8. How likely do you think it is that healthy eating will prevent future complications of your
diabetes?
Not at all likely
2

Slightly

3

Fairly

4

Very

5

Extremely likely

Health and Well-Being
The following items ask for your views about how you feel and how well you are able to
do your usual activities. For each of the following questions, please mark an "X" in the
one box? that best describes your answer.
1. In general, would you say your health:
Excellent

Very Good

o

Good

o

0

Fair

Poor

o

o

2. The following questions are about activities you might do during a typical day. Does
your health now limit you in these activities? If so, how much?
Yes,

Yes,

limited

limited

limited

a little

at all

a lot

No, not

Moderate activities, such as moving
a table, pushing a vacuum cleaner,

D ......................... 0 ...................... 0
Climbing several flights of stairs .................. D ......................... 0 ...................... 0
bowling, or playing golf..............................

3. During the past 4 weeks, how much of the time have you had any of the following
problems with your work or other regular daily activities as a result of your physical
health?
All of

Most

Some

A little

None

the

of the

of the

of the

of the

time

time

time

time

time

Accomplished less than you
would like .................... 0

................ 0 .................. 0 ................. 0 ............... 0

Were limited in the kind of work
or other activities ........... 0

................ 0 ................... 0 .................... 0 .................. 0
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4. During the past 4 weeks, how much of the time have you had any of the following
problems with your work or other regular daily activities as a result of any emotional
problems (such as feeling depressed or anxious)?
All of

Most

Some

A little

None

the

of the

of the

of the

of the

time

time

time

time

time

Accomplished less than you
would like .................. O ................. O ................. 0

................. 0 ............... 0

Did work or other activities less
carefully than usual .... O ................ 0

.................. 0 ................... 0 ................... 0

5. During the past 4 weeks, how much did pain interfere with your normal work
(including both work outside the home and housework)?
Not at all

A little bit

Moderately

Quite a bit

Extremely

o

ODD

o

6. These questions are about how you feel and how things have been with you during
the past 4 weeks. For each question, please give the one answer that comes closest to
the way you have been feeling. How much of the time during past 4 weeks ...
All of

Most

Some

A little

None

the

of the

of the

of the

of the

time

time

time

time

time

Have you felt calm and
peaceful? ............ 0

................ 0 ................. 0 ................. 0 ............... 0

Did you have a lot of energy?

0 ................ 0 .................. 0 ................... 0 .................. 0
Have you felt downhearted
and depressed? ..... O ......... '"

.... 0 .................. 0 ................... 0 ................. 0

7. During the past 4 weeks, how much of the time has your physical health or
emotional problems interfered with your social activities (like visiting friends, relatives,
etc.)?
All of the time Most of the time

o

o

Some of the time

A little of the time

o

o
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None of the time

o

Nota

Rarely a
Problem

, Problem1

?

2

Always

a
Often a Problem
Problem3
4

13. Feeling overwhelmed by your diabetes
.
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Feeling alo(le with diabetelS,

d 15. Feelings of deprivation regarding food and
;:meals.
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116. Not having clear and concrete goals for
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19. Feeling that friends/family are not supportive;
iabetes mana ement efforts.

feeling' unsatisfied with your diabetes
,
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Diabetes Self-Care

The questions below ask you about your diabetes self-care during the last 7 days.
If you were sick during the past 7 days, please think back to the last 7 days that you
were not sick.
DIET

How many of the last SEVEN DAYS have you followed a healthful eating plan?

o

1

2

4

3

5

6

7

On how many of the last SEVEN DAYS did you eat five or more servings of fruits and
vegetables?

o

1

2

4

3

5

6

7

On how many of the last SEVEN DAYS did you eat high fat foods such as red meat or
full-fat dairy products?
o
1
23
4
5
6
7
On how many of the last SEVEN DAYS did you space carbohydrates evenly through the
day?

o

1

2

4

3

5

6

7

EXERCISE

On how many of the last SEVEN DAYS did you participate in at least 30 minutes of
physical
activities?
o
1
2
4
5
7
3
6
On how many of the last SEVEN DAYS did you participate in a specific exercise session
(such as swimming, walking, biking) other than what you do around the house or as part
of your work:

o

1

2

3

4

5

6

7

BLOOD SUGAR TESTING
On how many days of the last SEVEN DAYS did you test your blood sugar?

o

1

2

4

3

5

6

7

On how many of the last SEVEN DAYS did you test your blood sugar the number of
times recommended by your health care provider?

o

1

2

4

3
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5

6

7

MEDICATIONS
On how many of the last SEVEN DAYS did you take your recommended diabetes
medications?

o

1

2

3

4

5

6

7

On how many of the last SEVEN DAYS did you take your recommended insulin
injections?

o

1

2

3

4

5

6

7

On how many of the last SEVEN DAYS did you take your recommended number of
diabetes pills?

o

1

2

4

3

5

6

7

SMOKING
Have you smoked a cigarette (even one puff) during the past SEVEN DAYS?
O. No
1. Yes. If yes, how many cigarettes did you smoke on an average day?
_ _ _.....;Average Number of cigarettes

189

CURRICULUM VITAE
Chelsea L. Rothschild
BIOGRAPHICAL INFORMATION
School Address:

Department of Psychological and Brain Sciences
University of Louisville
Louisville, KY 40292
chelsearothschild@mac.com

Home Address &
Contact Information:

2752 Gaston Ave. Apt. 814
Dallas, TX 75226
(502) 494-0623 (mobile)

Citizenship:

U.S.A.

EDUCATION
2009-2010

AP A Accredited Internship - Department of Veterans
Affairs, V A North Texas Healthcare System, Dallas, TX

2004-present Ph.D. Student in Clinical Psychology, University of Louisville
Dissertation Title: Emotional Distress as a key construct in The
Personal Model of Diabetes Management: Associations of Fatigue,
Diabetes-Specific Distress, and Depressive Symptomatology with SelfManagement and Quality of Life in Type 2 Diabetes Mellitus
Chair: Barbara Stetson, Ph.D.
Expected Completion: May 2010
2004

M.A., Psychology, University of Louisville

2002

B.A., Psychology, University of Louisville

1993-1997

Audiology/Deaf Education Baccalaureate Coursework
University of Tennessee, Knoxville

RESEARCH AND CLINICAL INTERESTS
Behavioral Medicine and Clinical Psychology in Primary Care Settings, Impact of Depressive

Symptomatology, Diabetes Specific Distress, and Fatigue on Self-Management of Diabetes

190

Mellitus, Health Behavior Change as Primary Prevention for Chronic Disease, Impact of
Depression and Anxiety on Chronic Pain, and Integrative Medicine

CLINICAL EXPERIENCE
2009-present

2008-2009

Medical Track Internship, Veterans Administration North Texas Healthcare
System, Dallas
•

PRIME/Ambulatory Care Rotation: Provided brief individual therapy for
individuals based on consult from Primary Care Provider. Interventions
included ACT, Motivational Interviewing, and CBT. Conducted weekly
smoking cessation group. Supervisor: Bradley Benedict, PsyD

•

Copper Team: Responsible for assessment and treatment of individuals
with a range of psychological health problems. Responsibilities include
individual and group therapy utilizing an ACT approach. Group
populations included Military Sexual Trauma, Women's Support, PTSD
Vietnam Veterans, and a CBT -based coping skills group. Supervisor:
Gloria Emmett, Ph.D

•

Medical/Surgical Rotation: Provide psychological evaluation for
individuals pursuing organ transplantation, bariatric surgery, and Inteferon
treatment for Hepatitis C. Conduct weekly MOVE groups which targets
weight loss in a population of veterans. Supervisor: Teresa Hale, Ph.D.

•

Poly trauma: Responsible for conducting neuropsychological testing to
veterans who experience severe injuries to multiple organ systems,
including Traumatic Brain Injury (TBI) at a VISN-17 Network Site.
Responsibilities include conducting comprehensive assessment, individual
and group psychotherapy. Supervisors: Shanan Roth, Ph.D. and Andrea
Zartman, Ph.D.

•

OIFIOEF ongoing therapy: Conducted individual therapy for individuals
with Military Sexual Trauma and combat trauma from the OIF/OEF era.
Utilized Cognitive Processing Therapy to treat individuals that have been
exposed to military and/or civilian trauma. Also co-led Seeking Safety
Group which is designed to address co-occurring PTSD and Substance
Use Disorder. Supervisors: Alina Suris, Ph.D. and Reed Robinson, Ph.D.

Graduate Student Therapist, University of Louisville Pain Management
Center, Louisville, KY.
Conducted psychological assessment as a part of a multi-disciplinary pain
management team. Assessments included screening for presence of
psychopathology, spinal chord stimulator implantation, and a variety of
self-management strategies to optimize treatment regimen. Utilized a
cognitive behavioral framework for both treatment and case
conceptualization.
(Supervisor: Brian Monsma, Ph.D.)

191

2006-2009

Clinic Graduate Teaching Assistant, Noble H. Kelley Psychological Services
Center, University of Louisville.
Conducted intake interviews for potential clinic clients, developed
integrative reports, conducted chart audits, presented new conceptualization
of new patients to clinical teams, performed crisis management including
voluntary and involuntary hospitalization, provided referral information to
clients seeking additional services, provided support and training to
therapists, arranged monthly clinical colloquia for the clinical students and
faculty, community outreach, assessment scoring and interpretation,
answered incoming clinic calls, and managed client scheduling and checkin for over 30 student therapists. Taught Clinical Interviewing Skills course
to first-year Ph.D. students. (Supervisor: Bernadette Walter, Ph.D.)

2007-2008

Graduate Student Therapist, Noble H. Kelley Psychological Services
Center, University of Louisville
Conducted treatment of individuals experiencing Axis-I, Axis-II,
and medical diagnoses, using mindfulness and acceptance techniques.
Learned techniques of Acceptance and Commitment Therapy and John
Kabat -Zinno Therapy centered around bringing awareness into the present
moment as a method of decentering the client from their distressing events
in their lives.
(Supervisor: Paul Salmon, Ph.D.)

2006 - 2007

Graduate Student Therapist, Noble H. Kelley Psychological Services Center,
University of Louisville
Conducted weekly treatment of individuals and couples experiencing
interpersonal and psychological concerns, using interpersonal therapy
(lPT). Received training in theoretical orientations and techniques of IPT.
Followed protocol for therapy based on a Time Limited Interpersonal
Therapy framework. Learned to apply the OQ-45, lIP, and IMI to
therapy.(Supervisor: Stanley Murrell, Ph.D.)

2005-2008

Graduate Student Therapist, Noble H. Kelley Psychological Services Center,
University of Louisville
Assessment: Conducted psychodiagnostic assessments for Personality,
ADHD, Learning Disabilities, Developmental Disabilities, and educational
placement. Included administration, scoring, and interpretation. Provided
feedback to clients directly with recommendations when appropriate.
(Supervisors: Paul Bock, Ph.D. and Bernadette Walter, Ph.D.)

2006 - 2007

Psychological Examiner, Private Practice of Dr. Steven Simon, Louisville,
Kentucky
Conducted psychological and neuropsychological assessments for the
Kentucky Department for Disability Determinations. Used a fixed battery
of instruments, including WAIS-III, WMS-III, WRAT-3, Bender, and
Trailmaking Tests. Additionally, MMPI-2, TOMM, Color Trails, WT AR,
and cognitive screening instruments also used.

2004 - 2006

Graduate Student Therapist, Home-Based Primary Care Team/Geriatrics &
Extended Care, Veterans Affairs Hospital, Louisville, KY

192

Conducted in-home assessment and long-tenn treatment of older veterans.
Specific responsibilities included smoking cessation treatment, relaxation
training, facilitating change in health behavior, improving diabetes selfcare, and cognitive-behavioral therapy. Other responsibilities included
attendance at interdisciplinary team meetings and assistance with treatment
planning. (Supervisor: Barbara Stetson, Ph.D.)
2002 - 2003

Senior Youth Counselor, Maryhurst, Inc., Louisville, KY
Assisted clients with activities of daily living within a locked milieu setting.
Co-facilitated groups dealing with sexual and emotional trauma,
independent living, and social skills. Managed PfSD-related symptoms
due to severe trauma, as well as chronic mental illness.
(Supervisor: Christine Sedita-Parson)

2002 - 2003

Group Facilitator, Intervention to reduce Impulsive Decision Making and
Enhance Problem Solving Skills. Substance Abuse Unit, Maryhurst, Inc.,
Louisville, KY
Facilitated 12-week cognitive-behavioral intervention group within a locked
treatment facility catering to adolescent females dealing with trauma related
issues. (Supervisor: Linda Burke M.S.)

1999

Crisis counselor, Rape Crisis Center, Frisco, CO.
Assisted clients via telephone to handle crisis situations, and provided
resources and referral infonnation. (Supervisor: Melissa Williams)

PUBLISHED MANUSCRIPTS
Beacham, A.O., Stetson, B.A., Braekkan, K.C., Rothschild, C.L., & Lynnfield, K. Causal
attributions regarding personal exercise goal attainment in exerciser schematics and
aschematics. International Journal of Sports and Exercise Psychology, In press, 2011.

MANSUCRIPTS UNDER REVIEW! IN PREPARATION
Rogers, W., Stetson, B., Bonner,J., Rothschild, c., Meyer, J., Krishnasamy, S.,
Richardson, K., and Mokshagundam, S. P. (Under review). Social isolation and
neighborhood characteristics in low-income adults with type 2 diabetes: Relation
to health indicators and quality of life.
Stetson, B.A. Schlundt, D.G., Rothschild, C.L., Mokshagundam, S.P. (Under Review). The
Personal Diabetes Questionnaire (PDQ): A Comprehensive Tool for Assessment of
Diabetes Self-Management.
Studts, J.L. and Rothschild, C. Addressing the dimensionality offatigue: A factor analysis
examining fatigue subscales from several valid instruments. Manuscript in Preparation.
PUBLISHED ABSTRACTS
Burgard, M., Rothschild, C., Stetson, B.A., Beacham, A.O., Mokshagundam, S.P. (2004). The
role of optimism in perceptions of vitality, physical and social functioning in diabetic
patients. Annals of Behavioral Medicine, 27, S080.

193

"

""'-"-,--"

--------------------------------------------

Stetson, B.A., Beacham, A.O., Meyer, J.A., Ulmer, C.S., Rothschild, CoL., Bonner, J.E. (2005).
Exercise cognitions differ by number of exercise relapse occurrences. Annals of
Behavioral Medicine, 29, S160.
Stetson, B.A., Beacham, A.O., Rothschild, CoL., Meyer,J.A. Bonner, J.E., Ulmer, C.S. (2005).
Combined utility of the transtheoretical/stage of change and relapse prevention models in
understanding the process of ongoing exercise. Annals of Behavioral Medicine, 29, S159.
Bonner, J., Stetson, B.A., Meyer, J.A., Rothschild, CoL., Ulmer, C.S., and Beacham, A.O.
(2006). The role of personality and schema in predicting exercise-related guilt. Annals
of Behavioral Medicine, 31, S 156.
Meyer,J. Bonner,J., Rothschild, Co, Rogers, W., Foster, M., Richardson, K., Robertson, E.,
Reitz, P., Stetson, B. (2008). Acceptance and Experiential Avoidance: Associations with
Quality of Life and Self-Care in Adults with Type 2 Diabetes. Annals of Behavioral
Medicine, 35, S46.
Rogers, W., Meyer, J. Rothschild, Co, Bonner, J. Das, N., Richardson, K.,
Mokshagundam, S. P., Krishnasamy, S., Kong, M., Stetson, B. (2009). Social
isolation is associated with geographic socioeconomic status and quality of life in
at -risk, underserved adults with type 2 diabetes. Annals of Behavioral Medicine,
37 (Supplement), S199.
Richardson, K., Rogers, W., Bonner, J., Rothschild, C., Meyer,J., Das, N.,
Mokshagundam, S. P., Krishnasamy, S., Kong, M., Stetson, B. (2009).
Geographic socioeconomic status, health literacy, and perceived barriers to selfcare in at-risk, underserved adults with type 2 diabetes. Annals of Behavioral
Medicine, 37 (Supplement), S197.

EDITORIAL REVIEW
Meyer, R. & Weaver, C. (2005) Law and Mental Health: A Case-Based Approach. New York:
Guilford. Completed library research and organized and prepared conceptual materials
for systematic review. Summarized material and edited book chapter in text book.

UNPUBLISHED CONFERENCE PRESENT ATIONS
Stetson, B., Schlundt, D., Rothschild, C., Prgers, W. Floyd, J., Krishnasamy, S.,
Mokshagundam, S.P. (Under Review). Reliability and Validity of a Theoretically-Based
Diabetes Self-Management Assessment Tool. Submitted to the 31 st Annual Meeting of
the Society of Behavioral Medicine, Seattle, April, 2010.
Rogers, W., Meyer, J., Rothschild, C., Bonner, J., Das, N., Richardson, K., Mokshagundam,
S.P., Krisnasamy, S., Kong, M., Stetson, B. (2008) Social isolation is associated with
geographic socioeconomic status and quality of life in at-risk, underserved adults with
type 2 diabetes. Poster presented at the 30th Annual Meeting of the Society of Behavioral
Medicine, Montreal, Canada.

194

Richardson, K., Rogers, W., Bonner, J., Rothschild, c., Meyer, J., Das, N.,
Mokshagundam, S.P., Krisnasamy, S., Kong, M., Stetson, B. (200S) Geographic
socioeconomic status, health literacy and perceived barriers to self-care in at-risk,
underserved adults with type 2 diabetes. Poster presented at the 30th Annual
Meeting of the Society of Behavioral Medicine, Montreal, Canada.
Meyer, J ., Stetson, B., Bonner, J ., Rothschild, C., Ulmer, C., Beacham, A. (November, 2006)
Demoralization and affective state and associations with exercise characteristics in a
sample of community exercisers. Poster presented at the 40 th Annual meeting of the
Association for the Advancement of Cognitive and Behavioral Therapies, Chicago, IL
Stetson,B., O'Malley, K., Rothschild, C., Kostiwa, I., Rogers, J., and Bonner, J. (November,
2006) Environmental and affective associations with physical function in Veterans
receiving interdisciplinary Home Based Primary Care. Poster presented at the 40th
Annual meeting of the Association for the Advancement of Cognitive and Behavioral
Therapies, Chicago, IL
Bonner, J., Stetson, B., Beacham, A., Ulmer, C., Rothschild, C., & Meyer, J. (November, 2005)
Associations between exercise schema and exercise behavior related to psychological
well-being in community dwelling adults. Poster Presented at the 39th annual meeting of
the Association for Behavioral and Cognitive Therapies, Washington, DC.
Stetson, B., Bonner, J., Meyer, J., Ulmer, c., Rothschild, c., Kurian, R., Mokshagundam, S.P.
(November, 2005) Home-based physical activity behaviors in older men with diabetic
neuropathy following cessation of supervised resistance training. Poster presented at the
39th Annual Meeting of the Association for Behavioral and Cognitive Therapies,
Washington, D.C.
Stetson, B., Beacham, A., Meyer, J., Ulmer, c., Rothschild, C., & Bonner, J. (March,2005)
Exercise cognitions differ by number of exercise relapse occurrences. Poster presented at
the 26th annual meeting of the Society of Behavioral Medicine, Boston, MA.
Stetson, B.A., Beacham, A.O., Meyer, J.A., Bonner, J., Ulmer, C., and Rothschild, C.L.
(November,2004) Consistency of physical activity patterns and relationship to mood in
community dwelling adults. Poster presented at the 3S th annual meeting of the
Association for the Advancement of Behavioral Therapy, New Orleans, Louisiana.
Stetson, B.A., Schlundt, D., Mokshagundam, S.P., Bonner, J., and Rothschild, C. (November,
2004) How do age cohort and distress impact health promotion in persons with chronic
disease? Age differences in distress and perceived exercise barriers in mid-life and older
adults with Diabetes. Poster presented at the 3S th annual meeting of the Associationfor
the Advancement of Behavioral Therapy, New Orleans, Louisiana.
COMMUNITY ORAL /PUBLIC SERVICE PRESENTATIONS
Rothschild, C.L. (200S, March) Stress and physical health in elderly populations. Kling Center,
Louisville, Kentucky.
Rothschild, C.L. (2007, April) Seminars on stress and shift work. Various
University of Louisville Hospital, Louisville, Kentucky.

195

cli~ical

departments,

Rothschild, C.L. (2006, October) Stress management techniques. National City Bank Wellness
Group, Louisville, Kentucky.

RESEARCH EXPERIENCE
2009-present

Internship Research Project, VA North Texas Healthcare System, Dallas, TX.
Conducted literature review and data analysis as part of an intern-led research
study examining the effects of childhood and military sexual trauma on quality of
life in a population of women Veterans.

2008-2009

Doctoral Dissertation Data Collection, for Ph.D. in Clinical Psychology,
University of Louisville Department of Psychological and Brain Sciences.
Dissertation Title: Emotional Distress as a key construct in The Personal Model
of Diabetes Management: Associations of Fatigue, Diabetes-specific Distress,
and Depressive Symptomatology with Self-Management and Quality of Life in
Type Diabetes Mellitus
Chair: Barbara Stetson, Ph.D.
Committee Members: Benjamin Mast, Ph.D., Paul Salmon, Ph.D., Jamie
Studts, Ph.D., Sandra Sephton, Ph.D., Sri Prakash Mokshagundam,
M.D.

2006

Predoctoral Research Assistant, Behavioral Oncology Lab, Department of
Medicine, University of Kentucky
Conducted factor analysis comparing several validated fatigue patients in
a population of orofacial pain patients in preparation for manuscript
submission.
(Supervisor: Jamie Studts, Ph.D.)

2002-2009

Predoctoral Research Assistant, Health Behavior Research Program,
Department of Psychological and Brain Sciences, University of Louisville.
Diabetes Self Management Study: Conducted data collection at the Metro Health
Diabetes Education Classes across the Louisville community, Ambulatory Care
Clinic and Endocrinology Clinic at the University of Louisville for a theoretically
based self-report study focusing on impact of attitudes and beliefs about diabetes.
Population included low income, underserved minority which enhanced cultural
diversity experiences.
Examining the Relapse Prevention Model in Community Exercisers. Relapse
Prevention Model based study of high-risk situations pertaining to
exercise. Independently coded descriptive attribution of high-risk situations for
exercise relapse.Data collection, data management, and data entry, theoretically
based self-report study focused on validating measures pertaining to health
related behavior, mindfulness, and physical activity. Participant recruitment
from community-based sites, university undergraduate subject pool. Examined
exercise schemas addressing the maintenance phase of physical activity in
preparation for manuscript submission.
Maintenance of Exercise Following Completion of VAMC Physical Activity Study
for Individuals with Diabetes. Developed intervention manual for theoretically
based physical activity program for adults with Type 2 Diabetes Mellitus,
components included phone screening protocol and script, initial eligibility

196

checklist, monthly newsletters with content based on the Relapse Prevention
Model, weekly session contact. Followed participants in a home based exercise
study with older adult males with peripheral neuropathy and comorbid diabetes
mellitus from the Louisville VAMC. Components included data entry,
completion of 3 and 6 month follow ups in person, monthly telephone interviews.
Supervisor: Barbara A. Stetson, PhD
Joslin Center for Diabetes Study. Analyzed large existing data set examining
optimism and quality of life in a theoretically based study focusing on beliefs and
perceptions of individuals with diabetes. Conducted additional analyses
validating the Personal Diabetes Questionnaire examining all domains of selfmanagement of diabetes.
2003

Predoctoral Research Assistant, Cognitive Development Lab, Department of
Psychological and Brain Sciences, University of Louisville
Developed research protocol which examined eye movement patterns when
completing an analogical reasoning task for reading acquisition
(Supervisor: Barbara M. Bums, Ph.D.)

2001

Undergraduate Research Assistant, Department of Psychological and Brain
Sciences, University of Louisville.
Library research to evaluate the empirical literature pertaining to forensic
hypnosis. Examined theoretical underpinnings and clinical outcome data.
(Supervisor: Robert Meyer, Ph.D.)

HONORS AND AWARDS
2005

Certificate of Outstanding Service. University of Louisville Department of
Psychological and Brain Sciences

2004

Graduate Dean's Citation for Outstanding Research, University of Louisville

2004 - 2008

Grawemeyer Foundation Student Research Funding (annual award)

2002

Graduate Student Scholarship, College of Arts and Sciences, University of
Louisville.

2001 - 2002

Dean's List, College of Arts and Sciences, University of Louisville

TEACHING EXPERIENCE
2005 - 2006

Graduate Teaching Assistant, Department of Psychological and Brain
Sciences, University of Louisville
Assisted in the undergraduate instruction of Abnormal Psychology.
Supervisors: Paul Salmon, Ph.D. and Robert Meyer, Ph.D.

2004 - 2005

Graduate Teaching Assistant, Department of Psychological and Brain
Sciences, University of Louisville
Assisted in the undergraduate instruction of Introduction to Psychology.
Taught three weekly recitation sections and proctored examinations.
Supervisors: Edna Ross, Ph.D., Paul DeMarco, Ph.D., and Maureen McCall,
Ph.D.

197

2003 - 2004

Graduate Teaching Assistant, Department of Psychological and Brain
Sciences, University of Louisville (Fall, 2003).
Assisted in the undergraduate instruction of Honors Developmental
Psychology and Identity Development in Women.
Supervisor: Barbara M. Bums, PhD

MEMBERSlllP IN PROFESSIONAL ORGANIZATIONS
Society of Behavioral Medicine, 2004-present
American Psychological Association, 2004-present
Psi Chi Honors Society, 2002-present
Golden Key Honors Society, 2001-present
Association for the Advancement of Behavioral Therapy/Association for the Advancement of
Cognitive and Behavioral Therapy, 2004-present

198

